BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:2950-73. [PMID: 32311448 DOI: 10.1016/j.jacc.2020.04.031] [Cited by in Crossref: 1202] [Cited by in F6Publishing: 1150] [Article Influence: 601.0] [Reference Citation Analysis]
Number Citing Articles
1 Aksoyalp ZŞ, Nemutlu-Samur D. Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms. Eur J Pharmacol 2021;912:174548. [PMID: 34606834 DOI: 10.1016/j.ejphar.2021.174548] [Reference Citation Analysis]
2 Sakr Y, Giovini M, Leone M, Pizzilli G, Kortgen A, Bauer M, Tonetti T, Duclos G, Zieleskiewicz L, Buschbeck S, Ranieri VM, Antonucci E. The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series. J Crit Care 2021;61:39-44. [PMID: 33075608 DOI: 10.1016/j.jcrc.2020.09.021] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight? Med Hypotheses 2020;144:110231. [PMID: 33254538 DOI: 10.1016/j.mehy.2020.110231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
4 Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L, Sanchez O, Lorut C, Chassagnon G, Revel MP. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020;56. [PMID: 32398297 DOI: 10.1183/13993003.01365-2020] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 72.0] [Reference Citation Analysis]
5 Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020;350:577436. [PMID: 33212316 DOI: 10.1016/j.jneuroim.2020.577436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
6 Bikdeli B, Chatterjee S, Arora S, Monreal M, Jimenez D, Krumholz HM, Goldhaber SZ, Elkind MSV, Piazza G. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am Coll Cardiol 2021;78:408-11. [PMID: 34116145 DOI: 10.1016/j.jacc.2021.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Zheng T, Ren H, Wu Y, Wang J. Association between clinical characteristics and CT findings in patients with coronavirus disease-2019. Medicine (Baltimore) 2021;100:e27435. [PMID: 34871209 DOI: 10.1097/MD.0000000000027435] [Reference Citation Analysis]
8 Syeda S, Baptiste C, Breslin N, Gyamfi-Bannerman C, Miller R. The clinical course of COVID in pregnancy. Semin Perinatol 2020;44:151284. [PMID: 32792262 DOI: 10.1016/j.semperi.2020.151284] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Üzümcügil AO, Demirkiran ND, Öner SK, Akkurt A, Alkan Çeviker S. Limb Ischemia Associated With Covid-19 and Its Treatment With Above-Knee Amputation. Int J Low Extrem Wounds 2021;:15347346211063257. [PMID: 34958256 DOI: 10.1177/15347346211063257] [Reference Citation Analysis]
10 Qiu C, Li T, Wei G, Xu J, Yu W, Wu Z, Li D, He Y, Chen T, Zhang J, He X, Hu J, Fang J, Zhang H. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19. SAGE Open Med 2021;9:20503121211020167. [PMID: 34104439 DOI: 10.1177/20503121211020167] [Reference Citation Analysis]
11 Sathler PC. Hemostatic abnormalities in COVID-19: A guided review. An Acad Bras Cienc 2020;92:e20200834. [PMID: 32844987 DOI: 10.1590/0001-3765202020200834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Minardi J, Marsh C, Sengupta P. Risk-Stratifying COVID-19 Patients the Right Way. JACC Cardiovasc Imaging 2020;13:2300-3. [PMID: 32739372 DOI: 10.1016/j.jcmg.2020.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Alloway BC, Yaeger SK, Mazzaccaro RJ, Villalobos T, Hardy SG. Suspected case of COVID-19-associated pancreatitis in a child. Radiol Case Rep 2020;15:1309-12. [PMID: 32572339 DOI: 10.1016/j.radcr.2020.06.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
14 Chi G, Lee JJ, Jamil A, Gunnam V, Najafi H, Memar Montazerin S, Shojaei F, Marszalek J. Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E2489. [PMID: 32756383 DOI: 10.3390/jcm9082489] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 18.5] [Reference Citation Analysis]
15 Mahan K, Kabrhel C, Goldsmith AJ. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli. Am J Emerg Med 2020;38:2245.e3-5. [PMID: 32513452 DOI: 10.1016/j.ajem.2020.05.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
16 Renaud-Picard B, Gallais F, Riou M, Zouzou A, Porzio M, Kessler R. Delayed pulmonary abscess following COVID-19 pneumonia: A case report. Respir Med Res 2020;78:100776. [PMID: 32623310 DOI: 10.1016/j.resmer.2020.100776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Strauss SA, Seo C, Carrier M, Jetty P. From cellular function to global impact: the vascular perspective on COVID-19. Can J Surg 2021;64:E289-97. [PMID: 33978563 DOI: 10.1503/cjs.023820] [Reference Citation Analysis]
18 Smeda M, Chlopicki S. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc Res 2020;116:e118-21. [PMID: 32707576 DOI: 10.1093/cvr/cvaa190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
19 Fernandez CE, Franz CK, Ko JH, Walter JM, Koralnik IJ, Ahlawat S, Deshmukh S. Imaging Review of Peripheral Nerve Injuries in Patients with COVID-19. Radiology 2021;298:E117-30. [PMID: 33258748 DOI: 10.1148/radiol.2020203116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
20 Franco-Moreno A, Muñoz-Rivas N, Mestre-Gómez B, Torres-Macho J. Pulmonary embolism and COVID-19: A paradigm change. Rev Clin Esp (Barc) 2020;220:459-61. [PMID: 32507399 DOI: 10.1016/j.rce.2020.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sandkovsky U, Colley P, Sam T, Modrykamien AM, Berhe M. The dynamic treatment of SARS-CoV-2 disease. Proc (Bayl Univ Med Cent) 2020;33:572-9. [PMID: 33100531 DOI: 10.1080/08998280.2020.1780086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Poulakou G, Dimakakos E, Kollias A, Kyriakoulis KG, Rapti V, Trontzas I, Thanos C, Abdelrasoul M, Vantana T, Leontis K, Kakalou E, Argyraki K, Baraboutis I, Michelakis E, Giamarellos-Bourboulis E, Dimakou K, Tsoukalas G, Rapti A, Michelakis ED, Syrigos KN. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo 2021;35:653-61. [PMID: 33402523 DOI: 10.21873/invivo.12305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
23 Satomi K, Watanabe E, Takatsuki S, Fukamizu S, Iwasaki YK, Takeuchi D, Nogami A. Statement for electrophysiological procedures under the COVID-19 pandemic from the Japanese heart rhythm society task force. J Arrhythm 2020;36:1117-21. [PMID: 33335638 DOI: 10.1002/joa3.12419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Reference Citation Analysis]
25 Salihi S, Perçin B, Erkengel HI, Özalp B, Saçlı H, Kara I. Does COVID-19 infection increase the risk of pulmonary embolism in ambulatory patients with deep vein thrombosis. Vascular 2021;:17085381211052207. [PMID: 34866519 DOI: 10.1177/17085381211052207] [Reference Citation Analysis]
26 Zdanyte M, Rath D, Gawaz M, Geisler T. Venous Thrombosis and SARS-CoV-2. Hamostaseologie 2021. [PMID: 34879422 DOI: 10.1055/a-1661-0283] [Reference Citation Analysis]
27 Lakshmanan HHS, Pore AA, Kohs TCL, Yazar F, Thompson RM, Jurney PL, Maddala J, Olson SR, Shatzel JJ, Vanapalli SA, McCarty OJT. Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients. Cell Mol Bioeng 2020;:1-9. [PMID: 32837586 DOI: 10.1007/s12195-020-00644-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Hendricks CL, Herd C, Nel M, Tintinger G, Pepper MS. The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time. Front Med (Lausanne) 2021;8:604087. [PMID: 33681243 DOI: 10.3389/fmed.2021.604087] [Reference Citation Analysis]
29 Flam B, Wintzell V, Ludvigsson JF, Mårtensson J, Pasternak B. Direct oral anticoagulant use and risk of severe COVID-19. J Intern Med 2021;289:411-9. [PMID: 33258156 DOI: 10.1111/joim.13205] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
30 Lavoie M, Ramirez A, Kunz J. A Unique Case of COVID-19-related Acute Coronary Thrombosis Complicated by Severe Hypokalemia. Mil Med 2021:usab100. [PMID: 33724426 DOI: 10.1093/milmed/usab100] [Reference Citation Analysis]
31 Purroy F, Arqué G. Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study. PLoS One 2021;16:e0252351. [PMID: 34106984 DOI: 10.1371/journal.pone.0252351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Alsaied T, Tremoulet AH, Burns JC, Saidi A, Dionne A, Lang SM, Newburger JW, de Ferranti S, Friedman KG. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021;143:78-88. [PMID: 33166178 DOI: 10.1161/CIRCULATIONAHA.120.049836] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 18.5] [Reference Citation Analysis]
33 Bastopcu M. Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection. Ann Vasc Surg 2021;72:205-8. [PMID: 33333188 DOI: 10.1016/j.avsg.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Wang J, Hajizadeh N, Shore-Lesserson L. The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00934-4. [PMID: 34802831 DOI: 10.1053/j.jvca.2021.10.015] [Reference Citation Analysis]
35 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
36 Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M, Brunetti ND. The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic. Cardiovasc Drugs Ther 2021. [PMID: 34328581 DOI: 10.1007/s10557-021-07217-8] [Reference Citation Analysis]
37 Cardinale V, Capurso G, Ianiro G, Gasbarrini A, Arcidiacono PG, Alvaro D. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig Liver Dis 2020;52:1383-9. [PMID: 33023827 DOI: 10.1016/j.dld.2020.09.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
38 Boeddinghaus J, Nestelberger T, Kaiser C, Twerenbold R, Fahrni G, Bingisser R, Khanna N, Tschudin-Sutter S, Widmer A, Jeger R, Kaufmann B, Pfister O, Sticherling C, Müller C, Osswald S, Zellweger MJ, Kühne M. Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland. Int J Cardiol Heart Vasc 2021;32:100686. [PMID: 33335974 DOI: 10.1016/j.ijcha.2020.100686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Natalello G, De Luca G, Gigante L, Campochiaro C, De Lorenzis E, Verardi L, Paglionico A, Petricca L, Martone AM, Calvisi S, Ripa M, Cavalli G, Della-Torre E, Tresoldi M, Landi F, Bosello SL, Gremese E, Dagna L. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res 2021;133:104071. [PMID: 32949574 DOI: 10.1016/j.mvr.2020.104071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
40 Pinninti SG, Pati S, Poole C, Latting M, Seleme MC, Yarbrough A, Arora N, Britt WJ, Boppana S. Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection. Pediatrics 2021;147:e2020037812. [PMID: 33622794 DOI: 10.1542/peds.2020-037812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Vizcaychipi MP, Shovlin CL, McCarthy A, Godfrey A, Patel S, Shah PL, Hayes M, Keays RT, Beveridge I, Davies G; Gary Davies on behalf of the ChelWest COVID19 Consortium. Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic). Braz J Infect Dis 2020;24:412-21. [PMID: 32857990 DOI: 10.1016/j.bjid.2020.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Yang XH, Li RR, Sun RH, Liu J, Chen DC. Focus on coronavirus disease 2019 associated coagulopathy. Chin Med J (Engl) 2020;133:2239-41. [PMID: 32858589 DOI: 10.1097/CM9.0000000000001019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 El Homsi M, Chung M, Bernheim A, Jacobi A, King MJ, Lewis S, Taouli B. Review of chest CT manifestations of COVID-19 infection. Eur J Radiol Open 2020;7:100239. [PMID: 32550256 DOI: 10.1016/j.ejro.2020.100239] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
44 Khan HMW, Khan MR, Munir A, Moughrabieh A, Changezi HU. A Giant Right-Heart Thrombus-in-Transit in a Patient with COVID-19 Pneumonia. Am J Case Rep 2020;21:e927380. [PMID: 33201863 DOI: 10.12659/AJCR.927380] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Sriram K, Loomba R, Insel PA. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges. Proc Natl Acad Sci U S A 2020;117:29274-82. [PMID: 33203679 DOI: 10.1073/pnas.2009875117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
46 Kadono Y, Nakamura Y, Ogawa Y, Yamamoto S, Kajikawa R, Nakajima Y, Matsumoto M, Kishima H. A case of COVID-19 infection presenting with a seizure following severe brain edema. Seizure 2020;80:53-5. [PMID: 32540636 DOI: 10.1016/j.seizure.2020.06.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
47 Khider L, Gendron N, Goudot G, Chocron R, Hauw-Berlemont C, Cheng C, Rivet N, Pere H, Roffe A, Clerc S, Lebeaux D, Debuc B, Veyer D, Rance B, Gaussem P, Bertil S, Badoual C, Juvin P, Planquette B, Messas E, Sanchez O, Hulot JS, Diehl JL, Mirault T, Smadja DM. Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost 2020;18:2391-9. [PMID: 32558198 DOI: 10.1111/jth.14968] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
48 Aktürk İF, Yıldız C, Karabulut D, Oflar E, Şahin A, Ertuğrul AS, Koyuncu A, Polat V, Karahan A, Koşar F, Alp İB, Keskin K, Çağlar FNT. Is the revascularisation strategy and outcome different in patients with acute coronary syndrome in COVID-19 pandemic era: a tertiary centre experience. Acta Cardiol 2021;:1-9. [PMID: 34427169 DOI: 10.1080/00015385.2021.1967614] [Reference Citation Analysis]
49 Jimenez-Guiu X, Huici-Sánchez M, Rmera-Villegas A, Izquierdo-Miranda A, Sancho-Cerro A, Vila-Coll R. Deep vein thrombosis in noncritically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in nonintensive care unit patients. J Vasc Surg Venous Lymphat Disord 2021;9:592-6. [PMID: 32911110 DOI: 10.1016/j.jvsv.2020.08.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Scheller B, Vukadinovic D, Ewen S, Mahfoud F. Off-the-shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID-19) pandemic. Clin Res Cardiol 2020;109:1507-9. [PMID: 32623491 DOI: 10.1007/s00392-020-01696-9] [Reference Citation Analysis]
51 Rivera-Caravaca JM, Harrison SL, Buckley BJR, Fazio-Eynullayeva E, Underhill P, Marín F, Lip GYH. Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases. Cardiovasc Diabetol 2021;20:176. [PMID: 34481513 DOI: 10.1186/s12933-021-01368-6] [Reference Citation Analysis]
52 Xiao M, Zhang Y, Zhang S, Qin X, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, Du B, Qin Y, Gao P, Lu M, Hou X, Wu X, Zhu H, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S. Antiphospholipid Antibodies in Critically Ill Patients With COVID-19. Arthritis Rheumatol 2020;72:1998-2004. [PMID: 32602200 DOI: 10.1002/art.41425] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 23.5] [Reference Citation Analysis]
53 Revzin MV, Raza S, Warshawsky R, D'Agostino C, Srivastava NC, Bader AS, Malhotra A, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications. Radiographics 2020;40:1574-99. [PMID: 33001783 DOI: 10.1148/rg.2020200149] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
54 Jiménez D, García-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P, Le Mao R, Rodríguez C, Hunt BJ, Monreal M. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest 2021;159:1182-96. [PMID: 33217420 DOI: 10.1016/j.chest.2020.11.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 33.0] [Reference Citation Analysis]
55 Junapudi SS, Junapudi S, Ega K, Chidipi B. Major cardiac concerns in therapy and vaccinations for COVID-19. Metabol Open 2021;11:100102. [PMID: 34222851 DOI: 10.1016/j.metop.2021.100102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy 2020;40:1130-51. [PMID: 33006163 DOI: 10.1002/phar.2465] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
57 Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird WC, Bauer KA, Zwicker JI. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. J Thromb Haemost 2020;18:2349-57. [PMID: 32692862 DOI: 10.1111/jth.15018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
58 Shao T, In-Bok Lee C, Jabori S, Rey J, Duran ER, Kang N. Acute upper limb ischemia as the first manifestation in a patient with COVID-19. J Vasc Surg Cases Innov Tech 2020;6:674-7. [PMID: 32844136 DOI: 10.1016/j.jvscit.2020.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
59 Soliz J, Schneider-Gasser EM, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G, Furuya WI, Trevizan-Baú P, Dhingra RR, Dutschmann M. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol 2020;279:103476. [PMID: 32522574 DOI: 10.1016/j.resp.2020.103476] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
60 Flaczyk A, Rosovsky RP, Reed CT, Bankhead-Kendall BK, Bittner EA, Chang MG. Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations. Crit Care 2020;24:559. [PMID: 32938471 DOI: 10.1186/s13054-020-03273-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
61 Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res 2021:cvab315. [PMID: 34609508 DOI: 10.1093/cvr/cvab315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Serrano M, Espinosa G, Lalueza A, Bravo-Gallego LY, Diaz-Simón R, Garcinuño S, Gil-Etayo J, Moises J, Naranjo L, Prieto-González S, Ruiz-Ortiz E, Sánchez B, Moreno-Castaño AB, Díaz-Pedroche C, Viñas-Gomis O, Cervera R, Serrano A; APS-COVID 19 Study Group/European Forum on Antiphospholipid Antibodies. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019. ACR Open Rheumatol 2021;3:267-76. [PMID: 33738987 DOI: 10.1002/acr2.11245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
63 Voicu S, Bonnin P, Stépanian A, Chousterman BG, Le Gall A, Malissin I, Deye N, Siguret V, Mebazaa A, Mégarbane B. High Prevalence of Deep Vein Thrombosis in Mechanically Ventilated COVID-19 Patients. J Am Coll Cardiol 2020;76:480-2. [PMID: 32479784 DOI: 10.1016/j.jacc.2020.05.053] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
64 Ferrandis R, Llau JV, Quintana M, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients? Crit Care 2020;24:332. [PMID: 32527286 DOI: 10.1186/s13054-020-03052-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Guo Z, Sun L, Li B, Tian R, Zhang X, Zhang Z, Clifford SP, Liu Y, Huang J, Li X. Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth 2021;35:389-97. [PMID: 32994131 DOI: 10.1053/j.jvca.2020.08.067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
66 Martini R. The compelling arguments for the need of microvascular investigation in COVID-19 critical patients. Clin Hemorheol Microcirc 2020;75:27-34. [PMID: 32568186 DOI: 10.3233/CH-200895] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 7.5] [Reference Citation Analysis]
67 Gill I, Chan S, Fitzpatrick D. COVID-19-associated pulmonary and cerebral thromboembolic disease. Radiol Case Rep 2020;15:1242-9. [PMID: 32542103 DOI: 10.1016/j.radcr.2020.05.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
68 Fauvel C, Weizman O, Trimaille A, Mika D, Pommier T, Pace N, Douair A, Barbin E, Fraix A, Bouchot O, Benmansour O, Godeau G, Mecheri Y, Lebourdon R, Yvorel C, Massin M, Leblon T, Chabbi C, Cugney E, Benabou L, Aubry M, Chan C, Boufoula I, Barnaud C, Bothorel L, Duceau B, Sutter W, Waldmann V, Bonnet G, Cohen A, Pezel T; Critical Covid-19 France Investigators. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J 2020;41:3058-68. [PMID: 32656565 DOI: 10.1093/eurheartj/ehaa500] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 40.5] [Reference Citation Analysis]
69 Efendizade A, Dmytriw AA, Hewitt K, Davies GA. Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report. Front Neurol 2020;11:573356. [PMID: 33101181 DOI: 10.3389/fneur.2020.573356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
70 Vaughn VM, Yost M, Abshire C, Flanders SA, Paje D, Grant P, Kaatz S, Kim T, Barnes GD. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19. JAMA Netw Open 2021;4:e2111788. [PMID: 34115129 DOI: 10.1001/jamanetworkopen.2021.11788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
71 Drakos S, Chatzantonis G, Bietenbeck M, Evers G, Schulze AB, Mohr M, Fonfara H, Meier C, Yilmaz A. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep 2021;11:15667. [PMID: 34341436 DOI: 10.1038/s41598-021-95277-z] [Reference Citation Analysis]
72 Thachil J, Srivastava A. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? Semin Thromb Hemost. 2020;46:777-780. [PMID: 32396963 DOI: 10.1055/s-0040-1712155] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 19.0] [Reference Citation Analysis]
73 Çabuk FK, Sakiz D. Necrotizing Skin Findings in Coronavirus Disease 2019: A Case Report. Iran J Pathol 2021;16:79-83. [PMID: 33391385 DOI: 10.30699/ijp.2020.128904.2408] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Lewis AE, Gerstein NS, Venkataramani R, Ramakrishna H. Evolving Management Trends and Outcomes in Catheter Management of Acute Pulmonary Embolism. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00882-X. [PMID: 34696967 DOI: 10.1053/j.jvca.2021.09.050] [Reference Citation Analysis]
75 Costanzo L, Failla G, Antignani PL, Fareed J, Gu Y, Pitha J, Aluigi L, Karplus T, Mansilha A. The vascular side of COVID-19 disease. Position paper of the International Union of Angiology. Int Angiol 2020;39:445-51. [PMID: 32892615 DOI: 10.23736/S0392-9590.20.04539-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Melegari G, Bertellini E, Melegari A, Trenti T, Malaguti S, Barbieri A. Hemoadsorption cartridge and coronavirus disease 2019 infections: A case report and brief literature review. Artif Organs 2021;45:E130-5. [PMID: 33084021 DOI: 10.1111/aor.13846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Raj A, Kaur N, Kaur N. Cavernous sinus thrombosis with central retinal artey occlusion in COVID-19: A case report and review of literature. Indian J Ophthalmol 2021;69:1327-9. [PMID: 33913893 DOI: 10.4103/ijo.IJO_3770_20] [Reference Citation Analysis]
78 Iaccarino G, Grassi G, Borghi C, Grassi D, Mancusi C, Muiesan ML, Salvetti M, Volpe M, Ferri C. Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients. Front Cardiovasc Med 2021;8:633878. [PMID: 34055928 DOI: 10.3389/fcvm.2021.633878] [Reference Citation Analysis]
79 Schultheiss HP, Baumeier C, Aleshcheva G, Bock CT, Escher F. Viral Myocarditis-From Pathophysiology to Treatment. J Clin Med 2021;10:5240. [PMID: 34830522 DOI: 10.3390/jcm10225240] [Reference Citation Analysis]
80 Pasha AK, McBane RD, Chaudhary R, Padrnos LJ, Wysokinska E, Pruthi R, Ashrani A, Daniels P, Sridharan M, Wysokinski WE, Houghton DE. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb Res 2021;207:150-7. [PMID: 34649175 DOI: 10.1016/j.thromres.2021.09.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Tsaplin S, Schastlivtsev I, Zhuravlev S, Barinov V, Lobastov K, Caprini JA. The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00105-0. [PMID: 33744497 DOI: 10.1016/j.jvsv.2021.02.018] [Reference Citation Analysis]
82 Li JY, Wang HF, Yin P, Li D, Wang DL, Peng P, Wang WH, Wang L, Yuan XW, Xie JY, Zhou F, Xiong N, Shao F, Wang CX, Tong X, Ye H, Wan WJ, Liu BD, Li WZ, Li Q, Tang LV, Hu Y, Lip GYH; Thrombo-COVID-19 Collaborative. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. J Thromb Haemost 2021;19:1038-48. [PMID: 33534149 DOI: 10.1111/jth.15261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
83 Briceño-Mayorga GP, Gutiérrez R, Sotomayor C, Ebner M, Allende F, Assar R. Pulmonary embolism risk factors for intensive care unit anticoagulated COVID-19 patients undergoing computed tomography angiography. Rev Bras Ter Intensiva 2021:S0103-507X2021005002201. [PMID: 34586296 DOI: 10.5935/0103-507X.20210053] [Reference Citation Analysis]
84 Coneybeare D, Das D, Lema P, Chang B, Ng L. COVUS: An Algorithm to Maximize the Use of Point-of-Care Ultrasound in the Emergency Management of COVID-19. J Emerg Med 2021;61:61-6. [PMID: 33785247 DOI: 10.1016/j.jemermed.2021.02.008] [Reference Citation Analysis]
85 Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz Martin AJ. Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol 2021;46:100742. [PMID: 33243440 DOI: 10.1016/j.cpcardiol.2020.100742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
86 Zhang C, Shen L, Le KJ, Pan MM, Kong LC, Gu ZC, Xu H, Zhang Z, Ge WH, Lin HW. Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2020;7:151. [PMID: 32850990 DOI: 10.3389/fcvm.2020.00151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
87 Lee E, Krajewski A, Clarke C, O'Sullivan D, Herbst T, Lee S. Arterial and venous thromboembolic complications of COVID-19 detected by CT angiogram and venous duplex ultrasound. Emerg Radiol 2021;28:469-76. [PMID: 33428043 DOI: 10.1007/s10140-020-01884-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ojha V, Mani A, Mukherjee A, Kumar S, Jagia P. Mesenteric ischemia in patients with COVID-19: an updated systematic review of abdominal CT findings in 75 patients. Abdom Radiol (NY) 2021. [PMID: 34761305 DOI: 10.1007/s00261-021-03337-9] [Reference Citation Analysis]
89 Mohan M, Perry BI, Saravanan P, Singh SP. COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis. Front Psychiatry 2021;12:666067. [PMID: 34079487 DOI: 10.3389/fpsyt.2021.666067] [Reference Citation Analysis]
90 Chang SH, Chen D, Paone D, Geraci TC, Scheinerman J, Bizekis C, Zervos M, Cerfolio RJ. Thoracic surgery outcomes for patients with Coronavirus Disease 2019. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00168-9. [PMID: 33642100 DOI: 10.1016/j.jtcvs.2021.01.069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
91 Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition 2020;79-80:110948. [PMID: 32911430 DOI: 10.1016/j.nut.2020.110948] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
92 Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, Woldman S, Jain AK, Knight CJ, Baumbach A, Mathur A, Jones DA. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 2020;76:1168-76. [PMID: 32679155 DOI: 10.1016/j.jacc.2020.07.022] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 36.5] [Reference Citation Analysis]
93 Recalcati S, Gianotti R, Fantini F. COVID-19: The experience from Italy. Clin Dermatol 2021;39:12-22. [PMID: 33972039 DOI: 10.1016/j.clindermatol.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Lawlor M, Gupta A, Ranard LS, Madhavan MV, Li J, Eisenberger A, Parikh SA, Sethi SS, Masoumi A. Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy. Thromb Res 2021;198:79-82. [PMID: 33302210 DOI: 10.1016/j.thromres.2020.11.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Prieto-Lobato A, Ramos-Martínez R, Vallejo-Calcerrada N, Corbí-Pascual M, Córdoba-Soriano JG. A Case Series of Stent Thrombosis During the COVID-19 Pandemic. JACC Case Rep 2020;2:1291-6. [PMID: 32835270 DOI: 10.1016/j.jaccas.2020.05.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
96 A Beccara L, Pacioni C, Ponton S, Francavilla S, Cuzzoli A. Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection. Eur J Case Rep Intern Med. 2020;7:001690. [PMID: 32399456 DOI: 10.12890/2020_001690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
97 Marone EM, Rinaldi LF. Reply. J Vasc Surg Venous Lymphat Disord 2020;8:901. [PMID: 32663524 DOI: 10.1016/j.jvsv.2020.06.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
98 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
99 Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E. Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection. Arch Med Res 2021;52:143-50. [PMID: 33160751 DOI: 10.1016/j.arcmed.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
100 Incognito AV, Millar PJ, Pyle WG. Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19. Am J Physiol Lung Cell Mol Physiol 2021;320:L331-8. [PMID: 33404365 DOI: 10.1152/ajplung.00223.2020] [Reference Citation Analysis]
101 Gazzaruso C, Paolozzi E, Valenti C, Brocchetta M, Naldani D, Grignani C, Salvucci F, Marino F, Coppola A, Gallotti P. Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. Nutr Metab Cardiovasc Dis 2020;30:1914-9. [PMID: 32907762 DOI: 10.1016/j.numecd.2020.07.040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
102 Cienfuegos JA, Almeida A, Aliseda D, Rotellar F. Pathogenesis of pneumoperitoneum in a COVID-19 patients. Cir Esp 2021;99:476-7. [PMID: 33563393 DOI: 10.1016/j.ciresp.2021.01.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Hajra A, Mathai SV, Ball S, Bandyopadhyay D, Veyseh M, Chakraborty S, Lavie CJ, Aronow WS. Management of Thrombotic Complications in COVID-19: An Update. Drugs 2020;80:1553-62. [PMID: 32803670 DOI: 10.1007/s40265-020-01377-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
104 Yu B, Gutierrez VP, Carlos A, Hoge G, Pillai A, Kelly JD, Menon V. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits. Biomark Res 2021;9:29. [PMID: 33933168 DOI: 10.1186/s40364-021-00283-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Siegal DM, Gross PL. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arterioscler Thromb Vasc Biol 2020;40:1958-60. [PMID: 32762455 DOI: 10.1161/ATVBAHA.120.314977] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Berzuini A, Bianco C, Paccapelo C, Bertolini F, Gregato G, Cattaneo A, Erba E, Bandera A, Gori A, Lamorte G, Manunta M, Porretti L, Revelli N, Truglio F, Grasselli G, Zanella A, Villa S, Valenti L, Prati D. Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19. Blood 2020;136:766-8. [PMID: 32559762 DOI: 10.1182/blood.2020006695] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
107 Pickworth KK, Blais D; Cardiology Pharmacy Collaborative. COVID-19 Pandemic: Challenges and Solutions from the Cardiology Pharmacist's Perspective. J Am Coll Clin Pharm 2020. [PMID: 32838223 DOI: 10.1002/jac5.1307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J Thromb Haemost 2021;19:46-50. [PMID: 33119197 DOI: 10.1111/jth.15156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
109 Tsivgoulis G, Katsanos AH, Ornello R, Sacco S. Ischemic Stroke Epidemiology During the COVID-19 Pandemic: Navigating Uncharted Waters With Changing Tides. Stroke 2020;51:1924-6. [PMID: 32496937 DOI: 10.1161/STROKEAHA.120.030791] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 17.5] [Reference Citation Analysis]
110 Molina MF, Al Saud AA, Al Mulhim AA, Liteplo AS, Shokoohi H. Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19. Am J Emerg Med 2020;38:1549.e1-2. [PMID: 32425320 DOI: 10.1016/j.ajem.2020.05.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, Holley AB, Jimenez D, Le Gal G, Rali P, Wells P. Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest 2020;158:1143-63. [PMID: 32502594 DOI: 10.1016/j.chest.2020.05.559] [Cited by in Crossref: 223] [Cited by in F6Publishing: 194] [Article Influence: 111.5] [Reference Citation Analysis]
112 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
113 Pipe SW, Kaczmarek R, Srivastava A, Pierce GF, Makris M, Hermans C; Interim Guidance., Coagulation Products Safety, Supply and Access (CPSSA) Committee of the World Federation of Hemophilia. Management of COVID-19-associated coagulopathy in persons with haemophilia. Haemophilia 2021;27:41-8. [PMID: 33216448 DOI: 10.1111/hae.14191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
114 Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood 2020;136:1342-6. [PMID: 32766883 DOI: 10.1182/blood.2020007938] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 28.5] [Reference Citation Analysis]
115 Lewis MJ, Anderson BR, Fremed M, Argenio M, Krishnan U, Weller R, Levasseur S, Sommer R, Lytrivi ID, Bacha EA, Vincent J, Chung WK, Rosenzweig EB, Starc TJ, Rosenbaum M; CUIMC Pediatric/Adult Congenital Heart Research Collaborative ‡. Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City. J Am Heart Assoc 2020;9:e017580. [PMID: 33196343 DOI: 10.1161/JAHA.120.017580] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
116 Buikema JW, Asselbergs FW, Tekstra J. COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization: a case report. Eur Heart J Case Rep 2021;5:ytaa525. [PMID: 33569525 DOI: 10.1093/ehjcr/ytaa525] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Feng Y, Armenti ST, Mian SI. COVID-19 and the Eye: A Comprehensive Review of the Literature. Int Ophthalmol Clin 2021;61:1-14. [PMID: 33337790 DOI: 10.1097/IIO.0000000000000339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
118 Sharma E, Meade S, D'Errico F, Pavlidis P, Luber R, Zeki S, Hill K, Duff A, O'Hanlon D, Tripoli S, Stanton A, Caracostea A, Honap S, Reynolds R, Anderson S, Ray S, Mawdsley J, Sanderson J, Samaan MA, Irving PM. The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre. GastroHep 2020;2:318-26. [PMID: 33362435 DOI: 10.1002/ygh2.433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
119 Menezes MO, Takemoto MLS, Nakamura-Pereira M, Katz L, Amorim MMR, Salgado HO, Melo A, Diniz CSG, de Sousa LAR, Magalhaes CG, Knobel R, Andreucci CB; Brazilian Group of Studies for COVID-19, Pregnancy. Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID-19 in Brazil. Int J Gynaecol Obstet 2020;151:415-23. [PMID: 33011966 DOI: 10.1002/ijgo.13407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
120 Mullan C, Powierza C, Miller PE, Geirsson A, Vallabhajosyula P, Assi R. Spontaneous coronavirus disease 2019 (COVID-19)-associated luminal aortic thrombus. J Thorac Cardiovasc Surg 2020;160:e13-4. [PMID: 32534745 DOI: 10.1016/j.jtcvs.2020.05.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Stals M, Kaptein F, Kroft L, Klok FA, Huisman MV. Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients. Postgrad Med 2021;133:36-41. [PMID: 33910469 DOI: 10.1080/00325481.2021.1920723] [Reference Citation Analysis]
122 Vanella G, Capurso G, Burti C, Fanti L, Ricciardiello L, Souza Lino A, Boskoski I, Bronswijk M, Tyberg A, Krishna Kumar Nair G, Angeletti S, Mauro A, Zingone F, Oppong KW, de la Iglesia-Garcia D, Pouillon L, Papanikolaou IS, Fracasso P, Ciceri F, Rovere-Querini P, Tomba C, Viale E, Eusebi LH, Riccioni ME, van der Merwe S, Shahid H, Sarkar A, Yoo JWG, Dilaghi E, Speight RA, Azzolini F, Buttitta F, Porcari S, Petrone MC, Iglesias-Garcia J, Savarino EV, Di Sabatino A, Di Giulio E, Farrell JJ, Kahaleh M, Roelandt P, Costamagna G, Artifon ELA, Bazzoli F, Testoni PA, Greco S, Arcidiacono PG. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol 2021;8:e000578. [PMID: 33627313 DOI: 10.1136/bmjgast-2020-000578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
123 Maruhashi T, Wada T, Masuda T, Yamaoka K, Asari Y. Tracheal Tube Obstruction Due to Hemoptysis Associated With Pulmonary Infarction in a Patient With Severe COVID-19 Pneumonia. Cureus 2021;13:e13599. [PMID: 33815999 DOI: 10.7759/cureus.13599] [Reference Citation Analysis]
124 Lippi G, Favaloro EJ. D-dimer measurement in COVID-19: Silver bullet or clinical distraction? Thromb Res 2020;196:635-7. [PMID: 33066999 DOI: 10.1016/j.thromres.2020.09.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Manek G, Gupta M, Congrete S, Datta D. Submassive Pulmonary Embolism in Mild COVID-19 Without Lung Infiltrates. Cureus 2021;13:e13978. [PMID: 33880305 DOI: 10.7759/cureus.13978] [Reference Citation Analysis]
126 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, Kutys B, Guo L, Cornelissen A, Mori M, Sato Y, Pescetelli I, Brivio M, Romero M, Guagliumi G, Virmani R, Finn AV. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol 2021;77:314-25. [PMID: 33478655 DOI: 10.1016/j.jacc.2020.11.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 39.0] [Reference Citation Analysis]
128 Bruce SS, Kahan J, Huq T, Santillan A, Navi BB, Merkler AE, Parikh NS, Mir S, Schweitzer AD, Segal AZ. Missed cerebrovascular events during prolonged sedation for COVID-19 pneumonia. J Clin Neurosci 2021;86:180-3. [PMID: 33775324 DOI: 10.1016/j.jocn.2021.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
129 Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235425 DOI: 10.7196/AJTCCM.2020.v26i3.107] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 2021;45:372-89. [PMID: 34803441 DOI: 10.3906/biy-2105-37] [Reference Citation Analysis]
131 Fujiwara S, Nakajima M, Kaszynski RH, Fukushima K, Tanaka M, Yajima K, Kobayashi T, Sekiya N, Yamamoto Y, Miwa M, Ishihata A, Yamauchi Y, Yamamoto K, Goto H, Imamura A. Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan. J Infect Chemother 2021;27:869-75. [PMID: 33663933 DOI: 10.1016/j.jiac.2021.02.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med 2020;46:1603-6. [PMID: 32415314 DOI: 10.1007/s00134-020-06088-1] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 32.0] [Reference Citation Analysis]
133 Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo KM, Siegal D, Skara M, Terrell DR, Touri K, Akl EA, Bou Akl I, Bognanni A, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Muti-Schünemann G, Noori A, Philip BA, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Schünemann HJ. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv 2021;5:3951-9. [PMID: 34474482 DOI: 10.1182/bloodadvances.2021005493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Gulko E, Oleksk ML, Gomes W, Ali S, Mehta H, Overby P, Al-Mufti F, Rozenshtein A. MRI Brain Findings in 126 Patients with COVID-19: Initial Observations from a Descriptive Literature Review. AJNR Am J Neuroradiol. 2020;41:2199-2203. [PMID: 32883670 DOI: 10.3174/ajnr.a6805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
135 Patti G, Lio V, Cavallari I, Gragnano F, Riva L, Calabrò P, Di Pasquale G, Pengo V, Rubboli A; Italian Study Group on Atherosclerosis, Thrombosis, Vascular Biology. Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology. Am J Cardiovasc Drugs 2020;20:559-70. [PMID: 33145698 DOI: 10.1007/s40256-020-00446-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
136 Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8:978-86. [PMID: 33128872 DOI: 10.1016/S2213-8587(20)30342-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
137 Christensen B, Favaloro EJ, Lippi G, Van Cott EM. Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2020;46:845-9. [PMID: 32877961 DOI: 10.1055/s-0040-1715458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
138 Lambert WC, Alhatem A, Lambert MW, Schwartz RA. What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside. Clin Dermatol 2021;39:107-17. [PMID: 33972037 DOI: 10.1016/j.clindermatol.2020.12.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Mukerji SS, Das S, Alabsi H, Brenner LN, Jain A, Magdamo C, Collens SI, Ye E, Keller K, Boutros CL, Leone MJ, Newhouse A, Foy B, Li MD, Lang M, Anahtar MN, Shao YP, Ge W, Sun H, Triant VA, Kalpathy-Cramer J, Higgins J, Rosand J, Robbins GK, Westover MB. Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19. Front Neurol 2021;12:642912. [PMID: 33897598 DOI: 10.3389/fneur.2021.642912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Stawiarski K, Loutoo A, Velardi L, Zarich S. D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19. Thromb Res 2021;201:151-3. [PMID: 33862518 DOI: 10.1016/j.thromres.2021.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Lamazou F, Oger P, Dieli-Crimi R, Guerin A, Letouzey V, Octernaud S, Place V, Calès P, Descamps P, Delaroche L. COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report. BMC Infect Dis 2020;20:845. [PMID: 33198681 DOI: 10.1186/s12879-020-05551-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation. J Arrhythm 2021;37:1389-426. [PMID: 34887945 DOI: 10.1002/joa3.12652] [Reference Citation Analysis]
143 Albini A, Di Guardo G, Noonan DM, Lombardo M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med 2020;15:759-66. [PMID: 32430651 DOI: 10.1007/s11739-020-02364-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 22.5] [Reference Citation Analysis]
144 Paidas MJ, Mohamed AB, Norenberg MD, Saad A, Barry AF, Colon C, Kenyon NS, Jayakumar AR. Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19. Viruses 2021;13:1703. [PMID: 34578284 DOI: 10.3390/v13091703] [Reference Citation Analysis]
145 Sharma P, Pradhan A, Vohra S, Sethi R. COVID-19 and Cardiovascular Diseases: Challenges and Solutions. Cardiol Res 2021;12:149-55. [PMID: 34046108 DOI: 10.14740/cr1244] [Reference Citation Analysis]
146 Reddy ST, Garg T, Shah C, Nascimento FA, Imran R, Kan P, Bowry R, Gonzales N, Barreto A, Kumar A, Volpi J, Misra V, Chiu D, Gadhia R, Savitz SI. Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series. Case Rep Neurol 2020;12:199-209. [PMID: 32647526 DOI: 10.1159/000508958] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 21.5] [Reference Citation Analysis]
147 Kalita B, Saviola AJ, Samuel SP, Mukherjee AK. State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? Int J Biol Macromol 2021;192:1040-57. [PMID: 34656540 DOI: 10.1016/j.ijbiomac.2021.10.015] [Reference Citation Analysis]
148 Yammine H, Ballast JK, Poulsen N, Arko FR 3rd. Endovascular aortic repair in an asymptomatic COVID-19-positive patient with a symptomatic inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech 2020;6:531-3. [PMID: 32904956 DOI: 10.1016/j.jvscit.2020.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Katchanov J, Kalisch J, Herzing W, Knorr F, Havla M, Klink T, Dommke C. Extensive Aortic Thrombosis in a Patient With COVID-19. Ann Emerg Med. 2020;76:373-374. [PMID: 32828336 DOI: 10.1016/j.annemergmed.2020.04.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Tiwari NR, Khatib KI, Dixit SB, Rathore PK, Melinkeri S, Ganapule A, Borawake KS, Mhatre U. Anticoagulation in COVID - 19: An Update. J Crit Care Med (Targu Mures) 2020;6:217-23. [PMID: 33200092 DOI: 10.2478/jccm-2020-0033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
151 Ananworanich J, Mogg R, Dunne MW, Bassyouni M, David CV, Gonzalez E, Rogalski-Salter T, Shih H, Silverman J, Medema J, Heaton P. Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19. Clin Infect Dis 2021:ciab813. [PMID: 34523673 DOI: 10.1093/cid/ciab813] [Reference Citation Analysis]
152 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
153 Xu K, Wei Y, Giunta S, Zhou M, Xia S. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people? Exp Gerontol 2021;151:111423. [PMID: 34048906 DOI: 10.1016/j.exger.2021.111423] [Reference Citation Analysis]
154 Olson MC, Lubner MG, Menias CO, Mellnick VM, Gettle LM, Kim DH, Elsayes KM, Pickhardt PJ. RadioGraphics Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis-Findings in COVID-19. Radiographics 2020;40:E24-8. [PMID: 32649264 DOI: 10.1148/rg.2020200119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
155 Mendoza-Pinto C, García-Carrasco M, Realpozo PM, Méndez-Martínez S. [Therapeutic options for the management of severe Covid-19: A rheumatology perspective]. Reumatol Clin (Engl Ed) 2020. [PMID: 32426002 DOI: 10.1016/j.reuma.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 An YW, Song S, Li WX, Chen YX, Hu XP, Zhao J, Li ZW, Jiang GY, Wang C, Wang JC, Yuan B, Liu HQ. Liver function recovery of COVID-19 patients after discharge, a follow-up study. Int J Med Sci. 2021;18:176-186. [PMID: 33390786 DOI: 10.7150/ijms.50691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
157 Bypareddy R, Rathod BLS, Shilpa YD, Hithashree HR, Nagaraj KB, Hemalatha BC, Basumatary J, Bekal D, Niranjan R, Anusha PG. Fundus evaluation in COVID-19 positives with non-severe disease. Indian J Ophthalmol 2021;69:1271-4. [PMID: 33913875 DOI: 10.4103/ijo.IJO_3227_20] [Reference Citation Analysis]
158 Pirraglia MP, Ceccarelli G, Cerini A, Visioli G, d'Ettorre G, Mastroianni CM, Pugliese F, Lambiase A, Gharbiya M. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep 2020;10:17419. [PMID: 33060700 DOI: 10.1038/s41598-020-74446-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
159 Cao T, Zhang G, Xie H, Pellegrini E, Li J, Chen X, Pan H. Case Report: The Coronavirus Disease 2019 (COVID-19) Pneumonia With Multiple Thromboembolism. Front Neurol. 2020;11:625272. [PMID: 33551979 DOI: 10.3389/fneur.2020.625272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Quintavalle G, Coppola A, Ruggieri A, Rivolta GF, Fronti E, Giangregorio F, Michieletti E, Tagliaferri A. Severe bleeding in a patient with factor XIII deficiency and COVID-19. Haemophilia 2021;27:e140-2. [PMID: 32516478 DOI: 10.1111/hae.14088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
161 Gazzaruso C, Mariani G, Ravetto C, Malinverni L, Tondelli E, Cerrone M, Sala V, Bevilacqua L, Altavilla T, Coppola A, Gallotti P. Lupus anticoagulant and mortality in patients hospitalized for COVID-19. J Thromb Thrombolysis 2021;52:85-91. [PMID: 33159639 DOI: 10.1007/s11239-020-02335-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
162 Savastano MC, Culiersi C, Savastano A, Gambini G, Caporossi T, Rizzo S. Focal superior quadrant haemorrhages in post COVID-19 patient: A target for personalized medicine. Eur J Ophthalmol 2021;:11206721211021296. [PMID: 34088221 DOI: 10.1177/11206721211021296] [Reference Citation Analysis]
163 Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, Li Y. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression. Clin Appl Thromb Hemost 2021;27:10760296211010976. [PMID: 33926262 DOI: 10.1177/10760296211010976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
164 de Roquetaillade C, Chousterman BG, Tomasoni D, Zeitouni M, Houdart E, Guedon A, Reiner P, Bordier R, Gayat E, Montalescot G, Metra M, Mebazaa A. Unusual arterial thrombotic events in Covid-19 patients. Int J Cardiol. 2021;323:281-284. [PMID: 32918938 DOI: 10.1016/j.ijcard.2020.08.103] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
165 Tsai ST, Lu MK, San S, Tsai CH. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol. 2020;11:498. [PMID: 32574246 DOI: 10.3389/fneur.2020.00498] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
166 Abutaleb A, Nathan S. COVID-19 infection-associated coagulopathy: Pathophysiology and clinical implications. Interv Neuroradiol 2021;27:6-12. [PMID: 34747644 DOI: 10.1177/15910199211035894] [Reference Citation Analysis]
167 Liang J, Wang Z, Xie J, Liang H, Liang J, Jiang M, Li S. Rigorous Assessment of Guidelines on COVID-19-Related Thrombotic or Thromboembolic Disease: Implications for Clinical Practice of Prevention, Diagnosis, and Treatment. Evid Based Complement Alternat Med 2021;2021:5513744. [PMID: 34589131 DOI: 10.1155/2021/5513744] [Reference Citation Analysis]
168 Martí-Fàbregas J, Guisado-Alonso D, Delgado-Mederos R, Martínez-Domeño A, Prats-Sánchez L, Guasch-Jiménez M, Cardona P, Núñez-Guillén A, Requena M, Rubiera M, Olivé M, Bustamante A, Gomis M, Amaro S, Llull L, Ustrell X, Castilho de Oliveira G, Seró L, Gomez-Choco M, Mena L, Serena J, Bashir Viturro S, Purroy F, Vicente M, Rodríguez-Campello A, Ois A, Catena E, Carmen Garcia-Carreira M, Barrachina O, Palomeras E, Krupinski J, Almeria M, Zaragoza J, Esteve P, Cocho D, Moreira A, van Eendenburg C, Emilio Codas J, Pérez de la Ossa N, Salvat M, Camps-Renom P; COVICTUS Collaborators. Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke. Stroke 2021;52:3908-17. [PMID: 34455823 DOI: 10.1161/STROKEAHA.121.034883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
169 Adrover JM, Pellico J, Fernández-barahona I, Martín-salamanca S, Ruiz-cabello J, Hidalgo A, Herranz F. Thrombo-tag, an in vivo formed nanotracer for the detection of thrombi in mice by fast pre-targeted molecular imaging. Nanoscale 2020;12:22978-87. [DOI: 10.1039/d0nr04538a] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Teitelbaum S, Diaz J, Singer R. Can Outpatient Plastic Surgery Be Done Safely During a COVID-19 Surge? Results of a July 2020 Los Angeles Survey and Literature Review. Aesthet Surg J 2021;41:98-108. [PMID: 33026419 DOI: 10.1093/asj/sjaa287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
171 Konstantinides SV. Thrombosis and Thromboembolism Related to COVID-19: Increase the Level of Awareness, Lower the Threshold of Suspicion, and Keep Following the Guidelines. JACC Case Rep 2020;2:1388-90. [PMID: 32840252 DOI: 10.1016/j.jaccas.2020.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
172 Rentsch CT, Beckman JA, Tomlinson L, Gellad WF, Alcorn C, Kidwai-Khan F, Skanderson M, Brittain E, King JT Jr, Ho YL, Eden S, Kundu S, Lann MF, Greevy RA Jr, Ho PM, Heidenreich PA, Jacobson DA, Douglas IJ, Tate JP, Evans SJW, Atkins D, Justice AC, Freiberg MS. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 2021;372:n311. [PMID: 33574135 DOI: 10.1136/bmj.n311] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 38.0] [Reference Citation Analysis]
173 De Rossi N, Scarpazza C, Filippini C, Cordioli C, Rasia S, Mancinelli CR, Rizzoni D, Romanelli G, Cossi S, Vettoretto N, Bove S, Manfredini S, Beindorf EA, Mosca C, Scipione V, Flamminio G, Albini EA, Giansiracusa P, Capra R; Montichiari COVID-19 Study Group. Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine 2020;25:100459. [PMID: 32838235 DOI: 10.1016/j.eclinm.2020.100459] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
174 Beckman M, Nyrén S, Kistner A. A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection. Thromb J 2020;18:19. [PMID: 32868974 DOI: 10.1186/s12959-020-00235-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
175 Chekkal M, Deba T, Hadjali S, Lamara H, Oulaa H, Zouai K, Hariti G. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology. Transfus Clin Biol 2020;27:203-6. [PMID: 33022374 DOI: 10.1016/j.tracli.2020.09.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
176 Mendoza-Pinto C, García-Carrasco M, Munguía Realpozo P, Méndez-Martínez S. Therapeutic options for the management of severe COVID-19: A rheumatology perspective. Reumatol Clin (Engl Ed) 2021;17:431-6. [PMID: 34625144 DOI: 10.1016/j.reumae.2020.05.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Motta NAV, Autran LJ, Brazão SC, Lopes RO, Scaramello CBV, Lima GF, Brito FCF. Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol 2021;92:107336. [PMID: 33418248 DOI: 10.1016/j.intimp.2020.107336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
178 Erel Ö, Neşelioğlu S, Ergin Tunçay M, Fırat Oğuz E, Eren F, Akkuş MS, Güner HR, Ateş İ. A sensitive indicator for the severity of COVID-19: thiol. Turk J Med Sci 2021;51:921-8. [PMID: 33306332 DOI: 10.3906/sag-2011-139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
179 Hasan ZT, Atrakji DMQYMAA, Mehuaiden DAK. The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients. Int J Infect Dis 2022;114:79-84. [PMID: 34653660 DOI: 10.1016/j.ijid.2021.10.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Aguiar de Sousa D, Sandset EC, Elkind MSV. The Curious Case of the Missing Strokes During the COVID-19 Pandemic. Stroke 2020;51:1921-3. [PMID: 32466737 DOI: 10.1161/STROKEAHA.120.030792] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
181 Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, Morrison RB, Leiva O, Fanikos J, Nauffal V, Almarzooq Z, Goldhaber SZ. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol 2020;76:2060-72. [PMID: 33121712 DOI: 10.1016/j.jacc.2020.08.070] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 29.5] [Reference Citation Analysis]
182 Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ;  Massachusetts Consortium for Pathogen Readiness. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11:5493. [PMID: 33127906 DOI: 10.1038/s41467-020-19057-5] [Cited by in Crossref: 163] [Cited by in F6Publishing: 143] [Article Influence: 81.5] [Reference Citation Analysis]
183 Niaz T, Hope K, Fremed M, Misra N, Altman C, Glickstein J, Sanchez-de-Toledo J, Fraisse A, Miller J, Snyder C, Johnson JN, Chowdhury D. Role of a Pediatric Cardiologist in the COVID-19 Pandemic. Pediatr Cardiol 2021;42:19-35. [PMID: 33015722 DOI: 10.1007/s00246-020-02476-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
184 Shi C, Tingting W, Li JP, Sullivan MA, Wang C, Wang H, Deng B, Zhang Y. Comprehensive Landscape of Heparin Therapy for COVID-19. Carbohydr Polym 2021;254:117232. [PMID: 33357843 DOI: 10.1016/j.carbpol.2020.117232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
185 Sethi SS, Zilinyi R, Green P, Eisenberger A, Brodie D, Agerstrand C, Takeda K, Kirtane AJ, Parikh SA, Rosenzweig EB. Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team. JACC Case Rep 2020;2:1391-6. [PMID: 32835284 DOI: 10.1016/j.jaccas.2020.05.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
186 Uppuluri EM, Shapiro NL. Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis. Am J Health Syst Pharm 2020;77:1957-60. [PMID: 32780839 DOI: 10.1093/ajhp/zxaa286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
187 Li W, Xu Z, Xiang H, Zhang C, Guo Y, Xiong J. Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status. Aging (Albany NY) 2021;13:9225-42. [PMID: 33818421 DOI: 10.18632/aging.202769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
188 Bozkurt B, Hershberger RE, Butler J, Grady KL, Heidenreich PA, Isler ML, Kirklin JK, Weintraub WS. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). Circ Cardiovasc Qual Outcomes 2021;14:e000102. [PMID: 33755495 DOI: 10.1161/HCQ.0000000000000102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
189 Alschuler L, Chiasson AM, Horwitz R, Sternberg E, Crocker R, Weil A, Maizes V. Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease. Explore (NY) 2020:S1550-8307(20)30417-1. [PMID: 33358750 DOI: 10.1016/j.explore.2020.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
190 Albasheer OB, Almutairi HA, Almalki FM, Malaka HM. Massive Arterial Cerebral Thrombosis in a 59-year old Female Patient With Severe COVID-19. Cureus 2021;13:e15553. [PMID: 34277178 DOI: 10.7759/cureus.15553] [Reference Citation Analysis]
191 Daneshgaran G, Dubin DP, Gould DJ. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol. 2020;21:627-639. [PMID: 32865778 DOI: 10.1007/s40257-020-00558-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
192 Elkattawy S, Younes I, Noori MAM. A Case Report of Polymerase Chain Reaction-Confirmed COVID-19 in a Patient With Right Ventricular Thrombus and Bilateral Deep Vein Thrombosis. Cureus 2020;12:e8633. [PMID: 32685302 DOI: 10.7759/cureus.8633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Banik J, Mezera V, Köhler C, Schmidtmann M. Antiplatelet therapy in patients with Covid-19: A retrospective observational study. Thrombosis Update 2021;2:100026. [DOI: 10.1016/j.tru.2020.100026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
194 Riley JS, Luks VL, de Pina LF, Al Adas Z, Stoecker JB, Jackson BM, Braslow BM, Holena DN. COVID-19 Pandemic Significantly Decreases Acute Surgical Complaints. Am Surg 2020;86:1492-500. [PMID: 32862669 DOI: 10.1177/0003134820949506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
195 Soares RA, Vedovello RS, de Medeiros SCG, Nunes CZ, Sian CA, Jorge PDM. COVID-19 diagnosis in a patient with critical limb ischemia: complications and clinical outcomes. J Vasc Bras 2020;19:e20200071. [PMID: 34211520 DOI: 10.1590/1677-5449.200071] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Nopp S, Janata-Schwatczek K, Prosch H, Shulym I, Königsbrügge O, Pabinger I, Ay C. Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital. Res Pract Thromb Haemost 2020;4:835-41. [PMID: 32685892 DOI: 10.1002/rth2.12391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
197 [DOI: 10.1101/2020.05.11.088500] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
198 Cau R, Pacielli A, Fatemeh H, Vaudano P, Arru C, Crivelli P, Stranieri G, Suri JS, Mannelli L, Conti M, Mahammedi A, Kalra M, Saba L. Complications in COVID-19 patients: Characteristics of pulmonary embolism. Clin Imaging 2021;77:244-9. [PMID: 34029929 DOI: 10.1016/j.clinimag.2021.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Thachil J, Cushman M, Srivastava A. A proposal for staging COVID-19 coagulopathy. Res Pract Thromb Haemost 2020;4:731-6. [PMID: 32685880 DOI: 10.1002/rth2.12372] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]
200 Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J Clin Med 2021;10:1545. [PMID: 33916917 DOI: 10.3390/jcm10081545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
201 Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets 2020;31:740-5. [DOI: 10.1080/09537104.2020.1768523] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
202 Sharma P, Chakraborty K. Delayed manifestation of extensive COVID-19-associated coagulopathy in high-risk patient. BMJ Case Rep 2021;14:e242921. [PMID: 34039554 DOI: 10.1136/bcr-2021-242921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Fridman S, Bres Bullrich M, Jimenez-Ruiz A, Costantini P, Shah P, Just C, Vela-Duarte D, Linfante I, Sharifi-Razavi A, Karimi N, Bagur R, Debicki DB, Gofton TE, Steven DA, Sposato LA. Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases. Neurology 2020;95:e3373-85. [PMID: 32934172 DOI: 10.1212/WNL.0000000000010851] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
204 Mantefardo B, Gube AA, Awlachew E, Sisay G. Novel Coronavirus (COVID-19)-Associated Guillain-Barre' Syndrome: Case Report. Int Med Case Rep J 2021;14:251-3. [PMID: 33907474 DOI: 10.2147/IMCRJ.S305693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Magalhaes GS, Rodrigues-Machado MDG, Motta-Santos D, Campagnole-Santos MJ, Santos RAS. Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection. Front Physiol 2020;11:730. [PMID: 32636762 DOI: 10.3389/fphys.2020.00730] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
206 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
207 Mustafa AK, Joshi DJ, Alexander PJ, Tabachnick DR, Cross CA, Jweied EE, Mody NS, Huh MH, Fasih S, Pappas PS, Tatooles AJ. Comparative Propensity Matched Outcomes in Severe COVID-19 Respiratory Failure-Extracorporeal Membrane Oxygenation or Maximum Ventilation Alone. Ann Surg 2021;274:e388-94. [PMID: 34617934 DOI: 10.1097/SLA.0000000000005187] [Reference Citation Analysis]
208 Vergori A, Pianura E, Lorenzini P, D'Abramo A, Di Stefano F, Grisetti S, Vita S, Pinnetti C, Donno DR, Marini MC, Nicastri E, Ianniello S, Antinori A; ReCOVeRI Study Group. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients. Ann Med 2021;53:295-301. [PMID: 33491498 DOI: 10.1080/07853890.2021.1875498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
209 Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms. Int J Endocrinol 2021;2021:7394378. [PMID: 33859687 DOI: 10.1155/2021/7394378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
210 Faucher A, Rey PA, Aguadisch E, Degos B. Isolated post SARS-CoV-2 diplopia. J Neurol 2020;267:3128-9. [PMID: 32533321 DOI: 10.1007/s00415-020-09987-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
211 Kyriakoulis KG, Kollias A, Kyriakoulis IG, Kyprianou IA, Papachrysostomou C, Makaronis P, Kotronias RA, Terentes-Printzios D, Toskas I, Mikhailidis DP. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports. Curr Vasc Pharmacol 2021. [PMID: 34431465 DOI: 10.2174/1570161119666210824160332] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
212 Franchini M, Marano G, Cruciani M, Mengoli C, Pati I, Masiello F, Veropalumbo E, Pupella S, Vaglio S, Liumbruno GM. COVID-19-associated coagulopathy. Diagnosis (Berl) 2020;7:357-63. [PMID: 32683333 DOI: 10.1515/dx-2020-0078] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
213 Mehrabadi ME, Hemmati R, Tashakor A, Homaei A, Yousefzadeh M, Hemati K, Hosseinkhani S. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity. Biomed Pharmacother 2021;137:111363. [PMID: 33582450 DOI: 10.1016/j.biopha.2021.111363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
214 Patell R, Midha S, Kimani S, Martin R, Neparidze N, Jaglal M, Freed J, Key NS. Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States. Thromb Haemost 2020;120:1725-32. [PMID: 32828072 DOI: 10.1055/s-0040-1715837] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
215 Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GYH, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:1635-54. [PMID: 34649702 DOI: 10.1016/j.jacc.2021.08.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Ranard LS, Fried JA, Abdalla M, Anstey DE, Givens RC, Kumaraiah D, Kodali SK, Takeda K, Karmpaliotis D, Rabbani LE, Sayer G, Kirtane AJ, Leon MB, Schwartz A, Uriel N, Masoumi A. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020;13:e007220. [PMID: 32500721 DOI: 10.1161/CIRCHEARTFAILURE.120.007220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
217 Nour S. Endothelial shear stress enhancements: a potential solution for critically ill Covid-19 patients. Biomed Eng Online 2020;19:91. [PMID: 33272285 DOI: 10.1186/s12938-020-00835-7] [Reference Citation Analysis]
218 Ahmadi AR, Ayazi-Nasrabadi R. Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19. Iran J Microbiol 2021;13:434-41. [PMID: 34557270 DOI: 10.18502/ijm.v13i4.6965] [Reference Citation Analysis]
219 Korkmaz H. Could Sumac Be Effective on COVID-19 Treatment? J Med Food 2021;24:563-8. [PMID: 32816615 DOI: 10.1089/jmf.2020.0104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Bejko J, Sgorlon G, Zanon C, Avruscio G, Zanon A. True Aneurysm on Posterior Tibial Artery as Late Complication of SARS-CoV-2. Ann Vasc Surg 2021:S0890-5096(21)00684-1. [PMID: 34644641 DOI: 10.1016/j.avsg.2021.08.005] [Reference Citation Analysis]
221 Canzano P, Brambilla M, Porro B, Cosentino N, Tortorici E, Vicini S, Poggio P, Cascella A, Pengo MF, Veglia F, Fiorelli S, Bonomi A, Cavalca V, Trabattoni D, Andreini D, Omodeo Salè E, Parati G, Tremoli E, Camera M. Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients. JACC Basic Transl Sci 2021;6:202-18. [PMID: 33649738 DOI: 10.1016/j.jacbts.2020.12.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
222 Spini A, Giudice V, Brancaleone V, Morgese MG, De Francia S, Filippelli A, Ruggieri A, Ziche M, Ortona E, Cignarella A, Trabace L. Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity. Pharmacol Res 2021;173:105848. [PMID: 34454035 DOI: 10.1016/j.phrs.2021.105848] [Reference Citation Analysis]
223 Ameri P, Inciardi RM, Di Pasquale M, Agostoni P, Bellasi A, Camporotondo R, Canale C, Carubelli V, Carugo S, Catagnano F, Danzi G, Dalla Vecchia L, Giovinazzo S, Gnecchi M, Guazzi M, Iorio A, La Rovere MT, Leonardi S, Maccagni G, Mapelli M, Margonato D, Merlo M, Monzo L, Mortara A, Nuzzi V, Piepoli M, Porto I, Pozzi A, Provenzale G, Sarullo F, Sinagra G, Tedino C, Tomasoni D, Volterrani M, Zaccone G, Lombardi CM, Senni M, Metra M. Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol 2021;110:1020-8. [PMID: 33141251 DOI: 10.1007/s00392-020-01766-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
224 Brandão SCS, Godoi ETAM, Ramos JOX, de Melo LMMP, Sarinho ESC. Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice. J Vasc Bras 2020;19:e20200131. [PMID: 34211530 DOI: 10.1590/1677-5449.200131] [Reference Citation Analysis]
225 Ibrahim YS, Karuppasamy G, Parambil JV, Alsoub H, Al-Shokri SD. Case Report: Paralytic Ileus: A Potential Extrapulmonary Manifestation of Severe COVID-19. Am J Trop Med Hyg. 2020;103:1600-1603. [PMID: 32876011 DOI: 10.4269/ajtmh.20-0894] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
226 Rosovsky RP, Grodzin C, Channick R, Davis GA, Giri JS, Horowitz J, Kabrhel C, Lookstein R, Merli G, Morris TA, Rivera-Lebron B, Tapson V, Todoran TM, Weinberg AS, Rosenfield K; PERT Consortium. Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium. Chest 2020;158:2590-601. [PMID: 32861692 DOI: 10.1016/j.chest.2020.08.2064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
227 Parzy G, Daviet F, Puech B, Sylvestre A, Guervilly C, Porto A, Hraiech S, Chaumoitre K, Papazian L, Forel JM. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans. Crit Care Med 2020;48:e971-5. [PMID: 32618700 DOI: 10.1097/CCM.0000000000004504] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
228 Cushman M. Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis. Res Pract Thromb Haemost 2020;4:672-3. [PMID: 32685873 DOI: 10.1002/rth2.12399] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
229 Barat S, Casian D. Off-Label Use of a Double-Layer Micromesh Carotid Stent for Hybrid Treatment of Popliteal Artery Aneurism Complicated by Chronic Distal Embolization. Case Rep Vasc Med 2021;2021:5546194. [PMID: 34239756 DOI: 10.1155/2021/5546194] [Reference Citation Analysis]
230 Galanis N, Stavraka C, Agathangelidis F, Petsatodis E, Giankoulof C, Givissis P. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. J Surg Case Rep. 2020;2020:rjaa204. [PMID: 32661487 DOI: 10.1093/jscr/rjaa204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
231 Emert R, Shah P, Zampella JG. COVID-19 and hypercoagulability in the outpatient setting. Thromb Res 2020;192:122-3. [PMID: 32473495 DOI: 10.1016/j.thromres.2020.05.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
232 Harrogate S, Mortimer A, Burrows L, Fiddes B, Thomas I, Rice CM. Non-aneurysmal subarachnoid haemorrhage in COVID-19. Neuroradiology 2021;63:149-52. [PMID: 32857213 DOI: 10.1007/s00234-020-02535-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
233 Ozsu S, Gunay E, Konstantinides SV. A review of venous thromboembolism in COVID-19: A clinical perspective. Clin Respir J 2021;15:506-12. [PMID: 33484090 DOI: 10.1111/crj.13330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
234 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
235 Narasimhan B, Lorente-Ros M, Aguilar-Gallardo JS, Lizardo CP, Narasimhan H, Morton C, Donahue KR, Aronow WS. Anticoagulation in COVID-19: a review of current literature and guidelines. Hosp Pract (1995) 2021;49:307-24. [PMID: 34807786 DOI: 10.1080/21548331.2021.2007648] [Reference Citation Analysis]
236 Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020;36:1068-80. [PMID: 32425328 DOI: 10.1016/j.cjca.2020.05.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 34.0] [Reference Citation Analysis]
237 Paredes-Ruiz D, Gómez-Cuervo C, Gómez-Martín C, Sánchez-Guerrero Á, González-Olmedo J, López-López F, Bover-Larroya M, Yarza-Barrio R, Jara-Casas DD, Castelo-Laureiro A, Revilla-Ostolaza Y, Paz-Ares L, Lumbreras-Bermejo C, Díaz-Pedroche C. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid. J Thromb Thrombolysis 2021. [PMID: 33890200 DOI: 10.1007/s11239-021-02448-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
238 Fernandez-Fernandez B, D'Marco L, Górriz JL, Jacobs-Cachá C, Kanbay M, Luis-Lima S, Porrini E, Sarafidis P, Soler MJ, Ortiz A. Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19. J Clin Med 2020;9:E2030. [PMID: 32605278 DOI: 10.3390/jcm9072030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
239 Keretsu S, Bhujbal SP, Cho SJ. Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation. Sci Rep 2020;10:17716. [PMID: 33077821 DOI: 10.1038/s41598-020-74468-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
240 Hall K, Mfone F, Shallcross M, Pathak V. Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19. Eurasian J Med 2021;53:137-43. [PMID: 34177298 DOI: 10.5152/eurasianjmed.2021.20384] [Reference Citation Analysis]
241 Brandariz-Nuñez D, Correas-Sanahuja M, Guarc E, Picón R, García B, Gil R. Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir. Med Clin (Engl Ed) 2020;155:281-7. [PMID: 32953990 DOI: 10.1016/j.medcle.2020.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
243 Chen L, Hu W, Guo X, Zhao P, Tang J, Gu Y, Huang N, Wang C, Cui A, Zhang D, Hu L, Feng Y, Hu S, Chen M, Duru F, Xiong C. Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19. Sci Rep 2021;11:4432. [PMID: 33627696 DOI: 10.1038/s41598-021-83822-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Bertoletti L, Bikdeli B, Zuily S, Blondon M, Mismetti P. Thromboprophylaxis strategies to improve the prognosis of COVID-19. Vascul Pharmacol 2021;139:106883. [PMID: 34091065 DOI: 10.1016/j.vph.2021.106883] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Napoli C, Tritto I, Mansueto G, Coscioni E, Ambrosio G. Immunosenescence exacerbates the COVID-19. Arch Gerontol Geriatr 2020;90:104174. [PMID: 32653765 DOI: 10.1016/j.archger.2020.104174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
246 Dakay K, Cooper J, Bloomfield J, Overby P, Mayer SA, Nuoman R, Sahni R, Gulko E, Kaur G, Santarelli J, Gandhi CD, Al-Mufti F. Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature. J Stroke Cerebrovasc Dis 2021;30:105434. [PMID: 33190109 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105434] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
247 Gill GS, Vlacancich R, Mehta N, Chaturvedi M, Papolos A. Spectrum of Cardiac Involvement in COVID-19. Cureus 2020;12:e8638. [PMID: 32685307 DOI: 10.7759/cureus.8638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
248 Zhao D, Zhang S, Igawa T, Frishman W. Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy? Cardiology in Review 2020;28:303-7. [DOI: 10.1097/crd.0000000000000340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
249 Burger AL, Kaufmann CC, Jäger B, Pogran E, Ahmed A, Wojta J, Farhan S, Huber K. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic : A review. Wien Klin Wochenschr 2021;133:1289-97. [PMID: 34671829 DOI: 10.1007/s00508-021-01956-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
250 Abdelmohsen MA, Alkandari BM, Abdel Razek AAK, Tobar AM, Gupta VK, Elsebaie N. Abdominal Computed Tomography Angiography and Venography in Evaluation of Hemorrhagic and Thrombotic lesions in Hospitalized COVID-19 patients. Clin Imaging 2021;79:12-9. [PMID: 33865171 DOI: 10.1016/j.clinimag.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Kreidieh F, Temraz S. Anticoagulation for COVID-19 Patients: A Bird's-Eye View. Clin Appl Thromb Hemost 2021;27:10760296211039288. [PMID: 34595937 DOI: 10.1177/10760296211039288] [Reference Citation Analysis]
252 Lippi G, Henry BM, Sanchis-Gomar F. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness. Semin Thromb Hemost 2021;47:460-2. [PMID: 33378783 DOI: 10.1055/s-0040-1716873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
253 Kakakhel MA, Wu F, Khan TA, Feng H, Hassan Z, Anwar Z, Faisal S, Ali I, Wang W. The first two months epidimiological study of COVID-19, related public health preparedness, and response to the ongoing epidemic in Pakistan. New Microbes New Infect 2020;37:100734. [PMID: 32884821 DOI: 10.1016/j.nmni.2020.100734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
254 Paar V, Wernly B, Zhou Z, Motloch LJ, Hoppe UC, Egle A, Lichtenauer M. Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? J Thromb Thrombolysis 2021;51:226-31. [PMID: 32632558 DOI: 10.1007/s11239-020-02212-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
255 Longhitano Y, Racca F, Zanza C, Muncinelli M, Guagliano A, Peretti E, Minerba AC, Mari M, Boverio R, Salio M, Chichino G, Franceschi F, Piccioni A, Abenavoli L, Salvini M, Artico M. Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study. Biology (Basel) 2020;9:E310. [PMID: 32987902 DOI: 10.3390/biology9100310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
256 Lanza E, Mancuso ME, Messana G, Ferrazzi P, Lisi C, Di Micco P, Barco S, Balzarini L, Lodigiani C. Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients. J Clin Med 2021;10:2894. [PMID: 34209720 DOI: 10.3390/jcm10132894] [Reference Citation Analysis]
257 Alonderytė A, Navickas G, Samalavičius RS, Šerpytis P. Review of New Clinical Aspects of Cardiac Pathology in Patients with COVID-19 Infection. Acta Med Litu 2021;28:31-5. [PMID: 34393626 DOI: 10.15388/Amed.2021.28.1.12] [Reference Citation Analysis]
258 Pereyra D, Heber S, Schrottmaier WC, Santol J, Pirabe A, Schmuckenschlager A, Kammerer K, Ammon D, Sorz T, Fritsch F, Hayden H, Pawelka E, Krüger P, Rumpf B, Traugott MT, Glaser P, Firbas C, Schörgenhofer C, Seitz T, Karolyi M, Pabinger I, Brostjan C, Starlinger P, Weiss G, Bellmann-Weiler R, Salzer HJF, Jilma B, Zoufaly A, Assinger A. Low molecular weight heparin use in COVID-19 is associated with curtailed viral persistence-a retrospective multicenter observational study. Cardiovasc Res 2021:cvab308. [PMID: 34609480 DOI: 10.1093/cvr/cvab308] [Reference Citation Analysis]
259 Elbadawi A, Elgendy IY, Sahai A, Bhandari R, McCarthy M, Gomes M, Bishop GJ, Bartholomew JR, Kapadia S, Cameron SJ. Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19. Arterioscler Thromb Vasc Biol 2021;41:545-7. [PMID: 32990453 DOI: 10.1161/ATVBAHA.120.315304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
260 Puzzitiello RN, Pagani NR, Moverman MA, Moon AS, Menendez ME, Ryan SP. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients With COVID-19: A Review of the Current Evidence and Our Surgical Experience. J Orthop Trauma 2020;34:389-94. [PMID: 32427809 DOI: 10.1097/BOT.0000000000001842] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Farsky PS, Feriani D, Valente BBP, Andrade MAG, Amato VL, Carvalho L, Ibanes AS, Godoy LF, Arnoni RT, Abboud CS. Coronary Artery Bypass Surgery in Patients With COVID-19: What Have We Learned? Circ Cardiovasc Qual Outcomes 2021;14:e007455. [PMID: 33302701 DOI: 10.1161/CIRCOUTCOMES.120.007455] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Kapoor S, Chand S, Dieiev V, Fazzari M, Tanner T, Lewandowski DC, Nalla A, Abdulfattah O, Aboodi MS, Shiloh AL, Gong MN. Thromboembolic Events and Role of Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive Care Unit Admission. J Intensive Care Med 2020;:885066620964392. [PMID: 33021131 DOI: 10.1177/0885066620964392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
263 Mai V, Tan BK, Mainbourg S, Potus F, Cucherat M, Lega JC, Provencher S. Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis. Vascul Pharmacol 2021;139:106882. [PMID: 34087481 DOI: 10.1016/j.vph.2021.106882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
264 Blumfield E, Levin TL. COVID-19 in pediatric patients: a case series from the Bronx, NY. Pediatr Radiol 2020;50:1369-74. [PMID: 32728901 DOI: 10.1007/s00247-020-04782-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
265 García-Ortega A, Oscullo G, Calvillo P, López-Reyes R, Méndez R, Gómez-Olivas JD, Bekki A, Fonfría C, Trilles-Olaso L, Zaldívar E, Ferrando A, Anguera G, Briones-Gómez A, Reig-Mezquida JP, Feced L, González-Jiménez P, Reyes S, Muñoz-Núñez CF, Carreres A, Gil R, Morata C, Toledo-Pons N, Martí-Bonmati L, Menéndez R, Martínez-García MÁ. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection. J Infect 2021;82:261-9. [PMID: 33440207 DOI: 10.1016/j.jinf.2021.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
266 Galyfos G, Sianou A, Frountzas M, Vasilios K, Vouros D, Theodoropoulos C, Michalopoulou V, Sigala F, Filis K. Acute limb ischemia among patients with COVID-19 infection. J Vasc Surg 2021:S0741-5214(21)01792-4. [PMID: 34390791 DOI: 10.1016/j.jvs.2021.07.222] [Reference Citation Analysis]
267 Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
268 Bhavana V, Thakor P, Singh SB, Mehra NK. COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic. Life Sci 2020;261:118336. [PMID: 32846164 DOI: 10.1016/j.lfs.2020.118336] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
269 Loomba RS, Aggarwal G, Villarreal EG, Farias JS, Flores S, Lavie CJ, Aggarwal S. Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: a meta-analysis. Blood Coagul Fibrinolysis 2021;32:23-8. [PMID: 33196516 DOI: 10.1097/MBC.0000000000000974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
270 Bikdeli B. Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence. Thromb Res 2020;196:638-40. [PMID: 33066998 DOI: 10.1016/j.thromres.2020.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
271 Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine 2020;29:100639. [PMID: 33251499 DOI: 10.1016/j.eclinm.2020.100639] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 41.0] [Reference Citation Analysis]
272 Burley NB, Dy PS, Kalantri S, Razzaq K. Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability. Cureus 2021;13:e16171. [PMID: 34258131 DOI: 10.7759/cureus.16171] [Reference Citation Analysis]
273 Giannis D, Douketis JD, Spyropoulos AC. Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions? Eur J Intern Med 2021:S0953-6205(21)00378-2. [PMID: 34799234 DOI: 10.1016/j.ejim.2021.11.003] [Reference Citation Analysis]
274 Zerwes S, Steinbauer M, Gosslau Y, Warm T, Hyhlik-Dürr A. [COVID-19 infection-Risk of thromboembolic complications]. Gefasschirurgie 2020;:1-6. [PMID: 32905019 DOI: 10.1007/s00772-020-00687-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Kovach CP, Perman SM. Impact of the COVID-19 pandemic on cardiac arrest systems of care. Curr Opin Crit Care 2021;27:239-45. [PMID: 33783396 DOI: 10.1097/MCC.0000000000000817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Langer F, Kluge S, Klamroth R, Oldenburg J. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis. Hamostaseologie 2020;40:264-9. [PMID: 32498097 DOI: 10.1055/a-1178-3551] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 19.5] [Reference Citation Analysis]
277 Bouck EG, Denorme F, Holle LA, Middelton EA, Blair AM, de Laat B, Schiffman JD, Yost CC, Rondina MT, Wolberg AS, Campbell RA. COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity. Arterioscler Thromb Vasc Biol 2021;41:401-14. [PMID: 33196292 DOI: 10.1161/ATVBAHA.120.315338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
278 Maab H, Mustafa F, Shabbir SJ. Cardiovascular impact of COVID-19: an array of presentations. Acta Biomed 2021;92:e2021021. [PMID: 33988162 DOI: 10.23750/abm.v92i2.10299] [Reference Citation Analysis]
279 Dennison JJ, Carlson S, Faehling S, Phelan H, Tariq M, Mubarik A. Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient. Radiol Case Rep 2021;16:999-1004. [PMID: 33619439 DOI: 10.1016/j.radcr.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
280 Favaloro EJ, Lippi G. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I. Semin Thromb Hemost 2020;46:757-62. [PMID: 33080660 DOI: 10.1055/s-0040-1717139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
281 Prendes CF, Bellmunt-Montoya S. Riding the First Covid-19 Wave: Vascular Surgery Lessons from Lombardy, Italy. Eur J Vasc Endovasc Surg 2021;61:698. [PMID: 33483218 DOI: 10.1016/j.ejvs.2021.01.001] [Reference Citation Analysis]
282 Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, Baldini PM, Fulgenzi F, Dennetta D, Bedetta S, Gasperoni L, Caraffa A, Frausini G. Safety of intermediate dose of low molecular weight heparin in COVID-19 patients. J Thromb Thrombolysis 2021;51:286-92. [PMID: 32794132 DOI: 10.1007/s11239-020-02243-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
283 Randhawa P, Singh PP, Guragai N, Kaur P, Singh B, Walia JS. Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association. J Community Hosp Intern Med Perspect 2021;11:311-4. [PMID: 34234900 DOI: 10.1080/20009666.2021.1893506] [Reference Citation Analysis]
284 Pang QL, He WC, Li JX, Huang L. Symptomatic and optimal supportive care of critical COVID-19: A case report and literature review. World J Clin Cases 2020; 8(23): 6181-6189 [PMID: 33344621 DOI: 10.12998/wjcc.v8.i23.6181] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
285 Cleary SJ, Pitchford SC, Amison RT, Carrington R, Robaina Cabrera CL, Magnen M, Looney MR, Gray E, Page CP. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br J Pharmacol 2020;177:4851-65. [PMID: 32462701 DOI: 10.1111/bph.15143] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 29.0] [Reference Citation Analysis]
286 Sweeney JM, Barouqa M, Krause GJ, Gonzalez-Lugo JD, Rahman S, Gil MR. Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients. TH Open 2021;5:e89-e103. [PMID: 33709050 DOI: 10.1055/s-0041-1723784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
287 Palleri D, Guidarini M, Mariucci E, Balducci A, Assenza GE, Esposito S, Donti A. Patent Foramen Ovale Related Cryptogenic Stroke during COVID-19 Disease in Three Patients: A Case Series. J Stroke Cerebrovasc Dis 2021;30:106115. [PMID: 34562792 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106115] [Reference Citation Analysis]
288 Vrachatis DA, Papathanasiou KA, Giotaki SG, Raisakis K, Kossyvakis C, Kaoukis A, Kolokathis F, Deftereos G, Iliodromitis KE, Avramides D, Bogossian H, Siasos G, Giannopoulos G, Reimers B, Lansky A, Tardif JC, Deftereos S. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine. J Clin Med 2021;10:5128. [PMID: 34768648 DOI: 10.3390/jcm10215128] [Reference Citation Analysis]
289 Bolevich SB, Bolevich SS. Complex mechanism of COVID-19 development. jour 2020;11:50-61. [DOI: 10.47093/2218-7332.2020.11.2.50-61] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Sun B, Hettie KS, Zhu S. Near-infrared Fluorophores for Thrombosis Diagnosis and Therapy. Adv Ther (Weinh) 2021;4:2000278. [PMID: 33997270 DOI: 10.1002/adtp.202000278] [Reference Citation Analysis]
291 Chinitz JS, Goyal R, Harding M, Veseli G, Gruberg L, Jadonath R, Maccaro P, Gandotra P, Ong L, Epstein LM. Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis? Pacing Clin Electrophysiol 2020;43:1199-204. [PMID: 32820823 DOI: 10.1111/pace.14042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
292 Böhm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol 2020;109:1446-59. [PMID: 32462267 DOI: 10.1007/s00392-020-01656-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
293 Kazmi S, Herekar F, Sarfaraz S. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series. Semin Thromb Hemost 2021;47:427-30. [PMID: 33336328 DOI: 10.1055/s-0040-1716871] [Reference Citation Analysis]
294 Jandial A, Gupta A, Malviya A, Agastam S, Kumar D. Coagulation abnormalities & thromboprophylaxis in COVID-19. Indian J Med Res 2021;153:606-18. [PMID: 34643567 DOI: 10.4103/ijmr.IJMR_3841_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Kruip MJHA, Cannegieter SC, Ten Cate H, van Gorp ECM, Juffermans NP, Klok FA, Maas C, Vonk-Noordegraaf A; Dutch COVID Thrombosis Coalition study group. Caging the dragon: Research approach to COVID-19-related thrombosis. Res Pract Thromb Haemost 2021;5:278-90. [PMID: 33733026 DOI: 10.1002/rth2.12470] [Reference Citation Analysis]
296 Thachil J, Agarwal S. Understanding the COVID-19 coagulopathy spectrum. Anaesthesia 2020;75:1432-6. [PMID: 32437586 DOI: 10.1111/anae.15141] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
297 Gagarkin DA, Dombrowski KE, Thakar KB, DePetrillo JC. Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report. J Med Case Rep 2021;15:219. [PMID: 33910640 DOI: 10.1186/s13256-021-02831-4] [Reference Citation Analysis]
298 Naudin I, Long A, Michel C, Devigne B, Millon A, Della-Schiava N. Acute aortoiliac occlusion in a patient with novel coronavirus disease-2019. J Vasc Surg 2021;73:18-21. [PMID: 33075454 DOI: 10.1016/j.jvs.2020.10.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
299 Spyropoulos AC, Bonaca MP. Studying the coagulopathy of COVID-19. Lancet 2021:S0140-6736(21)01906-1. [PMID: 34800425 DOI: 10.1016/S0140-6736(21)01906-1] [Reference Citation Analysis]
300 Piera Carbonell A, Frías Vargas M, García Vallejo O, García Lerín A, Cabrera Ferriols MA, Peiró Morant J, Carrasco Carrasco E; en nombre del Grupo de trabajo de Vasculopatías de SEMERGEN. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care]. Semergen 2020;46:479-86. [PMID: 33046353 DOI: 10.1016/j.semerg.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
301 Su YB, Kuo MJ, Lin TY, Chien CS, Yang YP, Chou SJ, Leu HB. Cardiovascular manifestation and treatment in COVID-19. J Chin Med Assoc 2020;83:704-9. [PMID: 32433342 DOI: 10.1097/JCMA.0000000000000352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
302 Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, Calleja P, Ostos F, González-Ortega G, Fuentes B, Alonso de Leciñana M, Díez-Tejedor E, García-Madrona S, Masjuan J, DeFelipe A, Turc G, Gonçalves B, Domigo V, Dan GA, Vezeteu R, Christensen H, Christensen LM, Meden P, Hajdarevic L, Rodriguez-Lopez A, Díaz-Otero F, García-Pastor A, Gil-Nuñez A, Maslias E, Strambo D, Werring DJ, Chandratheva A, Benjamin L, Simister R, Perry R, Beyrouti R, Jabbour P, Sweid A, Tjoumakaris S, Cuadrado-Godia E, Campello AR, Roquer J, Moreira T, Mazya MV, Bandini F, Matz K, Iversen HK, González-Duarte A, Tiu C, Ferrari J, Vosko MR, Salzer HJF, Lamprecht B, Dünser MW, Cereda CW, Quintero ÁBC, Korompoki E, Soriano-Navarro E, Soto-Ramírez LE, Castañeda-Méndez PF, Bay-Sansores D, Arauz A, Cano-Nigenda V, Kristoffersen ES, Tiainen M, Strbian D, Putaala J, Lip GYH. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke 2020;51:e254-8. [PMID: 32787707 DOI: 10.1161/STROKEAHA.120.031208] [Cited by in Crossref: 78] [Cited by in F6Publishing: 43] [Article Influence: 39.0] [Reference Citation Analysis]
303 Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XK, Dannenberg AJ, Kumar R, Sharaiha RZ. Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City. Obesity (Silver Spring) 2020;28:1606-12. [PMID: 32470210 DOI: 10.1002/oby.22923] [Cited by in Crossref: 93] [Cited by in F6Publishing: 79] [Article Influence: 46.5] [Reference Citation Analysis]
304 Kwon DH, Do Y, Eun MY, Lee J, Park H, Sohn SI, Hong JH. Characteristics of Acute Stroke in Patients with Coronavirus Disease 2019 and Challenges in Stroke Management during an Epidemic. J Korean Med Sci 2020;35:e324. [PMID: 32893524 DOI: 10.3346/jkms.2020.35.e324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
305 Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. [PMID: 32754159 DOI: 10.3389/fimmu.2020.01648] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 56.0] [Reference Citation Analysis]
306 Davoodi L, Jafarpour H, Taghavi M, Razavi A. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting. J Investig Med High Impact Case Rep 2020;8:2324709620931239. [PMID: 32493073 DOI: 10.1177/2324709620931239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
307 Zhang Y, Wang Z, Zhang Y, Tong H, Zhang Y, Lu T. Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019. Front Mol Biosci 2020;7:577285. [PMID: 33381519 DOI: 10.3389/fmolb.2020.577285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
308 Sisinni A, Rossi L, Battista A, Poletti E, Battista F, Battista RA, Malagoli A, Biagi A, Zanni A, Sticozzi C, Comastri G, Marrocco-Trischitta MM, Monello A, Margonato A, Bandera F, Vergara P, Guazzi M, Godino C. Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study. Int J Cardiol 2021;344:240-5. [PMID: 34619262 DOI: 10.1016/j.ijcard.2021.09.058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Mukherjee A, Ghosh R, Furment MM. Case Report: COVID-19 Associated Renal Infarction and Ascending Aortic Thrombosis. Am J Trop Med Hyg 2020;103:1989-92. [PMID: 32918409 DOI: 10.4269/ajtmh.20-0869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
310 Yildiz M, Yadigar S, Yildiz BŞ, Aladag NB, Keskin O, Ozer RS, Topel C, Kahraman S. Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement. Herz 2021;46:56-62. [PMID: 33433652 DOI: 10.1007/s00059-020-05014-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
311 Nori W, Hameed BH, Thamir AR, Fadhil A. COVID-19 in Pregnancy: Implication on Platelets and Blood Indices. Rev Bras Ginecol Obstet 2021;43:595-9. [PMID: 34547793 DOI: 10.1055/s-0041-1733912] [Reference Citation Analysis]
312 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
313 Viecca M, Radovanovic D, Forleo GB, Santus P. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res 2020;158:104950. [PMID: 32450344 DOI: 10.1016/j.phrs.2020.104950] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 24.5] [Reference Citation Analysis]
314 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
315 McManus NM, Offman R, Oetman JD. Emergency Department Management of COVID-19: An Evidence-Based Approach. West J Emerg Med 2020;21:32-44. [PMID: 33052814 DOI: 10.5811/westjem.2020.8.48288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
316 Ferrando C, Colomina MJ, Errando CL, Llau JV. Anesthesiology and the Anesthesiologists at COVID-19. Rev Esp Anestesiol Reanim (Engl Ed) 2020;67:289-91. [PMID: 32487319 DOI: 10.1016/j.redar.2020.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
317 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
318 Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: the clot thickens! Eur Respir J. 2020;56. [PMID: 32554532 DOI: 10.1183/13993003.01608-2020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 31.5] [Reference Citation Analysis]
319 Abrams MP, Wan EY, Waase MP, Morrow JP, Dizon JM, Yarmohammadi H, Berman JP, Rubin GA, Kushnir A, Poterucha TJ, Elias PA, Rubin DA, Ehlert F, Biviano A, Uriel N, Garan H, Saluja D. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort. J Cardiovasc Electrophysiol 2020;31:3086-96. [PMID: 33022765 DOI: 10.1111/jce.14772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
320 Castro-Verdes M, Gkouma A, Wort J, Ridge C, Mirsadraee S, Padley S, Sheikh A, Singh S. Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series. Eur Heart J Case Rep 2020;4:1-7. [PMID: 33442596 DOI: 10.1093/ehjcr/ytaa470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Soumagne T, Lascarrou JB, Hraiech S, Horlait G, Higny J, d'Hondt A, Grimaldi D, Gaudry S, Courcelle R, Carbutti G, Blonz G, Aissaoui N, Vinsonneau C, Vandenbunder B, Textoris J, Szychowiak P, Serck N, Sauneuf B, Piagnerelli M, Ly A, Lejeune F, Lefebvre L, Piton G. Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients. Crit Care Explor 2020;2:e0166. [PMID: 32766562 DOI: 10.1097/CCE.0000000000000166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
322 Khandelwal G, Ray A, Sethi S, Harikrishnan HK, Khandelwal C, Sadasivam B. COVID-19 and thrombotic complications-the role of anticoagulants, antiplatelets and thrombolytics. J Family Med Prim Care 2021;10:3561-7. [PMID: 34934647 DOI: 10.4103/jfmpc.jfmpc_1297_20] [Reference Citation Analysis]
323 Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary. Thromb Haemost 2021. [PMID: 34773920 DOI: 10.1055/s-0041-1739411] [Reference Citation Analysis]
324 Dumoulin DW, Gietema HA, Paats MS, Hendriks LEL, Cornelissen R. Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis. Front Oncol. 2020;10:577696. [PMID: 33194697 DOI: 10.3389/fonc.2020.577696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
325 Hoechter DJ, Becker-Pennrich A, Langrehr J, Bruegel M, Zwissler B, Schaefer S, Spannagl M, Hinske LC, Zoller M. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients. Thromb Res 2020;196:186-92. [PMID: 32891904 DOI: 10.1016/j.thromres.2020.08.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
326 Bonow RO, O'Gara PT, Yancy CW. Cardiology and COVID-19. JAMA 2020;324:1131-2. [PMID: 32960249 DOI: 10.1001/jama.2020.15088] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
327 Fernandes CJ, Ganem F, Olivieri FG, Vilibor MF, Helito AS. The Other Side of the Coin: Risks of Media Discussions of Scientific Medical Data During the COVID-19 Pandemic. Arq Bras Cardiol 2020;115:278-80. [PMID: 32876197 DOI: 10.36660/abc.20200449] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
328 Chima M, Williams D, Thomas NJ, Krawiec C. COVID-19-Associated Pulmonary Embolism in Pediatric Patients. Hosp Pediatr 2021;11:e90-4. [PMID: 33785517 DOI: 10.1542/hpeds.2021-005866] [Reference Citation Analysis]
329 Jenab Y, Rezaei N, Hedayat B, Naderian M, Shirani S, Hosseini K. Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID-19. Clin Case Rep 2020. [PMID: 32837723 DOI: 10.1002/ccr3.3112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
330 García-Cruz E, Manzur-Sandoval D, Baeza-Herrera LA, Díaz-Méndez A, López-Zamora A, González-Ruiz F, Ramos-Enríquez Á, Melano-Carranza E, Rojas-Velasco G, Álvarez-Álvarez RJ, Baranda-Tovar FM. Acute right ventricular failure in COVID-19 infection: A case series. J Cardiol Cases 2021;24:45-8. [PMID: 33520022 DOI: 10.1016/j.jccase.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Li Z, Shao W, Zhang J, Ma J, Huang S, Yu P, Zhu W, Liu X. Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:720129. [PMID: 34722658 DOI: 10.3389/fcvm.2021.720129] [Reference Citation Analysis]
332 Pietroboni AM, Lanfranconi S, Novella A, Carandini T, Arighi A, Abati E, Brusa R, Costamagna G, Lazzeri G, Mauri E, Pozzato M, Sacchi L, Valcamonica G, Villa D, Bonato S, Comi GP, Bresolin N, Galimberti D, Scarpini E, Nobili A; Neurology-COVID-19 Group. Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? Intern Emerg Med 2021;16:1247-52. [PMID: 33565035 DOI: 10.1007/s11739-021-02634-x] [Reference Citation Analysis]
333 Gulko E, Gomes W, Ali S, Al-Mufti F, Mehta H. Acute Common Carotid Artery Bifurcation Thrombus: An Emerging Pattern of Acute Strokes in Patients with COVID-19? AJNR Am J Neuroradiol 2020;41:E65-6. [PMID: 32616583 DOI: 10.3174/ajnr.A6657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
334 Oualha M, Bendavid M, Berteloot L, Corsia A, Lesage F, Vedrenne M, Salvador E, Grimaud M, Chareyre J, de Marcellus C, Dupic L, de Saint Blanquat L, Heilbronner C, Drummond D, Castelle M, Berthaud R, Angoulvant F, Toubiana J, Pinhas Y, Frange P, Chéron G, Fourgeaud J, Moulin F, Renolleau S. Severe and fatal forms of COVID-19 in children. Arch Pediatr 2020;27:235-8. [PMID: 32518045 DOI: 10.1016/j.arcped.2020.05.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 24.5] [Reference Citation Analysis]
335 Lauretani F, Ravazzoni G, Roberti MF, Longobucco Y, Adorni E, Grossi M, De Iorio A, La Porta U, Fazio C, Gallini E, Federici R, Salvi M, Ciarrocchi E, Rossi F, Bergamin M, Bussolati G, Grieco I, Broccoli F, Zucchini I, Ielo G, Morganti S, Artoni A, Arisi A, Tagliaferri S, Maggio M. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications. Acta Biomed 2020;91:150-68. [PMID: 32420939 DOI: 10.23750/abm.v91i2.9629] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
336 Kuebler WM, Jordt SE, Liedtke WB. Urgent reconsideration of lung edema as a preventable outcome in COVID-19: inhibition of TRPV4 represents a promising and feasible approach. Am J Physiol Lung Cell Mol Physiol 2020;318:L1239-43. [PMID: 32401673 DOI: 10.1152/ajplung.00161.2020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
337 Canoglu K, Saylan B. Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection. Ann Saudi Med 2020;40:462-8. [PMID: 33307734 DOI: 10.5144/0256-4947.2020.462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
338 Zamboni P, Bortolotti D, Occhionorelli S, Traina L, Neri LM, Rizzo R, Gafà R, Passaro A. Bowel ischemia as onset of COVID-19 in otherwise asymptomatic patients with persistently negative swab. J Intern Med 2021. [PMID: 34437741 DOI: 10.1111/joim.13385] [Reference Citation Analysis]
339 Roncon L, Zuin M, Zonzin P. Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no? J Thromb Thrombolysis 2020;50:221-2. [PMID: 32394238 DOI: 10.1007/s11239-020-02131-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
340 Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M. High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis. Clin Exp Med 2021. [PMID: 34741678 DOI: 10.1007/s10238-021-00769-x] [Reference Citation Analysis]
341 Candelaresi P, Manzo V, Servillo G, Muto M, Barone P, Napoletano R, Saponiero R, Andreone V, Palma V, Spitaleri D, D'Onofrio F, Maniscalco G, Salvatore S, Leone G, Capone E, Schettino C, Romano D, Martusciello G, Miniello S, Mazzaferro MP, Ascione S. The Impact of Covid-19 Lockdown on Stroke Admissions and Treatments in Campania. J Stroke Cerebrovasc Dis 2021;30:105448. [PMID: 33166767 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
342 Kogan EA, Berezovsky YS, Protsenko DD, Bagdasaryan TR, Gretsov EM, Demura SA, Demyashkin GA, Kalinin DV, Kukleva AD, Kurilina EV, Nekrasova TP, Paramonova NB, Ponomarev AB, Radenska-lopovok SG, Semyonova LA, Tertychny AS. PATHOLOGICAL ANATOMY OF INFECTION CAUSED BY SARS-COV-2. Sud med (Online) 2020;6:8-30. [DOI: 10.19048/2411-8729-2020-6-2-8-30] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 6.5] [Reference Citation Analysis]
343 Rafiq M, Macías-Díaz JE, Raza A, Ahmed N. Design of a nonlinear model for the propagation of COVID-19 and its efficient nonstandard computational implementation. Appl Math Model 2021;89:1835-46. [PMID: 32982020 DOI: 10.1016/j.apm.2020.08.082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
344 Goodarzi P, Mahdavi F, Mirzaei R, Hasanvand H, Sholeh M, Zamani F, Sohrabi M, Tabibzadeh A, Jeda AS, Niya MHK, Keyvani H, Karampoor S. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments. Int Immunopharmacol 2020;88:106885. [PMID: 32795893 DOI: 10.1016/j.intimp.2020.106885] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
345 Salah HM, Naser JA, Calcaterra G, Bassareo PP, Mehta JL. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection. Am J Cardiol 2020;134:155-7. [PMID: 32892991 DOI: 10.1016/j.amjcard.2020.08.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
346 Páramo JA. Inflammatory Response in Relation to COVID-19 and Other Prothrombotic Phenotypes. Reumatol Clin (Engl Ed) 2020:S1699-258X(20)30143-1. [PMID: 32600978 DOI: 10.1016/j.reuma.2020.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
347 MacDougall K, Spyropoulos AC. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era. Semin Respir Crit Care Med 2021;42:308-15. [PMID: 33548931 DOI: 10.1055/s-0041-1723018] [Reference Citation Analysis]
348 Roe K. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis. Transbound Emerg Dis 2020;67:1418-21. [PMID: 32436629 DOI: 10.1111/tbed.13634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
349 Rodriguez F, Solomon N, de Lemos JA, Das SR, Morrow DA, Bradley SM, Elkind MSV, Williams JH, Holmes D, Matsouaka RA, Gupta D, Gluckman TJ, Abdalla M, Albert MA, Yancy CW, Wang TY. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry. Circulation 2021;143:2332-42. [PMID: 33200953 DOI: 10.1161/CIRCULATIONAHA.120.052278] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
350 Kamel MH, Yin W, Zavaro C, Francis JM, Chitalia VC. Hyperthrombotic Milieu in COVID-19 Patients. Cells 2020;9:E2392. [PMID: 33142844 DOI: 10.3390/cells9112392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
351 Hsieh JYC, Kan JYL, Mattar SAM, Qin Y. The clinical implications of sinus tachycardia in mild COVID-19 infection: A retrospective cohort study. SAGE Open Med 2021;9:20503121211054973. [PMID: 34733514 DOI: 10.1177/20503121211054973] [Reference Citation Analysis]
352 Fu B, Chen Y, Li P. 2019 novel coronavirus disease with secondary ischemic stroke: two case reports. BMC Neurol 2021;21:4. [PMID: 33397310 DOI: 10.1186/s12883-020-02033-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
353 Cordie A, Gaber Y, AbdAllah M, Vergori A, Kharono B, Omran S, Afify S, Karkouri M, Chakroun M, Musa S, Moorhouse M, Esmat G. Gastrointestinal manifestations of human immunodeficiency virus and coronavirus disease 2019: Understanding the intersecting regions between the two epidemics. Arab J Gastroenterol 2021;22:75-87. [PMID: 34120849 DOI: 10.1016/j.ajg.2021.05.014] [Reference Citation Analysis]
354 Bersano A, Kraemer M, Touzé E, Weber R, Alamowitch S, Sibon I, Pantoni L. Stroke care during the COVID-19 pandemic: experience from three large European countries. Eur J Neurol 2020;27:1794-800. [PMID: 32492764 DOI: 10.1111/ene.14375] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 24.0] [Reference Citation Analysis]
355 Haddad K, Potter BJ, Matteau A, Gobeil F, Mansour S. Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter. Cardiovasc Revasc Med 2021;30:33-7. [PMID: 32988743 DOI: 10.1016/j.carrev.2020.09.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
356 Shih M, Swearingen B, Rhee R. Ruptured Abdominal Aortic Aneurysm Treated with Endovascular Repair in a Patient with Active COVID-19 Infection during the Pandemic. Ann Vasc Surg 2020;66:14-7. [PMID: 32437918 DOI: 10.1016/j.avsg.2020.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
357 Komiya K, Hamanaka R, Shuto H, Yoshikawa H, Yokoyama A, Hiramatsu K, Kadota JI. Re-expansion pulmonary edema following a pneumothorax drainage in a patient with COVID-19. BMC Pulm Med 2021;21:293. [PMID: 34530790 DOI: 10.1186/s12890-021-01661-w] [Reference Citation Analysis]
358 Keshavarz P, Rafiee F, Kavandi H, Goudarzi S, Heidari F, Gholamrezanezhad A. Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation. Clin Imaging. 2021;73:86-95. [PMID: 33341452 DOI: 10.1016/j.clinimag.2020.11.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
359 Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M. The looming storm: Blood and cytokines in COVID-19. Blood Rev 2021;46:100743. [PMID: 32829962 DOI: 10.1016/j.blre.2020.100743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
360 Trunz LM, Lee P, Lange SM, Pomeranz CL, Needleman L, Ford RW, Karambelkar A, Sundaram B. Imaging approach to COVID-19 associated pulmonary embolism. Int J Clin Pract 2021;:e14340. [PMID: 33966326 DOI: 10.1111/ijcp.14340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
361 Hippensteel JA, Burnham EL, Jolley SE. Prevalence of venous thromboembolism in critically ill patients with COVID-19. Br J Haematol 2020;190:e134-7. [PMID: 32484907 DOI: 10.1111/bjh.16908] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
362 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
363 Gomes BPFA, Arruda-Vasconcelos R, Louzada LM, Almeida-Gomes RF, de-Jesus-Soares A, Almeida LRF, Baldacci ER. SARS-CoV-2: A Professional and social gamechanger - Medical and dental aspects. Braz Dent J 2021;32:41-54. [PMID: 34877977 DOI: 10.1590/0103-6440202104144] [Reference Citation Analysis]
364 Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
365 Mihalick VL, Canada JM, Arena R, Abbate A, Kirkman DL. Cardiopulmonary exercise testing during the COVID-19 pandemic. Prog Cardiovasc Dis 2021;67:35-9. [PMID: 33964290 DOI: 10.1016/j.pcad.2021.04.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open 2020;3:e2013136. [PMID: 32579195 DOI: 10.1001/jamanetworkopen.2020.13136] [Cited by in Crossref: 150] [Cited by in F6Publishing: 146] [Article Influence: 75.0] [Reference Citation Analysis]
367 Baldacini M, Pop R, Sattler L, Mauvieux L, Bilger K, Gantzer J, Schneider F, Beaujeux R, Simand C, Herbrecht R. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia. Br J Haematol 2020;189:1054-6. [PMID: 32369614 DOI: 10.1111/bjh.16768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
368 Ali S, Mathew S, Pappachan JM. Acute cor pulmonale from saddle pulmonary embolism in a patient with previous COVID-19: should we prolong prophylactic anticoagulation? Int J Infect Dis. 2020;97:299-302. [PMID: 32544670 DOI: 10.1016/j.ijid.2020.06.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
369 Czupryniak L, Dicker D, Lehmann R, Prázný M, Schernthaner G. The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence? Cardiovasc Diabetol 2021;20:198. [PMID: 34598700 DOI: 10.1186/s12933-021-01389-1] [Reference Citation Analysis]
370 Fröhlich GM, Jeschke E, Eichler U, Thiele H, Alhariri L, Reinthaler M, Kastrati A, Leistner DM, Skurk C, Landmesser U, Günster C. Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany. Clin Res Cardiol 2021;110:1041-50. [PMID: 33416918 DOI: 10.1007/s00392-020-01783-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
371 Blanco-Tarrio E, Blanco Sánchez G. [Primary care, residential homes for the elderly, and COVID-19]. Semergen 2020;46 Suppl 1:26-34. [PMID: 32600935 DOI: 10.1016/j.semerg.2020.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
372 Salabei JK, Fishman TJ, Asnake ZT, Ali A, Iyer UG. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung 2021;50:357-60. [PMID: 33524866 DOI: 10.1016/j.hrtlng.2021.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
373 Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, Püschel K, Kluge S. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med 2020;173:268-77. [PMID: 32374815 DOI: 10.7326/M20-2003] [Cited by in Crossref: 913] [Cited by in F6Publishing: 682] [Article Influence: 456.5] [Reference Citation Analysis]
374 Ong WY, Go ML, Wang DY, Cheah IK, Halliwell B. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications. Mol Neurobiol 2021;58:106-17. [PMID: 32897518 DOI: 10.1007/s12035-020-02093-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
375 Tankere P, Cottenet J, Tubert-Bitter P, Mariet AS, Beltramo G, Cadranel J, Piroth L, Bonniaud P, Quantin C. Impact of COVID-19 and lockdowns on pulmonary embolism in hospitalized patients in France: a nationwide study. Respir Res 2021;22:298. [PMID: 34801044 DOI: 10.1186/s12931-021-01887-6] [Reference Citation Analysis]
376 Pandiar D, Kumar NS, Anand R, Kamboj M, Narwal A, Shameena PM. Does COVID 19 generate a milieu for propagation of mucormycosis? Med Hypotheses 2021;152:110613. [PMID: 34087613 DOI: 10.1016/j.mehy.2021.110613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
377 Vergori A, Lorenzini P, Cozzi-Lepri A, Donno DR, Gualano G, Nicastri E, Iacomi F, Marchioni L, Campioni P, Schininà V, Cicalini S, Agrati C, Capobianchi MR, Girardi E, Ippolito G, Vaia F, Petrosillo N, Antinori A, Taglietti F; ReCOVeRI Study Group. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia. Sci Rep 2021;11:11334. [PMID: 34059708 DOI: 10.1038/s41598-021-90713-6] [Reference Citation Analysis]
378 Anwaar MU, Adnan F, Abro A, Khan RA, Rehman AU, Osama M, Rainville C, Kumar S, Sterner D, Javed S, Jamal SB, Baig A, Shabbir MR, Ahsan W, Butt TR, Assir MZ. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. Comput Biol Med 2021;:105049. [PMID: 34823857 DOI: 10.1016/j.compbiomed.2021.105049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Kim HK, Tantry US, Smith SC Jr, Jeong MH, Park SJ, Kim MH, Lim DS, Shin ES, Park DW, Huo Y, Chen SL, Bo Z, Goto S, Kimura T, Yasuda S, Chen WJ, Chan M, Aradi D, Geisler T, Gorog DA, Sibbing D, Lip GYH, Angiolillo DJ, Gurbel PA, Jeong YH. The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. Thromb Haemost 2021;121:422-32. [PMID: 33171520 DOI: 10.1055/s-0040-1718729] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
380 Belcaro G, Corsi M, Agus GB, Cesarone MR, Cornelli U, Cotellese R, Feragalli B, Hu S. Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study. Minerva Med 2020;111:366-8. [PMID: 33032396 DOI: 10.23736/S0026-4806.20.06688-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
381 Parker K, Hamilton P, Hanumapura P, Castelino L, Murphy M, Challiner R, Thachil J, Ebah L. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients. BMC Nephrol 2021;22:224. [PMID: 34134645 DOI: 10.1186/s12882-021-02436-5] [Reference Citation Analysis]
382 Inama G, Dodi C, Provini M, Bossoni E, Inama L, Balzarini L, Mancini C, Ramponi S, Marvisi M. Coronavirus disease 2019 infection in patients with recent cardiac surgery: does chronic anticoagulant therapy have a protective effect? J Cardiovasc Med (Hagerstown) 2020;21:765-71. [PMID: 32890069 DOI: 10.2459/JCM.0000000000001066] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
383 Rubartelli P, Toselli A, Camerini A, Lupi G, Romeo M. A patient with COVID-19 presenting multiple thrombi in the left ventricle. Acta Cardiol 2021;76:211-3. [PMID: 33016817 DOI: 10.1080/00015385.2020.1826702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Xu Q, Wang T, Lu W. Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report. Open Life Sci 2021;16:809-14. [PMID: 34485700 DOI: 10.1515/biol-2021-0088] [Reference Citation Analysis]
385 Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, Aronne L, Puskarich M, Tamariz L, Palacio A, Bomberg E, Usher M, King S, Benson B, Vojta D, Tignanelli C, Ingraham N. Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. Front Endocrinol (Lausanne) 2021;12:587801. [PMID: 34367059 DOI: 10.3389/fendo.2021.587801] [Reference Citation Analysis]
386 Khandait H, Gandotra G, Sachdeva S, Kramer CA, Nye D, Golamari R, Jain R. COVID-19 and Hematology-What Do We Know So Far? SN Compr Clin Med 2020;:1-6. [PMID: 33134847 DOI: 10.1007/s42399-020-00607-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
387 [DOI: 10.1101/2020.06.05.20113738] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
388 Aghaei Moghadam E, Mahmoudi S, Safari Sharari A, Afsharipour M, Gorji M, Navaeian A, Ghamari A, Mamishi S. Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report. Thromb J 2021;19:31. [PMID: 33980250 DOI: 10.1186/s12959-021-00285-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
389 Noris M, Benigni A, Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020;98:314-322. [PMID: 32461141 DOI: 10.1016/j.kint.2020.05.013] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 58.0] [Reference Citation Analysis]
390 Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovasc Diabetol 2020;19:114. [PMID: 32690029 DOI: 10.1186/s12933-020-01089-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
391 Aliter KF, Al-Horani RA. Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients. Curr Pharm Des 2021;27:866-75. [PMID: 33001004 DOI: 10.2174/1381612826666201001125604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
392 Kite TA, Ludman PF, Gale CP, Wu J, Caixeta A, Mansourati J, Sabate M, Jimenez-Quevedo P, Candilio L, Sadeghipour P, Iniesta AM, Hoole SP, Palmer N, Ariza-Solé A, Namitokov A, Escutia-Cuevas HH, Vincent F, Tica O, Ngunga M, Meray I, Morrow A, Arefin MM, Lindsay S, Kazamel G, Sharma V, Saad A, Sinagra G, Sanchez FA, Roik M, Savonitto S, Vavlukis M, Sangaraju S, Malik IS, Kean S, Curzen N, Berry C, Stone GW, Gersh BJ, Gershlick AH; International COVID-ACS Registry Investigators. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol 2021;77:2466-76. [PMID: 34016259 DOI: 10.1016/j.jacc.2021.03.309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
393 Luan YY, Liu Y, Liu XY, Yu BJ, Chen RL, Peng M, Ren D, Li HL, Huang L, Li JX, Feng YW, Wu M. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study. Thromb Res. 2020;195:62-68. [PMID: 32659462 DOI: 10.1016/j.thromres.2020.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
394 Ulanowska M, Olas B. Modulation of Hemostasis in COVID-19; Blood Platelets May Be Important Pieces in the COVID-19 Puzzle. Pathogens 2021;10:370. [PMID: 33808640 DOI: 10.3390/pathogens10030370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 McBane RD 2nd, Torres Roldan VD, Niven AS, Pruthi RK, Franco PM, Linderbaum JA, Casanegra AI, Oyen LJ, Houghton DE, Marshall AL, Ou NN, Siegel JL, Wysokinski WE, Padrnos LJ, Rivera CE, Flo GL, Shamoun FE, Silvers SM, Nayfeh T, Urtecho M, Shah S, Benkhadra R, Saadi SM, Firwana M, Jawaid T, Amin M, Prokop LJ, Murad MH. Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc 2020;95:2467-86. [PMID: 33153635 DOI: 10.1016/j.mayocp.2020.08.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
396 Donatelli F, Miceli A, Glauber M, Cirri S, Maiello C, Coscioni E, Napoli C. Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience. Interact Cardiovasc Thorac Surg 2020;31:755-62. [PMID: 33099647 DOI: 10.1093/icvts/ivaa186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
397 Vanassche T, Orlando C, Vandenbosch K, Gadisseur A, Hermans C, Jochmans K, Minon JM, Motte S, Peperstraete H, Péters P, Sprynger M, Lancellotti P, Dehaene I, Emonts P, Vandenbriele C, Verhamme P, Oury C. Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19. Acta Clin Belg 2020;:1-6. [PMID: 33012274 DOI: 10.1080/17843286.2020.1829252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
398 Ghirardello S, Lecchi A, Artoni A, Panigada M, Aliberti S, Scalambrino E, La Marca S, Boscarino M, Gramegna A, Properzi P, Abruzzese C, Blasi F, Grasselli G, Mosca F, Tripodi A, Peyvandi F. Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study. Thromb Haemost 2021;121:1087-96. [PMID: 33545735 DOI: 10.1055/s-0041-1722919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
399 Goette A, Patscheke M, Henschke F, Hammwöhner M. COVID-19-Induced Cytokine Release Syndrome Associated with Pulmonary Vein Thromboses, Atrial Cardiomyopathy, and Arterial Intima Inflammation. TH Open 2020;4:e271-9. [PMID: 32995705 DOI: 10.1055/s-0040-1716717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
400 Subramaniam S, Ogoti Y, Hernandez I, Zogg M, Botros F, Burns R, DeRousse JT, Dockendorff C, Mackman N, Antoniak S, Fletcher C, Weiler H. A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C). Blood Adv 2021;5:2760-74. [PMID: 34242391 DOI: 10.1182/bloodadvances.2021004360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Wengerter SP, Wengerter KR, Masoudpoor H, Sagarwala A, Karim O, Rao N, Gillen J, Choi HM, Bernik T, Schwartz ML. Acute aortoiliac and infrainguinal arterial thrombotic events in four patients diagnosed with the novel coronavirus 2019. J Vasc Surg Cases Innov Tech 2020;6:698-702. [PMID: 33102991 DOI: 10.1016/j.jvscit.2020.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
402 Kogan EA, Kukleva AD, Berezovskiy YS, Blagova OV, Zharkov NV, Ainetdinova DK, Demyashkin GA. [Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue]. Arkh Patol 2021;83:5-13. [PMID: 34278755 DOI: 10.17116/patol2021830415] [Reference Citation Analysis]
403 Ceriello A, Prattichizzo F. Pharmacological management of COVID-19 in type 2 diabetes. J Diabetes Complications 2021;35:107927. [PMID: 33896714 DOI: 10.1016/j.jdiacomp.2021.107927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
404 Ghosh R, Roy D, Roy D, Mandal A, Dutta A, Naga D, Benito-León J. A Rare Case of SARS-CoV-2 Infection Associated With Pituitary Apoplexy Without Comorbidities. J Endocr Soc 2021;5:bvaa203. [PMID: 33501401 DOI: 10.1210/jendso/bvaa203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
405 Mann R, Perisetti A, Gajendran M, Gandhi Z, Umapathy C, Goyal H. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Front Med (Lausanne). 2020;7:581521. [PMID: 33282890 DOI: 10.3389/fmed.2020.581521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
406 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
407 Griffin DO, Jensen A, Khan M, Chin J, Chin K, Parnell R, Awwad C, Patel D. Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis. Br J Haematol 2020;190:e11-3. [PMID: 32374029 DOI: 10.1111/bjh.16792] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
408 Ganjali S, Bianconi V, Penson PE, Pirro M, Banach M, Watts GF, Sahebkar A. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone. Metabolism 2020;113:154375. [PMID: 32976855 DOI: 10.1016/j.metabol.2020.154375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
409 Morgenstern-Kaplan D, Buitano-Tang B, Martínez-Gil M, Zaldívar-Pérez Pavón A, Talavera JO. U-shaped-aggressiveness of SARS-CoV-2: Period between initial symptoms and clinical progression to COVID-19 suspicion. A population-based cohort study. PLoS One 2020;15:e0243268. [PMID: 33270769 DOI: 10.1371/journal.pone.0243268] [Reference Citation Analysis]
410 Natarajan JP, Mahenthiran AK, Bertges DJ, Huffman KM, Eldrup-Jorgensen J, Lemmon GW. Effects of coronavirus disease 2019 on the Society for Vascular Surgery Vascular Quality Initiative arterial procedure registry. J Vasc Surg 2021;73:1852-7. [PMID: 33548419 DOI: 10.1016/j.jvs.2020.12.087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
411 Rao GSNK, Gowthami B, Naveen NR, Samudrala PK. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100063. [PMID: 34870158 DOI: 10.1016/j.crphar.2021.100063] [Reference Citation Analysis]
412 Hernandez JJ, Beaty DE, Fruhwirth LL, Lopes Chaves AP, Riordan NH. Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells. J Transl Med 2021;19:149. [PMID: 33853637 DOI: 10.1186/s12967-021-02813-6] [Reference Citation Analysis]
413 Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020;24:100434. [PMID: 32766543 DOI: 10.1016/j.eclinm.2020.100434] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 90.0] [Reference Citation Analysis]
414 Ozcelik N, Ozyurt S, Yilmaz Kara B, Gumus A, Sahin U. The value of the platelet count and platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol 2021;93:2221-6. [PMID: 33135801 DOI: 10.1002/jmv.26645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
415 Sadler C, Alvarez Villela M, Van Hoesen K, Grover I, Lang M, Neuman T, Lindholm P. Diving after SARS-CoV-2 (COVID-19) infection: Fitness to dive assessment and medical guidance. Diving Hyperb Med 2020;50:278-87. [PMID: 32957131 DOI: 10.28920/dhm50.3.278-287] [Reference Citation Analysis]
416 Laghlam D, Rahoual G, Malvy J, Estagnasié P, Brusset A, Squara P. Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19. Front Med (Lausanne) 2021;8:655763. [PMID: 34277653 DOI: 10.3389/fmed.2021.655763] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
417 Mohanty SS, Sahoo CR, Padhy RN. Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19. AAPS PharmSciTech 2021;22:214. [PMID: 34378108 DOI: 10.1208/s12249-021-02089-5] [Reference Citation Analysis]
418 Singh K, Chen YC, Hassanzadeh S, Han K, Judy JT, Seifuddin F, Tunc I, Sack MN, Pirooznia M. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection. Front Genet 2021;12:599261. [PMID: 33796130 DOI: 10.3389/fgene.2021.599261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
419 Dauerman HL. The Unbearable Thrombus of COVID-19: Primary PCI, Thrombus, and COVID-19. J Am Coll Cardiol 2020;76:1177-80. [PMID: 32883410 DOI: 10.1016/j.jacc.2020.07.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
420 Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, Rosenson RS, Fuster V. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar. J Am Coll Cardiol 2020;76:1999-2010. [PMID: 33092736 DOI: 10.1016/j.jacc.2020.08.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
421 Lozano-Montoya I, Quezada-Feijoo M, Jaramillo-Hidalgo J, Garmendia-Prieto B, Lisette-Carrillo P, Gómez-Pavón FJ. Mortality risk factors in a Spanish cohort of oldest-old patients hospitalized with COVID-19 in an acute geriatric unit: the OCTA-COVID study. Eur Geriatr Med 2021. [PMID: 34287813 DOI: 10.1007/s41999-021-00541-0] [Reference Citation Analysis]
422 Martinot M, Eyriey M, Gravier S, Bonijoly T, Kayser D, Ion C, Mohseni-Zadeh M, Camara S, Dubois J, Haerrel E, Drouaine J, Kaiser J, Ongagna JC, Schieber-Pachart A, Kempf C; Centre Alsace COVID-19 Study Group. Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients. Infect Dis Now 2021:S2666-9919(21)00425-5. [PMID: 34242842 DOI: 10.1016/j.idnow.2021.07.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Lippi G, Sanchis-Gomar F, Favaloro EJ, Lavie CJ, Henry BM. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc 2021;96:203-17. [PMID: 33413819 DOI: 10.1016/j.mayocp.2020.10.031] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
424 Li W, Yue H. Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner. Front Med (Lausanne) 2021;8:653773. [PMID: 33829029 DOI: 10.3389/fmed.2021.653773] [Reference Citation Analysis]
425 Betsch D, Freund PR. Neuro-Ophthalmologic Manifestations of Novel Coronavirus. Adv Ophthalmol Optom 2021;6:275-88. [PMID: 33937586 DOI: 10.1016/j.yaoo.2021.04.017] [Reference Citation Analysis]
426 Liu D, Zeng X, Ding Z, Lv F, Mehta JL, Wang X. Adverse Cardiovascular Effects of Anti-COVID-19 Drugs. Front Pharmacol 2021;12:699949. [PMID: 34512335 DOI: 10.3389/fphar.2021.699949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Jacob MHF, Leal TCAT, Soares PR, Soeiro AM. Mechanical Aortic Prosthetic Thrombosis in a 65-Year-Old Woman with SARS-CoV-2 Infection. Arq Bras Cardiol 2020;115:1180-3. [PMID: 33470321 DOI: 10.36660/abc.20200754] [Reference Citation Analysis]
428 Tamargo J. Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? Int J Cardiol 2021;331:340-1. [PMID: 33515615 DOI: 10.1016/j.ijcard.2021.01.019] [Reference Citation Analysis]
429 Cai M, Chen X, Shan J, Yang R, Guo Q, Bi X, Xu P, Shi X, Chu L, Wang L. Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation. Front Pharmacol 2021;12:643619. [PMID: 33995053 DOI: 10.3389/fphar.2021.643619] [Reference Citation Analysis]
430 Mohammad RA, Nguyen CT, Costello PG, Poyant JO, Yan Amy Yeung S, Landolf K, Kim A, Artman KL, Taylor DC, Kenes MT, Alkhateeb T, Stollings JL. Medication Changes and Diagnosis of New Chronic Illnesses in COVID-19 Intensive Care Unit Survivors. Ann Pharmacother. [DOI: 10.1177/10600280211063319] [Reference Citation Analysis]
431 DiNicolantonio JJ, McCarty M. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase. Open Heart 2020;7:e001337. [PMID: 32532805 DOI: 10.1136/openhrt-2020-001337] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
432 Sharma A, Matta A, Matta D, Bande D. Non-ST Segment Elevation Myocardial Infarction Secondary to Coronary Multi-Vessel Thrombosis in the Setting of COVID-19. Cureus 2021;13:e19258. [PMID: 34881121 DOI: 10.7759/cureus.19258] [Reference Citation Analysis]
433 Ciaccio M, Agnello L. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berl) 2020;7:365-72. [PMID: 32589600 DOI: 10.1515/dx-2020-0057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
434 Dabbish AM, Yonis N, Salama M, Essa MM, Qoronfleh MW. Inflammatory pathways and potential therapies for COVID-19: A mini review. Eur J Inflamm 2021;19:205873922110029. [DOI: 10.1177/20587392211002986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
435 Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, Turagam MK, Lakkireddy D, Garg J. Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Cardiol Rev. 2020;28:295-302. [PMID: 33017364 DOI: 10.1097/crd.0000000000000330] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
436 Gue YX, Tennyson M, Gao J, Ren S, Kanji R, Gorog DA. Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. Sci Rep 2020;10:21379. [PMID: 33288840 DOI: 10.1038/s41598-020-78505-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
437 Paone G. Commentary: Cause for concern or 1 in 33 million? JTCVS Tech 2020;4:114-5. [PMID: 33111130 DOI: 10.1016/j.xjtc.2020.10.033] [Reference Citation Analysis]
438 Endres P, Rosovsky R, Zhao S, Krinsky S, Percy S, Kamal O, Roberts RJ, Lopez N, Sise ME, Steele DJR, Lundquist AL, Rhee EP, Hibbert KA, Hardin CC, Mc Causland FR, Czarnecki PG, Mutter W, Tolkoff-Rubin N, Allegretti AS. Filter clotting with continuous renal replacement therapy in COVID-19. J Thromb Thrombolysis 2021;51:966-70. [PMID: 33026569 DOI: 10.1007/s11239-020-02301-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
439 Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, Cooke EA, Woeste MR, Martin ZC, Chen O, Bush SE, Zhang HG, Cavallazzi R, Clifford SP, Chen J, Ghare S, Barve SS, Cai L, Kong M, Rouchka EC, McLeish KR, Uriarte SM, Watson CT, Huang J, Yan J. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. JCI Insight 2021;6:148435. [PMID: 33986193 DOI: 10.1172/jci.insight.148435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
440 Pamukçu B. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. Anatol J Cardiol 2020;24:224-34. [PMID: 33001051 DOI: 10.14744/AnatolJCardiol.2020.56727] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
441 Fraiman P, Godeiro Junior C, Moro E, Cavallieri F, Zedde M. COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management. Front Neurol 2020;11:574694. [PMID: 33250845 DOI: 10.3389/fneur.2020.574694] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
442 Vyas V, Kanagalingam G, Yadava S, Gambhir HS, Costanza M, Chaudhuri D. Bilateral pulmonary artery thrombectomy with saddle embolism and COVID-19 infection. Proc (Bayl Univ Med Cent) 2020;33:666-7. [PMID: 33100564 DOI: 10.1080/08998280.2020.1799133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
443 Sobol I, Yuzefpolskaya M, Roth Z, Colombo PC, Horn E, Takeda K, Sayer G, Uriel N, Naka Y. Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19. J Card Fail. 2020;26:895-897. [PMID: 32956813 DOI: 10.1016/j.cardfail.2020.09.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
444 Lorenzo C, Francesca B, Francesco P, Elena C, Luca S, Paolo S. Acute pulmonary embolism in COVID-19 related hypercoagulability. J Thromb Thrombolysis 2020;50:223-6. [PMID: 32474757 DOI: 10.1007/s11239-020-02160-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
445 Lee CH, Franchi F, Angiolillo DJ. Clopidogrel drug interactions: a review of the evidence and clinical implications. Expert Opin Drug Metab Toxicol 2020;16:1079-96. [PMID: 32835535 DOI: 10.1080/17425255.2020.1814254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
446 Maldonado E, Tao D, Mackey K. Antithrombotic Therapies in COVID-19 Disease: a Systematic Review. J Gen Intern Med. 2020;35:2698-2706. [PMID: 32556875 DOI: 10.1007/s11606-020-05906-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
447 Avruscio G, Camporese G, Campello E, Bernardi E, Persona P, Passarella C, Noventa F, Cola M, Navalesi P, Cattelan A, Tiberio I, Boscolo A, Spiezia L, Simioni P; COVID-VTE Study Group. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward. Clin Transl Sci 2020;13:1108-14. [PMID: 32989908 DOI: 10.1111/cts.12907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
448 Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
449 Naderi M, Malek F, Miri Aliabad G, Behnampoor M, Karimi M, De Sanctis V. Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations. Acta Biomed 2020;91:e2020028. [PMID: 32921723 DOI: 10.23750/abm.v91i3.10203] [Reference Citation Analysis]
450 Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
451 Colantuoni A, Martini R, Caprari P, Ballestri M, Capecchi PL, Gnasso A, Lo Presti R, Marcoccia A, Rossi M, Caimi G. COVID-19 Sepsis and Microcirculation Dysfunction. Front Physiol 2020;11:747. [PMID: 32676039 DOI: 10.3389/fphys.2020.00747] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
452 Ventura-Díaz S, Quintana-Pérez JV, Gil-Boronat A, Herrero-Huertas M, Gorospe-Sarasúa L, Montilla J, Acosta-Batlle J, Blázquez-Sánchez J, Vicente-Bártulos A. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study. Emerg Radiol 2020;27:679-89. [PMID: 33025219 DOI: 10.1007/s10140-020-01859-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
453 Agus M, Ferrara ME, Bianco P, Manieli C, Mura P, Sechi R, Runfola M, Polo F, Cillara N. Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature. Case Rep Surg 2021;2021:5553619. [PMID: 34194865 DOI: 10.1155/2021/5553619] [Reference Citation Analysis]
454 Ansari-Lari M, Saadat M. The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups. Eur J Prev Cardiol 2021;28:e26-8. [PMID: 34551081 DOI: 10.1177/2047487320939216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
455 Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM, Cretu O. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening. J Clin Med 2020;9:E2084. [PMID: 32630746 DOI: 10.3390/jcm9072084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
456 Medvedev VE, Frolova VI, Gushanskaya EV, Kotova OV, Zuikova NL, Palin AV. [Astenic disorders within the framework of post-covid syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:152-8. [PMID: 34037369 DOI: 10.17116/jnevro2021121041152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Hayama H, Ide S, Moroi M, Kitami Y, Bekki N, Kubota S, Uemura Y, Hara H, Kutsuna S, Ohmagari N, Hiroi Y. Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019. Glob Health Med 2021;3:95-101. [PMID: 33937572 DOI: 10.35772/ghm.2021.01025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Zhou X, Cheng Z, Luo L, Zhu Y, Lin W, Ming Z, Chen W, Hu Y. Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis. Thromb Res 2021;201:23-9. [PMID: 33631519 DOI: 10.1016/j.thromres.2021.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
459 Dima M, Enatescu I, Craina M, Petre I, Iacob ER, Iacob D. First neonates with severe acute respiratory syndrome coronavirus 2 infection in Romania: Three case reports. Medicine (Baltimore) 2020;99:e21284. [PMID: 32871986 DOI: 10.1097/MD.0000000000021284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
460 Vechi HT, Maia LR, Alves MDM. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Rev Inst Med Trop Sao Paulo 2020;62:e63. [PMID: 32901760 DOI: 10.1590/S1678-9946202062063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
461 Abdulgayoom M, Abdelmahmuod E, Elfaki A, Halabiya MA. Cerebral Venous Sinus Thrombosis as an Unexpected Complication of COVID-19 Pneumonia. Cureus 2021;13:e16498. [PMID: 34430113 DOI: 10.7759/cureus.16498] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Menezes MCS, Pestana DVS, Gameiro GR, da Silva LFF, Baron Ė, Rouby JJ, Auler JOC Jr. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review. Crit Care 2021;25:53. [PMID: 33557908 DOI: 10.1186/s13054-020-03399-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
463 Tan BK, Mainbourg S, Friggeri A, Bertoletti L, Douplat M, Dargaud Y, Grange C, Lobbes H, Provencher S, Lega JC. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax 2021:thoraxjnl-2020-215383. [PMID: 33622981 DOI: 10.1136/thoraxjnl-2020-215383] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 21.0] [Reference Citation Analysis]
464 Poterucha TJ, Elias P, Jain SS, Sayer G, Redfors B, Burkhoff D, Rosenblum H, DeFilippis EM, Gupta A, Lawlor M, Madhavan MV, Griffin J, Raikhelkar J, Fried J, Clerkin KJ, Kim A, Perotte A, Maurer MS, Saluja D, Dizon J, Ehlert FA, Morrow JP, Yarmohammadi H, Biviano AB, Garan H, Rabbani L, Leon MB, Schwartz A, Uriel N, Wan EY. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc 2021;10:e018476. [PMID: 33169643 DOI: 10.1161/JAHA.120.018476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
465 Chohan A, Chohan F, Rad P, Michel G, Yatzkan G. Cerebral Venous Sinus Thrombosis in a Patient With Mild Symptoms of COVID-19 Pneumonia. Cureus 2021;13:e19885. [PMID: 34966603 DOI: 10.7759/cureus.19885] [Reference Citation Analysis]
466 Ilyas S, Henkin S, Martinez-Camblor P, Suckow BD, Beach JM, Stone DH, Goodney PP, Ebinger JE, Creager MA, Columbo JA. Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19. J Am Heart Assoc 2021;10:e022829. [PMID: 34845920 DOI: 10.1161/JAHA.121.022829] [Reference Citation Analysis]
467 Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir Res 2020;21:198. [PMID: 32723327 DOI: 10.1186/s12931-020-01462-5] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 57.0] [Reference Citation Analysis]
468 Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract 2020;10:1271. [PMID: 32509258 DOI: 10.4081/cp.2020.1271] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 52.0] [Reference Citation Analysis]
469 Galwankar SC, Paladino L, Gaieski DF, Nanayakkara KDPWB, Somma SD, Grover J, Stawicki SP. Management Algorithm for Subclinical Hypoxemia in Coronavirus Disease-2019 Patients: Intercepting the "Silent Killer". J Emerg Trauma Shock 2020;13:110-3. [PMID: 33013088 DOI: 10.4103/JETS.JETS_72_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
470 Gaddh M, Maier CL. Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center. JCO Oncol Pract 2021;:OP2001056. [PMID: 34019440 DOI: 10.1200/OP.20.01056] [Reference Citation Analysis]
471 Dagar S, Rathi V. Incidental floating aortic thrombus in severe pulmonary COVID-19 infection. Indian J Med Res 2021;153:705-6. [PMID: 34145086 DOI: 10.4103/ijmr.IJMR_4590_20] [Reference Citation Analysis]
472 Scudiero F, Pitì A, Keim R, Parodi G. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J Case Rep 2021;5:ytaa388. [PMID: 33542972 DOI: 10.1093/ehjcr/ytaa388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
473 Fazio S, Tufano A, de Simone G. Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2021. [PMID: 33962473 DOI: 10.1055/s-0041-1729857] [Reference Citation Analysis]
474 Kuno T, So M, Takahashi M, Egorova NN. Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid. J Thromb Thrombolysis 2021. [PMID: 34528165 DOI: 10.1007/s11239-021-02569-2] [Reference Citation Analysis]
475 Gauchel N, Krauel K, Hamad MA, Bode C, Duerschmied D. Thromboinflammation as a Driver of Venous Thromboembolism. Hamostaseologie 2021;41:428-32. [PMID: 34942655 DOI: 10.1055/a-1661-0257] [Reference Citation Analysis]
476 Zamboni P. Vascular Biomarkers: Physics Parameters and Circulating Molecules Can Be Two Faces of the Same Coin. Diagnostics (Basel) 2021;11:217. [PMID: 33540677 DOI: 10.3390/diagnostics11020217] [Reference Citation Analysis]
477 Lega S, Naviglio S, Volpi S, Tommasini A. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19. Vaccines (Basel) 2020;8:E224. [PMID: 32423059 DOI: 10.3390/vaccines8020224] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
478 Martínez-Botía P, Bernardo Á, Acebes-Huerta A, Caro A, Leoz B, Martínez-Carballeira D, Palomo-Antequera C, Soto I, Gutiérrez L. Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns. J Clin Med 2021;10:1073. [PMID: 33806709 DOI: 10.3390/jcm10051073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
479 Aladdin Y, Algahtani H, Shirah B. Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine. J Stroke Cerebrovasc Dis 2021;30:105938. [PMID: 34171649 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105938] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
480 Cazzola M, de Novellis V, Bianco A, Rogliani P, Matera MG. Disputes over the production and dissemination of misinformation in the time of COVID-19. Respir Med 2021;182:106380. [PMID: 33930690 DOI: 10.1016/j.rmed.2021.106380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
481 Debela D, Ababulgu E, Desu G, Abebe S, Adugna T. Distal Deep Vein Thrombosis in a Patient Cured of Severe COVID-19 Pneumonia at Jimma, Oromia, Ethiopia 2021: A Rare Case Report. Int Med Case Rep J 2021;14:519-22. [PMID: 34393520 DOI: 10.2147/IMCRJ.S322301] [Reference Citation Analysis]
482 Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gómez-Arbeláez D, Ibarra G, Garcia-Gutierrez A. [Mortality of covid-19 patients with vascular thrombotic complications]. Med Clin (Barc) 2021;156:112-7. [PMID: 33342556 DOI: 10.1016/j.medcli.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
483 Meena RA, Sharifpour M, Gaddh M, Cui X, Xie Y, Di M, Brewster LP, Duwayri Y, Alabi O. COVID-19-associated venous thromboembolism portends worse survival. Semin Vasc Surg 2021;34:117-24. [PMID: 34642031 DOI: 10.1053/j.semvascsurg.2021.08.001] [Reference Citation Analysis]
484 Benson JC, Hunt CH, Klaas JP, Kallmes DF. Intracranial microhemorrhages in the setting of COVID-19: what we know so far. Neuroradiol J 2021;:19714009211004144. [PMID: 33765876 DOI: 10.1177/19714009211004144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Abohamr SI, Aldossari MA, Amer HA, Saadeddin HM, Abulhamid SW, Bhat FA, Elsheikh E. The Incidence of Acute Pulmonary Embolism with COVID-19 Pneumonia in Saudi Arabia: A Retrospective Single-Center Study. J Saudi Heart Assoc 2021;33:128-34. [PMID: 34183909 DOI: 10.37616/2212-5043.1253] [Reference Citation Analysis]
486 Ramadan MS, Bertolino L, Marrazzo T, Florio MT, Durante-Mangoni E; The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med 2021. [PMID: 34046852 DOI: 10.1007/s11739-021-02763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
487 Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? Cardiol Ther 2021. [PMID: 34191268 DOI: 10.1007/s40119-021-00232-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
488 Ai L, Jiang L, Xu Z, Yan H, Luo P, He Q. COVID-19 epidemic: a special focus on diagnosis, complications, and management. Expert Rev Clin Pharmacol 2020;13:1085-93. [PMID: 32896175 DOI: 10.1080/17512433.2020.1821651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
489 Jamir I, Lohia P, Pande RK, Setia R, Singhal AK, Chaudhary A. Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia. Ann Hepatobiliary Pancreat Surg 2020;24:526-32. [PMID: 33234758 DOI: 10.14701/ahbps.2020.24.4.526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
490 Stookey JD, Allu PKR, Chabas D, Pearce D, Lang F. Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19. Med Hypotheses 2020;144:110237. [PMID: 33254543 DOI: 10.1016/j.mehy.2020.110237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
491 Di Tano G, Moschini L, Loffi M, Testa S, Danzi GB. Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment. Eur J Case Rep Intern Med 2020;7:001790. [PMID: 32665940 DOI: 10.12890/2020_001790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
492 Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236-43. [PMID: 32802325 DOI: 10.1016/j.amsu.2020.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
493 Kessler C, Stricker H, Demundo D, Elzi L, Monotti R, Bianchi G, Llamas M, Spinedi L, Rossi D, Chiesa AF, Pagnamenta A, Conti M, Casso G, Stoira E, Valenti E, Colucci G, Stussi G, Gerber B, Previsdomini M. Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis. J Thromb Thrombolysis 2020;50:833-6. [PMID: 32803737 DOI: 10.1007/s11239-020-02244-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
494 Liang HW, Mung SM, Douglass C, Jude EB. COVID-19-related vasculopathy of the brain. BMJ Case Rep 2021;14:e242028. [PMID: 34315736 DOI: 10.1136/bcr-2021-242028] [Reference Citation Analysis]
495 Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, Jia T, Zhao Y, Wang D, Xiao A, Yin B. Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine 2020;25:100484. [PMID: 32838240 DOI: 10.1016/j.eclinm.2020.100484] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 50.5] [Reference Citation Analysis]
496 Jung F, Krüger-Genge A, Franke RP, Hufert F, Küpper JH. COVID-19 and the endothelium. Clin Hemorheol Microcirc 2020;75:7-11. [PMID: 32568187 DOI: 10.3233/CH-209007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 17.5] [Reference Citation Analysis]
497 Brizneda MV, Bansal A, Jain V, Kapadia S, Svensson LG, Menon V, Cremer P, Reed G, Rampersad P, Grimm R, Griffin BP, Xu B. Coronavirus disease and the cardiovascular system: a narrative review of the mechanisms of injury and management implications. Cardiovasc Diagn Ther 2021;11:939-53. [PMID: 34295715 DOI: 10.21037/cdt-20-779] [Reference Citation Analysis]
498 Sackner MA, Adams JA. Endothelial pulsatile shear stress is a backstop for COVID-19. Emerg Top Life Sci 2020;4:379-87. [PMID: 33200786 DOI: 10.1042/ETLS20200260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
499 Parks AL, Auerbach AD, Schnipper JL, Anstey JE, Sterken DG, Hecht TEH, Fang MC; Hospital Medicine Reengineering Network (HOMERuN). COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic. Thromb Res 2020;196:355-8. [PMID: 32977136 DOI: 10.1016/j.thromres.2020.09.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
500 Esposito A, Palmisano A, Toselli M, Vignale D, Cereda A, Rancoita PMV, Leone R, Nicoletti V, Gnasso C, Monello A, Biagi A, Turchio P, Landoni G, Gallone G, Monti G, Casella G, Iannopollo G, Nannini T, Patelli G, Di Mare L, Loffi M, Sergio P, Ippolito D, Sironi S, Pontone G, Andreini D, Mancini EM, Di Serio C, De Cobelli F, Ciceri F, Zangrillo A, Colombo A, Tacchetti C, Giannini F. Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy. Eur Radiol 2021;31:4031-41. [PMID: 33355697 DOI: 10.1007/s00330-020-07622-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
501 Ogawa M, Doo FX, Somwaru AS, Roudenko A, Kamath A, Friedman B. Peripheral arterial occlusion due to COVID-19: CT angiography findings of nine patients. Clin Imaging 2021;73:43-7. [PMID: 33307372 DOI: 10.1016/j.clinimag.2020.11.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
502 Mondal S, Quintili AL, Karamchandani K, Bose S. Thromboembolic disease in COVID-19 patients: A brief narrative review. J Intensive Care 2020;8:70. [PMID: 32939266 DOI: 10.1186/s40560-020-00483-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
503 Piro R, Casalini E, Livrieri F, Fontana M, Ghidoni G, Taddei S, Facciolongo N. Interventional pulmonology during COVID-19 pandemic: current evidence and future perspectives. J Thorac Dis 2021;13:2495-509. [PMID: 34012596 DOI: 10.21037/jtd-20-2192] [Reference Citation Analysis]
504 Kartsios C, Lokare A, Osman H, Perrin D, Razaq S, Ayub N, Daddar B, Fair S. Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants? J Thromb Thrombolysis 2021;51:947-52. [PMID: 32910408 DOI: 10.1007/s11239-020-02257-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
505 Piagnerelli M, Cauchie P, Vancutsem M, Thooft A, Zouaoui Boudjeltia K, Biston P, Wautrecht JC. Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor 2020;2:e0177. [PMID: 32766568 DOI: 10.1097/CCE.0000000000000177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
506 Fiscon G, Conte F, Farina L, Paci P. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLoS Comput Biol 2021;17:e1008686. [PMID: 33544720 DOI: 10.1371/journal.pcbi.1008686] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
507 Ahmed MH. Black and Minority Ethnic (BAME) Alliance Against COVID-19: One Step Forward. J Racial Ethn Health Disparities 2020;7:822-8. [PMID: 32789564 DOI: 10.1007/s40615-020-00837-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
508 Berkenblit G, O'Connell K, Mixter S, Dowd-Green C, Stewart RW. Postdischarge Evaluation for Individuals Hospitalized with COVID-19. South Med J 2022;115:13-7. [PMID: 34964054 DOI: 10.14423/SMJ.0000000000001346] [Reference Citation Analysis]
509 López-Otero D, López-Pais J, Antúnez-Muiños PJ, Cacho-Antonio C, González-Ferrero T, González-Juanatey JR. [Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry]. Rev Esp Cardiol 2021;74:105-8. [PMID: 32958975 DOI: 10.1016/j.recesp.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Kumar R, Lee MH, Mickael C, Kassa B, Pasha Q, Tuder R, Graham B. Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19. ERJ Open Res 2020;6:00405-2020. [PMID: 33313306 DOI: 10.1183/23120541.00405-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
511 Siddiqui F, Hoppensteadt D, Bontekoe E, Farooqui A, Jeske W, Fareed J. Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components. Clin Appl Thromb Hemost 2020;26:1076029620954913. [PMID: 33030036 DOI: 10.1177/1076029620954913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
512 Hashemi A, Madhavan MV, Bikdeli B. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19. Semin Thromb Hemost 2020;46:789-95. [PMID: 32820478 DOI: 10.1055/s-0040-1714273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
513 Siegal DM, Barnes GD, Langlois NJ, Lee A, Middeldorp S, Skeith L, Wood WA, Le Gal G. A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies. Blood Adv 2020;4:6259-73. [PMID: 33351119 DOI: 10.1182/bloodadvances.2020003269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
514 Çora AR, Çelik E, Karadem KB. Aortic Thrombosis in the Course of Covid-19 Disease; Two Rare Cases. Ann Vasc Surg 2021;73:119-21. [PMID: 33689757 DOI: 10.1016/j.avsg.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
515 Tung-Chen Y, Calderón R, Marcelo C, Deodati F, Mateos M, Castellano A, Álvarez B, Marco J, Ordieres L. Duplex Ultrasound Screening for Deep and Superficial Vein Thrombosis in COVID-19 Patients. J Ultrasound Med 2021. [PMID: 34342886 DOI: 10.1002/jum.15798] [Reference Citation Analysis]
516 Actis GC, Ribaldone DG, Fagoonee S, Pellicano R. COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence. Minerva Med 2021;112:144-52. [PMID: 33104300 DOI: 10.23736/S0026-4806.20.07054-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
517 Zelop CM, Bonney EA. COVID-19 in pregnancy: possible mechanisms not to be discounted. J Matern Fetal Neonatal Med 2020;:1-4. [PMID: 32811230 DOI: 10.1080/14767058.2020.1807508] [Reference Citation Analysis]
518 Hesam-Shariati S, Fatehi P, Abouzaripour M, Fathi F, Hesam-Shariati N, Hesam Shariati MB. Increased pulmonary embolism in patients with COVID-19: a case series and literature review. Trop Dis Travel Med Vaccines 2021;7:16. [PMID: 34118995 DOI: 10.1186/s40794-021-00145-3] [Reference Citation Analysis]
519 Sarkar M, Madabhavi IV, Quy PN, Govindagoudar MB. COVID-19 and coagulopathy. Clin Respir J 2021. [PMID: 34399021 DOI: 10.1111/crj.13438] [Reference Citation Analysis]
520 Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gómez-Arbeláez D, Ibarra G, Garcia-Gutierrez A. Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 2021;156:112-7. [PMID: 33521296 DOI: 10.1016/j.medcle.2020.10.008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
521 Pellicori P, Platz E, Dauw J, Ter Maaten JM, Martens P, Pivetta E, Cleland JGF, McMurray JJV, Mullens W, Solomon SD, Zannad F, Gargani L, Girerd N. Ultrasound imaging of congestion in heart failure: examinations beyond the heart. Eur J Heart Fail 2021;23:703-12. [PMID: 33118672 DOI: 10.1002/ejhf.2032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
522 Ansari Ramandi MM, Yarmohammadi H, Beikmohammadi S, Hosseiny Fahimi BH, Hatami F, Beydokhti H, Bakhshandeh H, Naderi N. Comparison of the cardiovascular presentations, complications and outcomes following different coronaviruses' infection: A systematic review. J Cardiovasc Thorac Res 2021;13:92-101. [PMID: 34326962 DOI: 10.34172/jcvtr.2021.29] [Reference Citation Analysis]
523 Abu-Farha M, Al-Sabah S, Hammad MM, Hebbar P, Channanath AM, John SE, Taher I, Almaeen A, Ghazy A, Mohammad A, Abubaker J, Arefanian H, Al-Mulla F, Thanaraj TA. Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism. Front Pharmacol 2020;11:587451. [PMID: 33362545 DOI: 10.3389/fphar.2020.587451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
524 Mesquita D, Carmo P, Cabanelas N, Santos N, Martins V, Sanfins V, Costa HC, Fontes JP, Fonseca P, Parreira L; Portuguese Association of Arrhythmology, Pacing and Electrophysiology (APAPE). Cardiac arrhythmias in patients presenting with COVID-19 treated in Portuguese hospitals: A national registry from the Portuguese Association of Arrhythmology, Pacing and Electrophysiology. Rev Port Cardiol 2021;40:573-80. [PMID: 33781608 DOI: 10.1016/j.repc.2020.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
525 Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021;17:731-48. [PMID: 34716418 DOI: 10.1038/s41584-021-00709-9] [Reference Citation Analysis]
526 Salamanna F, Maglio M, Landini MP, Fini M. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Platelets 2020;31:627-32. [PMID: 32397915 DOI: 10.1080/09537104.2020.1762852] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
527 Weichmann F, Rohdewald P. Projected supportive effects of Pycnogenol in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection. Int J Antimicrob Agents 2020;56:106191. [PMID: 33045354 DOI: 10.1016/j.ijantimicag.2020.106191] [Reference Citation Analysis]
528 Gungor B, Atici A, Baycan OF, Alici G, Ozturk F, Tugrul S, Asoglu R, Cevik E, Sahin I, Barman HA. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am J Emerg Med 2021;39:173-9. [PMID: 33069541 DOI: 10.1016/j.ajem.2020.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
529 Marchandot B, Trimaille A, Curtiaud A, Matsushita K, Jesel L, Morel O. Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic. J Thromb Thrombolysis 2020;50:799-808. [PMID: 32696172 DOI: 10.1007/s11239-020-02231-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
530 Cadd M, Nunn M. An A-E assessment of post-ICU COVID-19 recovery. J Intensive Care 2021;9:29. [PMID: 33743819 DOI: 10.1186/s40560-021-00544-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Kung S, Doppen M, Black M, Braithwaite I, Kearns C, Weatherall M, Beasley R, Kearns N. Underestimation of COVID-19 mortality during the pandemic. ERJ Open Res 2021;7:00766-2020. [PMID: 33614772 DOI: 10.1183/23120541.00766-2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
532 Gaetani E, Passali GC, Riccioni ME, Tortora A, Pola R, Costamagna G, Gasbarrini A; Multidisciplinary Gemelli Group for HHT. Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID-19 pandemic. J Thromb Haemost 2020;18:1799-801. [PMID: 32348627 DOI: 10.1111/jth.14885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
533 Lawrenson JG, Buckley RJ. COVID-19 and the eye. Ophthalmic Physiol Opt 2020;40:383-8. [PMID: 32627913 DOI: 10.1111/opo.12708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
534 Medjeral-Thomas NR, Thomson T, Ashby D, Muthusamy A, Nevin M, Duncan N, Loucaidou M. Cohort Study of Outpatient Hemodialysis Management Strategies for COVID-19 in North-West London. Kidney Int Rep 2020;5:2055-65. [PMID: 32864514 DOI: 10.1016/j.ekir.2020.08.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
535 Vrints CJM, Krychtiuk KA, Van Craenenbroeck EM, Segers VF, Price S, Heidbuchel H. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications. Acta Cardiol 2021;76:109-24. [PMID: 33208052 DOI: 10.1080/00015385.2020.1846921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
536 Qanadli SD, Gudmundsson L, Rotzinger DC. Catheter-directed thrombolysis in COVID-19 pneumonia with acute PE: Thinking beyond the guidelines. Thromb Res 2020;192:9-11. [PMID: 32416366 DOI: 10.1016/j.thromres.2020.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
537 Guéant JL, Guéant-Rodriguez RM, Fromonot J, Oussalah A, Louis H, Chery C, Gette M, Gleye S, Callet J, Raso J, Blanchecotte F, Lacolley P, Guieu R, Regnault V. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19. Allergy 2021;76:1846-58. [PMID: 33484168 DOI: 10.1111/all.14746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
538 Potì F, Pozzoli C, Adami M, Poli E, Costa LG. Treatments for COVID-19: emerging drugs against the coronavirus. Acta Biomed 2020;91:118-36. [PMID: 32420936 DOI: 10.23750/abm.v91i2.9639] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
539 Constant O, Barthelemy J, Bolloré K, Tuaillon E, Gosselet F, Chable-Bessia C, Merida P, Muriaux D, Van de Perre P, Salinas S, Simonin Y. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Front Immunol 2021;12:697329. [PMID: 34386007 DOI: 10.3389/fimmu.2021.697329] [Reference Citation Analysis]
540 Mazzone A, Castelnovo L, Tamburello A, Gatti A, Brando B, Faggioli P, Mumoli N. Monocytes could be a bridge from inflammation to thrombosis on COVID-19 injury: A case report. Thrombosis Update 2020;1:100007. [DOI: 10.1016/j.tru.2020.100007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
541 Gaisa M. COVID-19: A Call for Action, Collaboration, Reason, and Unity. Eur Urol Focus 2020;6:1026-7. [PMID: 32513520 DOI: 10.1016/j.euf.2020.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 Moschonas IC, Tselepis AD. SARS-CoV-2 infection and thrombotic complications: a narrative review. J Thromb Thrombolysis 2021;52:111-23. [PMID: 33449290 DOI: 10.1007/s11239-020-02374-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
543 Palaskas NL, Koutroumpakis E, Deswal A. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep 2020;22:171. [PMID: 33040241 DOI: 10.1007/s11886-020-01421-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
544 Launay M, Demartin AL, Ragey SP, Mismetti P, Botelho-Nevers E, Delavenne X. Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round. Ther Drug Monit 2021;43:455-8. [PMID: 33908408 DOI: 10.1097/FTD.0000000000000899] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
545 Bunch CM, Thomas AV, Stillson JE, Gillespie L, Khan RZ, Zackariya N, Shariff F, Al-Fadhl M, Mjaess N, Miller PD, McCurdy MT, Fulkerson DH, Miller JB, Kwaan HC, Moore EE, Moore HB, Neal MD, Martin PL, Kricheff ML, Walsh MM. Preventing Thrombohemorrhagic Complications of Heparinized COVID-19 Patients Using Adjunctive Thromboelastography: A Retrospective Study. J Clin Med 2021;10:3097. [PMID: 34300263 DOI: 10.3390/jcm10143097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319-29. [PMID: 33824483 DOI: 10.1038/s41577-021-00536-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 33.0] [Reference Citation Analysis]
547 Moreno G, Carbonell R, Bodí M, Rodríguez A. [Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients]. Med Intensiva (Engl Ed) 2021;45:42-55. [PMID: 32646669 DOI: 10.1016/j.medin.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
548 Mahajan K, Batra A. Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era. Indian Heart J 2020;72:209-11. [PMID: 32768026 DOI: 10.1016/j.ihj.2020.05.009] [Reference Citation Analysis]
549 Elgendy IY, Kolte D, Mansour MK, Sakhuja R, Elmariah S, Jaffer FA, Neilan TG, Januzzi JL, Weinberg I, Albaghdadi MS. Incidence, Predictors, and Outcomes of Thrombotic Events in Hospitalized Patients With Viral Pneumonia. Am J Cardiol 2021;143:164-5. [PMID: 33453170 DOI: 10.1016/j.amjcard.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
550 Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, Minville V, Sié P, Bura-Rivière A, Voisin S, Payrastre B. Thromboembolic events and Covid-19. Adv Biol Regul 2020;77:100735. [PMID: 32773098 DOI: 10.1016/j.jbior.2020.100735] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
551 Di Micco P, Imbalzano E, Russo V, Attena E, Mandaliti V, Orlando L, Lombardi M, Di Micco G, Camporese G, Annunziata S, Piccinocchi G, Pacelli W, Del Guercio M. Heparin and SARS-CoV-2: Multiple Pathophysiological Links. Viruses 2021;13:2486. [PMID: 34960754 DOI: 10.3390/v13122486] [Reference Citation Analysis]
552 Quesada-Gomez JM, Entrenas-Castillo M, Bouillon R. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166. J Steroid Biochem Mol Biol 2020;202:105719. [PMID: 32535032 DOI: 10.1016/j.jsbmb.2020.105719] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
553 Bhatnagar D. The COVID-19 pandemic: lifestyle and cardiovascular risk factors. Curr Opin Lipidol 2021;32:71-3. [PMID: 33315619 DOI: 10.1097/MOL.0000000000000725] [Reference Citation Analysis]
554 Pizzi R, Gini G, Caiano L, Castelli B, Dotan N, Magni F, Virano A, Roveda A, Bertù L, Ageno W. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency. Thromb Res 2020;196:209-12. [PMID: 32911392 DOI: 10.1016/j.thromres.2020.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
555 Prasad M, Leon M, Lerman LO, Lerman A. Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19. Mayo Clin Proc 2021;96:3099-108. [PMID: 34863398 DOI: 10.1016/j.mayocp.2021.06.027] [Reference Citation Analysis]
556 Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Bäck M. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116:2177-84. [PMID: 32750108 DOI: 10.1093/cvr/cvaa230] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 44.5] [Reference Citation Analysis]
557 Nelson M, Shi D, Gordon M, Chavda Y, Grimaldi C, Bajaj T. Where There's Smoke, There's Fire: A Case Report of Turbulent Blood Flow in Lower Extremity Point-of-care Ultrasound in COVID-19. Clin Pract Cases Emerg Med 2021;5:30-4. [PMID: 33560947 DOI: 10.5811/cpcem.2020.10.48809] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Tsikala Vafea M, Zhang R, Kalligeros M, Mylona EK, Shehadeh F, Mylonakis E. Mortality in mechanically ventilated patients with COVID-19: a systematic review. Expert Rev Med Devices 2021;18:457-71. [PMID: 33836621 DOI: 10.1080/17434440.2021.1915764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
559 Wong S, Payton JI, Lombana NF, Hanasono MM, Lee GK, Saint-Cyr M, Altman AM, Brooke SM. A Protocol for Safe Head and Neck Reconstructive Surgery in the COVID-19 Pandemic. Plast Reconstr Surg Glob Open 2020;8:e3258. [PMID: 33299720 DOI: 10.1097/GOX.0000000000003258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
560 Borczuk AC, Salvatore SP, Seshan SV, Patel SS, Bussel JB, Mostyka M, Elsoukkary S, He B, Del Vecchio C, Fortarezza F, Pezzuto F, Navalesi P, Crisanti A, Fowkes ME, Bryce CH, Calabrese F, Beasley MB. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol 2020;33:2156-68. [PMID: 32879413 DOI: 10.1038/s41379-020-00661-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 128] [Article Influence: 63.5] [Reference Citation Analysis]
561 Colling ME, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25:471-478. [PMID: 32558620 DOI: 10.1177/1358863x20932640] [Cited by in Crossref: 73] [Cited by in F6Publishing: 47] [Article Influence: 36.5] [Reference Citation Analysis]
562 Jiménez-Soto R, Aguilar-Soto M, Rodríguez-Toledo CA, Camiro-Zúñiga A, Demichelis R; ARMII Study Group. The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19. Thromb Res 2021;202:14-6. [PMID: 33711753 DOI: 10.1016/j.thromres.2021.02.031] [Reference Citation Analysis]
563 Chen EC, Zon RL, Battinelli EM, Connors JM. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review. Oncologist 2020;25:e1500-8. [PMID: 32881209 DOI: 10.1634/theoncologist.2020-0682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
564 Muhammad K, Tantawy TG, Makar RR, Olojugba O. Successful Catheter-Directed Thrombolysis for Acute Lower Limb Ischemia Secondary to COVID-19 Infection. Ann Vasc Surg 2021;71:103-11. [PMID: 33157249 DOI: 10.1016/j.avsg.2020.09.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
565 Degauque N, Haziot A, Brouard S, Mooney N. Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection. FASEB J 2021;35:e21577. [PMID: 33831263 DOI: 10.1096/fj.202100024R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
566 Verdoia M, De Luca G. Potential role of hypovitaminosis D and vitamin D supplementation during COVID-19 pandemic. QJM 2021;114:3-10. [PMID: 32735326 DOI: 10.1093/qjmed/hcaa234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
567 Davis PJ, Lin HY, Hercbergs A, Keating KA, Mousa SA. Coronaviruses and Integrin αvβ3: Does Thyroid Hormone Modify the Relationship? Endocr Res 2020;45:210-5. [PMID: 32628899 DOI: 10.1080/07435800.2020.1767127] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
568 Mohammadyari E, Ahmadi I, Mohammadyari A, Tavan H, Norozi S. The frequency of arrhythmias in COVID-19 patients, a study in the Shahid Mostafa Khomeini Hospital of Ilam from March to August 2020. New Microbes New Infect 2021;41:100867. [PMID: 33758669 DOI: 10.1016/j.nmni.2021.100867] [Reference Citation Analysis]
569 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J 2021:ehab697. [PMID: 34791154 DOI: 10.1093/eurheartj/ehab697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
570 Sia J. Dizziness can be an early sole clinical manifestation for COVID-19 infection: A case report. J Am Coll Emerg Physicians Open 2020. [PMID: 32838388 DOI: 10.1002/emp2.12185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
571 Abrams MP, Coromilas EJ, Wan EY, Rubin GA, Garan H, Dizon JM. Malignant ventricular arrhythmias in patients with severe acute respiratory distress syndrome due to COVID-19 without significant structural heart disease. HeartRhythm Case Rep 2020;6:858-62. [PMID: 32864335 DOI: 10.1016/j.hrcr.2020.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
572 Doyen D, Dupland P, Morand L, Fourrier E, Saccheri C, Buscot M, Hyvernat H, Ferrari E, Bernardin G, Cariou A, Mira JP, Jamme M, Dellamonica J, Jozwiak M. Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019. Chest 2021;159:1974-85. [PMID: 33129792 DOI: 10.1016/j.chest.2020.10.056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
573 Stogiannos N, Fotopoulos D, Woznitza N, Malamateniou C. COVID-19 in the radiology department: What radiographers need to know. Radiography (Lond) 2020;26:254-63. [PMID: 32532596 DOI: 10.1016/j.radi.2020.05.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
574 Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
575 Raskob GE, Spyropoulos AC, Spiro TE, Lu W, Yuan Z, Levitan B, Suh E, Barnathan ES. Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER. J Am Heart Assoc 2021;10:e021579. [PMID: 34755519 DOI: 10.1161/JAHA.121.021579] [Reference Citation Analysis]
576 Di Micco P, Tufano A, Cardillo G, Imbalzano E, Amitrano M, Lodigiani C, Bellizzi A, Camporese G, Cavalli A, De Stefano C, Russo V, Voza A, Perrella A, Prandoni P. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study. Viruses 2021;13:1720. [PMID: 34578301 DOI: 10.3390/v13091720] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. J Clin Med 2021;10:5381. [PMID: 34830660 DOI: 10.3390/jcm10225381] [Reference Citation Analysis]
578 Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clin Appl Thromb Hemost. 2020;26:1076029620938149. [PMID: 32677459 DOI: 10.1177/1076029620938149] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 45.0] [Reference Citation Analysis]
579 Capotosto L, Nguyen BL, Ciardi MR, Mastroianni C, Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography 2020;37:1454-64. [PMID: 32885490 DOI: 10.1111/echo.14834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
580 Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, García-García A, García-Fernández-Bravo I, Ji Z, de-Miguel-Diez J, Álvarez-Sala-Walther LA, Del-Toro-Cervera J, Galeano-Valle F. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res 2020;192:23-6. [PMID: 32405101 DOI: 10.1016/j.thromres.2020.05.018] [Cited by in Crossref: 155] [Cited by in F6Publishing: 143] [Article Influence: 77.5] [Reference Citation Analysis]
581 Zhou QA, Kato-Weinstein J, Li Y, Deng Y, Granet R, Garner L, Liu C, Polshakov D, Gessner C, Watkins S. Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections. ACS Pharmacol Transl Sci 2020;3:813-34. [PMID: 33062950 DOI: 10.1021/acsptsci.0c00074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
582 Ortega-Paz L, Galli M, Capodanno D, Franchi F, Rollini F, Bikdeli B, Mehran R, Montalescot G, Gibson CM, Lopes RD, Andreotti F, Angiolillo DJ. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother 2021:pvab070. [PMID: 34519777 DOI: 10.1093/ehjcvp/pvab070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
583 Schmid A, Petrovic M, Akella K, Pareddy A, Velavan SS. Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19. Int J Vasc Med 2021;2021:6693895. [PMID: 34035963 DOI: 10.1155/2021/6693895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
584 Shen L, Qiu L, Liu D, Wang L, Huang H, Ge H, Xiao Y, Liu Y, Jin J, Liu X, Wang DW, Peterson ED, He B, Zhou N. The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19. Cardiovasc Drugs Ther 2021. [PMID: 33394360 DOI: 10.1007/s10557-020-07133-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
585 Kottlors J, Zopfs D, Fervers P, Bremm J, Abdullayev N, Maintz D, Tritt S, Persigehl T. Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study. Eur J Radiol 2020;132:109274. [PMID: 32961451 DOI: 10.1016/j.ejrad.2020.109274] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
586 Stone R, Scheib S. Advantages of, and Adaptations to, Enhanced Recovery Protocols for Perioperative Care during the COVID-19 Pandemic. J Minim Invasive Gynecol 2021;28:481-9. [PMID: 33359742 DOI: 10.1016/j.jmig.2020.12.024] [Reference Citation Analysis]
587 Vannini L, Llanos Gómez JM, Quijada-Fumero A, Fernández Pérez AB, Hernández Afonso JS. COVID-19 quarantine and acute pulmonary embolism. Rev Esp Cardiol (Engl Ed) 2020;73:680-2. [PMID: 32513625 DOI: 10.1016/j.rec.2020.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
588 Usman AA, Han J, Acker A, Olia SE, Bermudez C, Cucchiara B, Mikkelsen ME, Wald J, Mackay E, Szeto W, Vernick WJ, Gutsche JT. A Case Series of Devastating Intracranial Hemorrhage During Venovenous Extracorporeal Membrane Oxygenation for COVID-19. J Cardiothorac Vasc Anesth 2020;34:3006-12. [PMID: 32828653 DOI: 10.1053/j.jvca.2020.07.063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
589 Zaidel EJ, Forsyth CJ, Novick G, Marcus R, Ribeiro ALP, Pinazo MJ, Morillo CA, Echeverría LE, Shikanai-Yasuda MA, Buekens P, Perel P, Meymandi SK, Ralston K, Pinto F, Sosa-Estani S. COVID-19: Implications for People with Chagas Disease. Glob Heart 2020;15:69. [PMID: 33150134 DOI: 10.5334/gh.891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
590 Parsi K, van Rij AM, Meissner MH, Davies AH, De Maeseneer M, Gloviczki P, Benson S, Bottini O, Manuel Canata V, Dinnen P, Gasparis A, Gianesini S, Huber D, Jenkins D, Lal BK, Kabnick L, Lim A, Marston W, Granados AM, Morrison N, Nicolaides A, Paraskevas P, Patel M, Roberts S, Rogan C, Schul MW, Komlos P, Stirling A, Thibault S, Varghese R, Welch HJ, Wittens CHA. Triage of patients with venous and lymphatic diseases during the COVID-19 pandemic - The Venous and Lymphatic Triage and Acuity Scale (VELTAS):: A consensus document of the International Union of Phlebology (UIP), Australasian College of Phlebology (ACP), American Vein and Lymphatic Society (AVLS), American Venous Forum (AVF), European College of Phlebology (ECoP), European Venous Forum (EVF), Interventional Radiology Society of Australasia (IRSA), Latin American Venous Forum, Pan-American Society of Phlebology and Lymphology and the Venous Association of India (VAI). J Vasc Surg Venous Lymphat Disord 2020;8:706-10. [PMID: 32426220 DOI: 10.1016/j.jvsv.2020.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
591 Yahalomi T, Pikkel J, Arnon R, Pessach Y. Central retinal vein occlusion in a young healthy COVID-19 patient: A case report. Am J Ophthalmol Case Rep 2020;20:100992. [PMID: 33225111 DOI: 10.1016/j.ajoc.2020.100992] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
592 Zaman S, MacIsaac AI, Jennings GL, Schlaich MP, Inglis SC, Arnold R, Kumar S, Thomas L, Wahi S, Lo S, Naismith C, Duffy SJ, Nicholls SJ, Newcomb A, Almeida AA, Wong S, Lund M, Chew DP, Kritharides L, Chow CK, Bhindi R. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement. Med J Aust 2020;213:182-7. [PMID: 32734645 DOI: 10.5694/mja2.50714] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 15.5] [Reference Citation Analysis]
593 Cardillo G, Viggiano GV, Russo V, Mangiacapra S, Cavalli A, Castaldo G, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Fontanella A, Di Micco P; FondenoxavidStudy Group. Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study. J Blood Med 2021;12:69-75. [PMID: 33603528 DOI: 10.2147/JBM.S285214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
594 Nakazawa D, Ishizu A. Immunothrombosis in severe COVID-19. EBioMedicine 2020;59:102942. [PMID: 32810824 DOI: 10.1016/j.ebiom.2020.102942] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
595 Constantinou C, Kolokotroni O, Mosquera MC, Heraclides A, Demetriou C, Karayiannis P, Quattrocchi A, Charalambous A. Developing a holistic contingency plan: Challenges and dilemmas for cancer patients during the COVID-19. Cancer Med 2020;9:6082-92. [PMID: 32687677 DOI: 10.1002/cam4.3271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
596 Sutandi N, Lee F. Vitreoretinal abnormalities in corona virus disease 2019 patients: What we know so far. Taiwan J Ophthalmol 2021;11:232-43. [PMID: 34703738 DOI: 10.4103/tjo.tjo_30_21] [Reference Citation Analysis]
597 Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, Rasouli L, Zetkulic M, Balani B, Ogedegbe C, Bawa H, Berrol L, Qureshi N, Aschner JL. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One 2020;15:e0243882. [PMID: 33306721 DOI: 10.1371/journal.pone.0243882] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 19.5] [Reference Citation Analysis]
598 Pasha AK, Rabinstein A, McBane RD 2nd. Pulmonary venous thrombosis in a patient with COVID-19 infection. J Thromb Thrombolysis 2021;51:985-8. [PMID: 33515360 DOI: 10.1007/s11239-021-02388-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
599 Alkhamis A, Alshamali Y, Alyaqout K, Lari E, Alkhamis MA, Althuwaini S, Lari A, Alfili M, Alkhayat A, Jamal MH, Alsabah S. Prevalence, predictors and outcomes of bleeding events in patients with COVID-19 infection on anticoagulation: Retrospective cohort study. Ann Med Surg (Lond) 2021;68:102567. [PMID: 34306676 DOI: 10.1016/j.amsu.2021.102567] [Reference Citation Analysis]
600 Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci 2020;21:E5168. [PMID: 32708334 DOI: 10.3390/ijms21145168] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 20.0] [Reference Citation Analysis]
601 Baccellieri D, Bertoglio L, Apruzzi L, Ardita V, D'Angelo A, Bossi M, Rinaldi E, Bilman V, Calvisi S, Castagna A, Galli L, Landoni G, Melissano G, Querini PR, Tresoldi M, De Cobelli F, Zangrillo A, Ciceri F, Chiesa R. Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak. Phlebology 2021;36:375-83. [PMID: 33241746 DOI: 10.1177/0268355520975592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
602 Indes JE, Koleilat I, Hatch AN, Choinski K, Jones DB, Aldailami H, Billett H, Denesopolis JM, Lipsitz E. Early experience with arterial thromboembolic complications in patients with COVID-19. J Vasc Surg 2021;73:381-389.e1. [PMID: 32861865 DOI: 10.1016/j.jvs.2020.07.089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
603 Sang CJ 3rd, Burkett A, Heindl B, Litovsky SH, Prabhu SD, Benson PV, Rajapreyar I. Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovasc Pathol 2021;54:107370. [PMID: 34273507 DOI: 10.1016/j.carpath.2021.107370] [Reference Citation Analysis]
604 Shi J, Xiao Y, Zhang Y, Geng D, Cong D, Shi KX, Knapp RJ. Challenges of drug development during the COVID-19 pandemic: Key considerations for clinical trial designs. Br J Clin Pharmacol 2021;87:2170-85. [PMID: 33119136 DOI: 10.1111/bcp.14629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
605 Long A, Grimaldo F. The authors' response to "A more realistic relationship between covid 19 and hemopneumothorax". Am J Emerg Med 2020;38:2219. [PMID: 32948395 DOI: 10.1016/j.ajem.2020.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
606 Vidali S, Morosetti D, Cossu E, Luisi MLE, Pancani S, Semeraro V, Consales G. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res 2020;6:00260-2020. [PMID: 32685436 DOI: 10.1183/23120541.00260-2020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
607 Sagris M, Theofilis P, Antonopoulos AS, Tsioufis C, Oikonomou E, Antoniades C, Crea F, Kaski JC, Tousoulis D. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int J Mol Sci 2021;22:6607. [PMID: 34205487 DOI: 10.3390/ijms22126607] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
608 Kumar A, Narayan RK, Kumari C, Faiq MA, Kulandhasamy M, Kant K, Pareek V. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients. Med Hypotheses 2020;145:110320. [PMID: 33032170 DOI: 10.1016/j.mehy.2020.110320] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
609 Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020;50:54-67. [PMID: 32415579 DOI: 10.1007/s11239-020-02134-3] [Cited by in Crossref: 222] [Cited by in F6Publishing: 204] [Article Influence: 111.0] [Reference Citation Analysis]
610 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
611 Tan JY, Tan CW, Wong WH, Cheong MA, Lee LH, Kalimuddin S, Low JGH, Ng HJ. Post-hospitalization venous thromboembolism in COVID-19 patients: Evidence against routine post-hospitalization prophylactic anticoagulation. Int J Lab Hematol 2021. [PMID: 34146452 DOI: 10.1111/ijlh.13633] [Reference Citation Analysis]
612 Tan L, Lin ZC, Ray J, Wesselingh R, Oxley TJ, McFadyen J, Kapoor M, Hutton E. Neurological implications of COVID-19: a review of the science and clinical guidance. BMJ Neurol Open 2020;2:e000101. [PMID: 33681805 DOI: 10.1136/bmjno-2020-000101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
613 Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Gero M, Serrano A, Marcos P. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection. Rev Esp Anestesiol Reanim (Engl Ed) 2020;67:391-9. [PMID: 32591185 DOI: 10.1016/j.redar.2020.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
614 Richard SA, Pollett SD, Lanteri CA, Millar EV, Fries AC, Maves RC, Utz GC, Lalani T, Smith A, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Lindholm DA, Madar C, Chi S, Huprikar N, Larson DT, Bazan SE, English C, Parmelee E, Mende K, Laing ED, Broder CC, Blair PW, Chenoweth JG, Simons MP, Tribble DR, Agan BK, Burgess TH; EPICC COVID-19 Cohort Study Group . COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment. Open Forum Infect Dis 2021;8:ofab556. [PMID: 34909439 DOI: 10.1093/ofid/ofab556] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
615 White TG, Martinez G, Wang J, Gribko M, Boltyenkov A, Arora R, Katz JM, Woo HH, Sanelli PC. Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Presentation, Treatment, and Outcomes. Stroke Res Treat 2021;2021:8653396. [PMID: 34336181 DOI: 10.1155/2021/8653396] [Reference Citation Analysis]
616 Flumignan RL, Tinôco JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev 2020;10:CD013739. [PMID: 33502773 DOI: 10.1002/14651858.CD013739] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
617 Harari R, Bangalore S, Chang E, Shah B. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock. Catheter Cardiovasc Interv 2021;97:E661-6. [PMID: 32427416 DOI: 10.1002/ccd.28992] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
618 Benito N, Filella D, Mateo J, Fortuna AM, Gutierrez-Alliende JE, Hernandez N, Gimenez AM, Pomar V, Castellvi I, Corominas H, Casademont J, Domingo P. Pulmonary Thrombosis or Embolism in a Large Cohort of Hospitalized Patients With Covid-19. Front Med (Lausanne) 2020;7:557. [PMID: 32984388 DOI: 10.3389/fmed.2020.00557] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
619 Arabadjian ME, Reuter MC, Stepanovic A, Sherrid MV, Massera D. COVID-19 in Adults With Hypertrophic Cardiomyopathy. Front Cardiovasc Med 2021;8:745790. [PMID: 34859067 DOI: 10.3389/fcvm.2021.745790] [Reference Citation Analysis]
620 Sparr SA, Bieri PL. Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time. Stroke 2020;51:e223-6. [PMID: 32684144 DOI: 10.1161/STROKEAHA.120.030434] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
621 Rezaeian N, Hosseini L, Asadian S. Cardiac magnetic resonance findings in coronavirus disease 2019. Clin Case Rep 2021. [PMID: 33821185 DOI: 10.1002/ccr3.3972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
622 McBride JD, Narang J, Simonds R, Agrawal S, Rodriguez ER, Tan CD, Baldwin WM, Dvorina N, Krywanczyk AR, Fernandez AP. Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course. J Cutan Pathol 2021;48:1166-72. [PMID: 33931901 DOI: 10.1111/cup.14038] [Reference Citation Analysis]
623 Fiorini NB, Garagoli F, Bustamante RC, Pizarro R. Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report. Eur Heart J Case Rep 2021;5:ytaa563. [PMID: 33521514 DOI: 10.1093/ehjcr/ytaa563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
624 Hosoda T, Orikasa H. A fatal case of extensive gastrointestinal necrosis due to portal and mesenteric vein thrombosis in the post-acute phase of COVID-19. J Infect Chemother 2022;28:108-11. [PMID: 34711507 DOI: 10.1016/j.jiac.2021.10.015] [Reference Citation Analysis]
625 Costa A, Weinstein ES, Sahoo DR, Thompson SC, Faccincani R, Ragazzoni L. How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients. Disaster Med Public Health Prep 2020;14:391-405. [PMID: 32613929 DOI: 10.1017/dmp.2020.195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
626 Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Drugs 2020;80:1383-96. [PMID: 32705604 DOI: 10.1007/s40265-020-01365-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
627 Tu TM, Seet CYH, Koh JS, Tham CH, Chiew HJ, De Leon JA, Chua CYK, Hui AC, Tan SSY, Vasoo SS, Tan BY, Umapathi NT, Tambyah PA, Yeo LLL. Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men. JAMA Netw Open 2021;4:e217498. [PMID: 33885771 DOI: 10.1001/jamanetworkopen.2021.7498] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
628 Hsieh YC. Editorial to "Atrial fibrillation and the risk of 30-day incident thromboembolic events and mortality in adults ≥50 years with COVID-19". J Arrhythm 2020. [PMID: 33362884 DOI: 10.1002/joa3.12477] [Reference Citation Analysis]
629 Dirican A, Ildir S, Uzar T, Karaman I, Ozkaya S. The role of endotheliitis in COVID-19: Real-world experience of 11 190 patients and literature review for a pathophysiological map to clinical categorisation. Int J Clin Pract 2021;75:e14843. [PMID: 34519155 DOI: 10.1111/ijcp.14843] [Reference Citation Analysis]
630 Task Force for the management of COVID-19 of the European Society of Cardiology . European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Eur Heart J 2021:ehab696. [PMID: 34791157 DOI: 10.1093/eurheartj/ehab696] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
631 Bussani R, Schneider E, Zentilin L, Collesi C, Ali H, Braga L, Volpe MC, Colliva A, Zanconati F, Berlot G, Silvestri F, Zacchigna S, Giacca M. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 2020;61:103104. [PMID: 33158808 DOI: 10.1016/j.ebiom.2020.103104] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 39.5] [Reference Citation Analysis]
632 McCarthy CP, Murphy S, Jones-O'Connor M, Olshan DS, Khambhati JR, Rehman S, Cadigan JB, Cui J, Meyerowitz EA, Philippides G, Friedman LS, Kadar AY, Hibbert K, Natarajan P, Massaro AF, Bohula EA, Morrow DA, Woolley AE, Januzzi JL Jr, Wasfy JH. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine 2020;26:100504. [PMID: 32838244 DOI: 10.1016/j.eclinm.2020.100504] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
633 Singh B, Kaur P, Reid RJ, Shamoon F, Bikkina M. COVID-19 and Influenza Co-Infection: Report of Three Cases.Cureus. 2020;12:e9852. [PMID: 32832306 DOI: 10.7759/cureus.9852] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
634 Siddiqui NA, Luvsannyam E, Jain MS, Abbas M, Jayaraman A, Zhuleku R, Ullah N, Corona A, Hussain MT. Acute Limb Ischemia Complicated by Heparin-Induced Thrombocytopenia in an Asymptomatic COVID-19 Patient. Cureus 2021;13:e16162. [PMID: 34367772 DOI: 10.7759/cureus.16162] [Reference Citation Analysis]
635 Montorfano L, Miret R, Rahman AU, Alonso M, Maron DJ, Roy M, Ferri F, Bejarano P, Wexner SD. Colorectal surgery obesity-related morbidity during COVID-19. Surg Obes Relat Dis 2020;16:1372-5. [PMID: 32723601 DOI: 10.1016/j.soard.2020.06.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
636 Tantisattamo E, Dafoe DC, Ferrey AJ, Ichii H, Lee RA, Zuckerman JE, Sisk AEJ, Farzaneh T, Guccione J, Kabutey NK, Kalantar-Zadeh K, Reddy UG. Kidney allograft infarction associated with transplant renal artery stenosis in a COVID-19 kidney transplant recipient. Clin Nephrol Case Stud 2021;9:93-104. [PMID: 34476173 DOI: 10.5414/CNCS110462] [Reference Citation Analysis]
637 Sahay S, Farber HW. Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection. Pulm Circ 2020;10:2045894020933480. [PMID: 32595934 DOI: 10.1177/2045894020933480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
638 Cormican DS, Winter D, McHugh S, Sonny A, Crowley J, Yu R, Barrack F, Núñez-Gil IJ, Ramakrishna H. Severe Acute Respiratory Syndrome Coronavirus-2 Cardiovascular Complications: Implications for Cardiothoracic Anesthesiology. J Cardiothorac Vasc Anesth 2021;35:932-43. [PMID: 32601001 DOI: 10.1053/j.jvca.2020.05.035] [Reference Citation Analysis]
639 Pathangey G, Fadadu PP, Hospodar AR, Abbas AE. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies. Am J Physiol Lung Cell Mol Physiol 2021;320:L301-30. [PMID: 33237815 DOI: 10.1152/ajplung.00259.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
640 Orsi FA, De Paula EV, Santos FO, Teruchkin MM, Campêlo DHC, Mello TT, Chindamo MC, Macedo AVS, Rocha AT, Ramacciotti E, Nascimento ACK, Annichino-Bizzacchi J, Lourenco DM, Guerra JCC, Rezende SM, Cavalheiro Filho C. Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy. Hematol Transfus Cell Ther 2020;42:300-8. [PMID: 32565232 DOI: 10.1016/j.htct.2020.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
641 Planquette B, Le Berre A, Khider L, Yannoutsos A, Gendron N, de Torcy M, Mohamedi N, Jouveshomme S, Smadja DM, Lazareth I, Goudot G, Fournier L, Bruel C, Diehl JL, Mourad JJ, Meyer G, Priollet P, Messas E, Sanchez O, Beaussier H, Mirault T, Zins M, Chatelier G, Emmerich J. Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. Thromb Res. 2021;197:94-99. [PMID: 33190025 DOI: 10.1016/j.thromres.2020.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
642 Lee KS, Talenfeld AD, Browne WF, Holzwanger DJ, Harnain C, Kesselman A, Pua BB. Role of interventional radiology in the treatment of COVID-19 patients: Early experience from an epicenter. Clin Imaging 2021;71:143-6. [PMID: 33259979 DOI: 10.1016/j.clinimag.2020.10.048] [Reference Citation Analysis]
643 Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, Carrera C, Andreu-Febrer C, Sanz-Beltran J, Riquelme-Mc Loughlin C, Riera-Monroig J, Combalia A, Bosch-Amate X, Morgado-Carrasco D, Pigem R, Toll-Abelló A, Martí-Martí I, Rizo-Potau D, Serra-García L, Alamon-Reig F, Iranzo P, Almuedo-Riera A, Muñoz J, Puig S, Mascaró JM Jr. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. J Clin Med 2020;9:E3261. [PMID: 33053817 DOI: 10.3390/jcm9103261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
644 Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord 2021;9:23-35. [PMID: 32916371 DOI: 10.1016/j.jvsv.2020.08.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
645 Mestre-Gómez B, Lorente-Ramos RM, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, Saez-Vaquero T, Torres-Macho J, Abad-Motos A, Cortina-Camarero C, Such-Diaz A, Ruiz-Velasco E, Churruca-Sarasqueta J, Muñoz-Rivas N; Infanta Leonor Thrombosis Research Group. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis 2021;51:40-6. [PMID: 32613385 DOI: 10.1007/s11239-020-02190-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 27.0] [Reference Citation Analysis]
646 Anthi A, Konstantonis D, Theodorakopoulou M, Apostolopoulou O, Karampela I, Konstantopoulou G, Patsilinakou S, Armaganidis A, Dimopoulos G. A Severe COVID-19 Case Complicated by Right Atrium Thrombus. Am J Case Rep 2020;21:e926915. [PMID: 32963216 DOI: 10.12659/AJCR.926915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
647 Brem FL, Missaoui Z, Arghal M, Rasras H, Aichouni N, Skiker I, Ouafi NE, Zakaria B. Late-onset of pulmonary embolism following hospitalization for COVID-19 despite thromboprophylaxis: a report of two cases. Pan Afr Med J 2021;38:226. [PMID: 34046131 DOI: 10.11604/pamj.2021.38.226.28503] [Reference Citation Analysis]
648 Asadian S, Hosseini L, Maadani M, Jahanshahi B, Rezaeian N. Two Challenging Cases with COVID heart. Clin Case Rep 2021;9:241-5. [PMID: 33489167 DOI: 10.1002/ccr3.3506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
649 [DOI: 10.1101/2020.05.30.20117929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
650 Oliva A, Cammisotto V, Cangemi R, Ferro D, Miele MC, De Angelis M, Cancelli F, Pignatelli P, Venditti M, Pugliese F, Mastroianni CM, Violi F. Low-Grade Endotoxemia and Thrombosis in COVID-19. Clin Transl Gastroenterol 2021;12:e00348. [PMID: 34092777 DOI: 10.14309/ctg.0000000000000348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
651 Imoto W, Kaga S, Noda T, Oshima K, Mizobata Y, Kakeya H. Coronavirus disease with multiple infarctions. QJM 2020;113:907-8. [PMID: 33000142 DOI: 10.1093/qjmed/hcaa240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
652 Bieksiene K, Zaveckiene J, Malakauskas K, Vaguliene N, Zemaitis M, Miliauskas S. Post COVID-19 Organizing Pneumonia: The Right Time to Interfere. Medicina (Kaunas) 2021;57:283. [PMID: 33803690 DOI: 10.3390/medicina57030283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
653 Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res 2020;8:37. [PMID: 32879731 DOI: 10.1186/s40364-020-00217-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
654 Berman JP, Abrams MP, Kushnir A, Rubin GA, Ehlert F, Biviano A, Morrow JP, Dizon J, Wan EY, Yarmohammadi H, Waase MP, Rubin DA, Garan H, Saluja D. Cardiac electrophysiology consultative experience at the epicenter of the COVID-19 pandemic in the United States. Indian Pacing Electrophysiol J 2020;20:250-6. [PMID: 32861812 DOI: 10.1016/j.ipej.2020.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
655 Frazer JS, Tyrynis Everden AJ. Emerging patterns of hypercoagulability associated with critical COVID-19: A review. Trends in Anaesthesia and Critical Care 2020;34:4-13. [DOI: 10.1016/j.tacc.2020.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
656 Kar S, Mottamal M, Al-Horani RA. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia. ChemistryOpen 2020;9:1161-72. [PMID: 33204588 DOI: 10.1002/open.202000277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
657 Ali MAM, Spinler SA. COVID-19 and thrombosis: From bench to bedside. Trends Cardiovasc Med 2021;31:143-60. [PMID: 33338635 DOI: 10.1016/j.tcm.2020.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
658 Tatooles AJ, Mustafa AK, Joshi DJ, Pappas PS. Extracorporeal Membrane Oxygenation with Right Ventricular Support in COVID-19 patients with severe ARDS. JTCVS Open 2021. [PMID: 34746873 DOI: 10.1016/j.xjon.2021.10.054] [Reference Citation Analysis]
659 Lukaszewicz K, Hillegass E, Puthoff ML, MacPhedran AK. Clinical Update for Physical Therapists: Coagulopathy and COVID-19. Phys Ther 2020;100:2127-33. [PMID: 32914188 DOI: 10.1093/ptj/pzaa157] [Reference Citation Analysis]
660 Kumar P, Mediwake R, Rhead C. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19. Br J Hosp Med 2020;81:1-2. [DOI: 10.12968/hmed.2020.0210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
661 Abeysekera KW, Karteszi H, Clark A, Gordon FH. Spontaneous portomesenteric thrombosis in a non-cirrhotic patient with SARS-CoV-2 infection. BMJ Case Rep 2020;13:e238906. [PMID: 33371000 DOI: 10.1136/bcr-2020-238906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
662 Coutrot M, Delrue M, Joly BS, Siguret V. Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report. Eur Heart J Case Rep 2021;5:ytab206. [PMID: 34104863 DOI: 10.1093/ehjcr/ytab206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
663 Frattini S, Maccagni G, Italia L, Metra M, Danzi GB. Coronavirus disease 2019 and cardiovascular implications. J Cardiovasc Med (Hagerstown) 2020;21:725-32. [PMID: 32858623 DOI: 10.2459/JCM.0000000000001068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
664 Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, Terry M, Jacobson CA, Wrijil L, Ducat S, Brook OR, Miller AD, Porto M, Pellegrini KL, Pino M, Hoang TN, Chandrashekar A, Patel S, Stephenson K, Bosinger SE, Andersen H, Lewis MG, Hecht JL, Sorger PK, Martinot AJ, Estes JD, Barouch DH. Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques. Cell 2020;183:1354-1366.e13. [PMID: 33065030 DOI: 10.1016/j.cell.2020.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 22.0] [Reference Citation Analysis]
665 Gong X, Kang S, Guo X, Li Y, Gao H, Yuan Y. Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19. BMC Infect Dis 2021;21:549. [PMID: 34112084 DOI: 10.1186/s12879-021-06282-6] [Reference Citation Analysis]
666 Hasan SA, Haque A, Nazir F. Acute Limb Ischemia: A Rare Complication of COVID-19. Cureus 2020;12:e11488. [PMID: 33335817 DOI: 10.7759/cureus.11488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
667 Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes. Chest 2020;158:1397-408. [PMID: 32553536 DOI: 10.1016/j.chest.2020.06.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 85] [Article Influence: 36.0] [Reference Citation Analysis]
668 Kasirajan K. Acute upper extremity ischemia and symptomatic popliteal artery aneurysm secondary to coronavirus disease 2019. J Vasc Surg Cases Innov Tech 2021;7:267-70. [PMID: 33681541 DOI: 10.1016/j.jvscit.2021.02.009] [Reference Citation Analysis]
669 Patell R, Chiasakul T, Bauer E, Zwicker JI. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis. Thromb Haemost 2021;121:76-85. [PMID: 33378787 DOI: 10.1055/s-0040-1721664] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
670 Rivera-Caravaca JM, Núñez-Gil IJ, Vivas D, Viana-Llamas MC, Uribarri A, Becerra-Muñoz VM, Trabattoni D, Fernández Rozas I, Feltes G, López-Pais J, El-Battrawy I, Macaya C, Fernandez-Ortiz A, Estrada V, Marín F; HOPE COVID-19 Investigators. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19. Eur J Clin Invest 2021;51:e13436. [PMID: 33080051 DOI: 10.1111/eci.13436] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
671 Jain U. Effect of COVID-19 on the Organs. Cureus 2020;12:e9540. [PMID: 32905500 DOI: 10.7759/cureus.9540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
672 Massey PR, Jones KM. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic. Semin Oncol 2020;47:330-4. [PMID: 32736881 DOI: 10.1053/j.seminoncol.2020.05.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
673 Talasaz AH, Sadeghipour P, Kakavand H, Aghakouchakzadeh M, Kordzadeh-Kermani E, Van Tassell BW, Gheymati A, Ariannejad H, Hosseini SH, Jamalkhani S, Sholzberg M, Monreal M, Jimenez D, Piazza G, Parikh SA, Kirtane AJ, Eikelboom JW, Connors JM, Hunt BJ, Konstantinides SV, Cushman M, Weitz JI, Stone GW, Krumholz HM, Lip GYH, Goldhaber SZ, Bikdeli B. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;77:1903-21. [PMID: 33741176 DOI: 10.1016/j.jacc.2021.02.035] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
674 Talmor G, Grube JG, Eloy JA, Liu JK, Hsueh WD. Nasoseptal Flap Necrosis After Endoscopic Skull Base Surgery in the Setting of COVID-19 Pandemic. World Neurosurg 2020;140:374-7. [PMID: 32479908 DOI: 10.1016/j.wneu.2020.05.237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
675 Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, Cody MJ, Manne BK, Portier I, Harris ES, Petrey AC, Beswick EJ, Caulin AF, Iovino A, Abegglen LM, Weyrich AS, Rondina MT, Egeblad M, Schiffman JD, Yost CC. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 2020;136:1169-79. [PMID: 32597954 DOI: 10.1182/blood.2020007008] [Cited by in Crossref: 317] [Cited by in F6Publishing: 341] [Article Influence: 158.5] [Reference Citation Analysis]
676 Ruocco G, McCullough PA, Tecson KM, Mancone M, De Ferrari GM, D'Ascenzo F, De Rosa FG, Paggi A, Forleo G, Secco GG, Pistis G, Monticone S, Vicenzi M, Rota I, Blasi F, Pugliese F, Fedele F, Palazzuoli A. Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection. Am J Cardiol 2020;137:111-7. [PMID: 32991860 DOI: 10.1016/j.amjcard.2020.09.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
677 Ladani AP, Loganathan M, Kolikonda MK, Lippmann S. COVID-19 Legacy. South Med J 2021;114:751-9. [PMID: 34853850 DOI: 10.14423/SMJ.0000000000001337] [Reference Citation Analysis]
678 Rodriguez-Cubillo B, de la Higuera MAM, Lucena R, Franci EV, Hurtado M, Romero NC, Moreno AR, Valencia D, Velo M, Fornie IS, Sanchez-Fructuoso AI. Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2? Am J Transplant 2020;20:3173-81. [PMID: 32529737 DOI: 10.1111/ajt.16141] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 16.5] [Reference Citation Analysis]
679 Sebuhyan M, Mirailles R, Crichi B, Frere C, Bonnin P, Bergeron-Lafaurie A, Denis B, Liegeon G, Peyrony O, Farge D; Saint-Louis CORE (COVID-19 RESEARCH) group. How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units. J Med Vasc 2020;45:334-43. [PMID: 33248536 DOI: 10.1016/j.jdmv.2020.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
680 Pozzi N, Zuckerman A, Son J, Geraci TC, Chang SH, Cerfolio RJ. Managing Scarcity: Innovation and Resilience During the COVID-19 Pandemic. Front Surg 2021;8:769962. [PMID: 34722628 DOI: 10.3389/fsurg.2021.769962] [Reference Citation Analysis]
681 Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, Matin S, Amin A, Parhizgar SE, Jimenez D, Gupta A, Madhavan MV, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Mohebbi B, Piazza G, Kirtane AJ, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res 2020;196:382-94. [PMID: 32992075 DOI: 10.1016/j.thromres.2020.09.027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
682 Long B, Gottlieb M. Higher-dose versus standard-dose prophylactic anticoagulation in hospitalized patients with COVID-19. Acad Emerg Med 2021. [PMID: 34779548 DOI: 10.1111/acem.14417] [Reference Citation Analysis]
683 Cooper SL, Boyle E, Jefferson SR, Heslop CRA, Mohan P, Mohanraj GGJ, Sidow HA, Tan RCP, Hill SJ, Woolard J. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID. Int J Mol Sci 2021;22:8255. [PMID: 34361021 DOI: 10.3390/ijms22158255] [Reference Citation Analysis]
684 Abdulrahman A, Hussain T, Nawaz S, AlShaikh S, Almadani A, Bardooli F. Is Atrial Fibrillation a Risk Factor for Worse Outcomes in Severe COVID-19 Patients: A Single Center Retrospective Cohort. J Saudi Heart Assoc 2021;33:160-8. [PMID: 34285872 DOI: 10.37616/2212-5043.1255] [Reference Citation Analysis]
685 Shahzamani K, Mahmoudian F, Ahangarzadeh S, Ranjbar MM, Beikmohammadi L, Bahrami S, Mohammadi E, Esfandyari S, Alibakhshi A, Javanmard SH. Vaccine design and delivery approaches for COVID-19. Int Immunopharmacol 2021;100:108086. [PMID: 34454291 DOI: 10.1016/j.intimp.2021.108086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
686 Martin AC, Godier A, Karam N. Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection. J Am Coll Cardiol 2021;77:104. [PMID: 33413932 DOI: 10.1016/j.jacc.2020.08.090] [Reference Citation Analysis]
687 Manolis AS, Manolis TA, Manolis AA, Papatheou D, Melita H. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management. J Cardiovasc Pharmacol Ther 2021;26:12-24. [PMID: 32924567 DOI: 10.1177/1074248420958973] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
688 Bikdeli B, Jiménez D, Del Toro J, Piazza G, Rivas A, Fernández-Reyes JL, Sampériz Á, Otero R, Suriñach JM, Siniscalchi C, Martín-Guerra JM, Castro J, Muriel A, Lip GYH, Goldhaber SZ, Monreal M; RIETE Investigators †. Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism. J Am Heart Assoc 2021;10:e021467. [PMID: 34459215 DOI: 10.1161/JAHA.121.021467] [Reference Citation Analysis]
689 Ekici Gok Z, Gok A, Acun Delen L, Kasapoglu US, Gurbuz E, Mutlu K. Evaluation of eye care and ocular findings in critically ill COVID-19 patients. Int J Clin Pract 2021;:e14909. [PMID: 34553470 DOI: 10.1111/ijcp.14909] [Reference Citation Analysis]
690 Borrelli MP, Buora A, Scrivere P, Sponza M, Frigatti P. Arterial Thrombotic Sequalae After Covid-19: Mind the Gap. Ann Vasc Surg 2021;75:128-35. [PMID: 33940162 DOI: 10.1016/j.avsg.2021.04.009] [Reference Citation Analysis]
691 Tritschler T, Mathieu M, Skeith L, Rodger M, Middeldorp S, Brighton T, Sandset PM, Kahn SR, Angus DC, Blondon M, Bonten MJ, Cattaneo M, Cushman M, Derde LPG, Desancho MT, Diehl J, Goligher E, Jilma B, Jüni P, Lawler PR, Marietta M, Marshall JC, Mcarthur C, Miranda CH, Mirault T, Morici N, Perepu U, Schörgenhofer C, Sholzberg M, Spyropoulos AC, Webb SA, Zarychanski R, Zuily S, Le Gal G; for the International Network of VENous Thromboembolism Clinical Research Networks INVENT‐VTE. Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost 2020;18:2958-67. [DOI: 10.1111/jth.15094] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 20.0] [Reference Citation Analysis]
692 Hardy M, Lecompte T, Douxfils J, Lessire S, Dogné JM, Chatelain B, Testa S, Gouin-Thibault I, Gruel Y, Medcalf RL, Ten Cate H, Lippi G, Mullier F. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J 2020;18:17. [PMID: 32922211 DOI: 10.1186/s12959-020-00230-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
693 Kumar S, Kumar A, Goel P, Vyas S, Baitha U, Wig N. Use of ultrasonography in COVID-19: Probing for success. J Family Med Prim Care. 2020;9:3863-3866. [PMID: 33110780 DOI: 10.4103/jfmpc.jfmpc_764_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
694 Khan M, Singh GK, Abrar S, Ganeshan R, Morgan K, Harky A. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opin Pharmacother 2021;:1-20. [PMID: 34464223 DOI: 10.1080/14656566.2021.1960311] [Reference Citation Analysis]
695 Massironi S, Viganò C, Dioscoridi L, Filippi E, Pagliarulo M, Manfredi G, Conti CB, Signorelli C, Redaelli AE, Bonato G, Iiritano E, Frego R, Zucchini N, Ungari M, Pedaci M, Bono F, Di Bella C, Buscarini E, Mutignani M, Penagini R, Dinelli ME, Invernizzi P. Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy.Clin Gastroenterol Hepatol. 2020;18:2375-2377. [PMID: 32480008 DOI: 10.1016/j.cgh.2020.05.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
696 Madala S, Krzyzak M, Dehghani S. Is COVID-19 an Independent Risk Factor for Heparin-Induced Thrombocytopenia? Cureus 2021;13:e13425. [PMID: 33758713 DOI: 10.7759/cureus.13425] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
697 Yarımoglu R, Yarımoglu S, Tastan H, Erkengel HI. Acute infrarenal abdominal aortic occlusion in a patient with COVID-19. Ann Saudi Med 2021;41:392-5. [PMID: 34873931 DOI: 10.5144/0256-4947.2021.392] [Reference Citation Analysis]
698 Jawaid Akhtar M. COVID19 inhibitors: A prospective therapeutics. Bioorg Chem 2020;101:104027. [PMID: 32629280 DOI: 10.1016/j.bioorg.2020.104027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
699 Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO). Eur Heart J Suppl 2021;23:C128-53. [PMID: 34456641 DOI: 10.1093/eurheartj/suab067] [Reference Citation Analysis]
700 Elkholy KO, Khizar A, Khan A, Hakobyan N, Sahni S. Subacute Stent Thrombosis in a Patient With COVID-19 Despite Adherence to Antiplatelets. Cureus 2021;13:e13194. [PMID: 33717736 DOI: 10.7759/cureus.13194] [Reference Citation Analysis]
701 Wijeratne T, Sales CA, Crewther SG, Nguyen V, Karimi L. First Australian Case of Good Recovery of a COVID-19 Patient With Severe Neurological Symptoms Post Prolonged Hospitalization. Cureus 2020;12:e10366. [PMID: 33062489 DOI: 10.7759/cureus.10366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
702 Rahimi L, Malek M, Ismail-Beigi F, Khamseh ME. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature. Adv Ther 2020;37:3450-62. [PMID: 32632851 DOI: 10.1007/s12325-020-01417-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
703 Çakır Edis E. Chronic Pulmonary Diseases and COVID-19. Turk Thorac J 2020;21:345-9. [PMID: 33031727 DOI: 10.5152/TurkThoracJ.2020.20091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
704 Siepmann T, Barlinn K. [Association of COVID-19 and Stroke: Pathophysiology and Clinical Relevance]. Fortschr Neurol Psychiatr 2021;89:289-95. [PMID: 34020462 DOI: 10.1055/a-1484-0224] [Reference Citation Analysis]
705 Gergi M, Goodwin A, Freeman K, Colovos C, Volod O. Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients: a practical guide for clinicians. Blood Coagul Fibrinolysis 2021;32:225-8. [PMID: 33443923 DOI: 10.1097/MBC.0000000000000999] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
706 Lopes RD, Fanaroff AC. Anticoagulation in COVID-19: It Is Time for High-Quality Evidence. J Am Coll Cardiol 2020;76:1827-9. [PMID: 33059827 DOI: 10.1016/j.jacc.2020.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
707 Nalbandian A, Sehgal K, Gupta A, Madhavan MV, Mcgroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-nigoghossian C, Liyanage-don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15. [DOI: 10.1038/s41591-021-01283-z] [Cited by in Crossref: 209] [Cited by in F6Publishing: 238] [Article Influence: 209.0] [Reference Citation Analysis]
708 Calabrese M, Garofano M, Palumbo R, Di Pietro P, Izzo C, Damato A, Venturini E, Iesu S, Virtuoso N, Strianese A, Ciccarelli M, Galasso G, Vecchione C. Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art. Life (Basel) 2021;11:259. [PMID: 33801080 DOI: 10.3390/life11030259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
709 Galland J, Thoreau B, Delrue M, Neuwirth M, Stepanian A, Chauvin A, Dellal A, Nallet O, Roriz M, Devaux M, London J, Martin-Lecamp G, Froissart A, Arab N, Ferron B, Groff MH, Queyrel V, Lorut C, Regard L, Berthoux E, Bayer G, Comarmond C, Lioger B, Mekinian A, Szwebel TA, Sené T, Amador-Boreiro B, Mangin O, Sellier PO, Mouly S, Kevorkian JP, Siguret V, Vodovar D, Sene D; Lariboisière COVID Group. White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study. Eur J Haematol 2021;107:190-201. [PMID: 34288162 DOI: 10.1111/ejh.13638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
710 Santana MF, Frank CHM, Almeida TVR, Jeronimo CMP, de Araújo Pinto RA, Martins YF, de Farias MEL, Dutra BG, Brito-Sousa JD, Baía-da-Silva DC, Xavier MS, Lacerda MVG, Almeida Val FF, Monteiro GC, Sampaio VS, Monteiro WM, Ferreira LCL. Hemorrhagic and thrombotic manifestations in the central nervous system in COVID-19: A large observational study in the Brazilian Amazon with a complete autopsy series. PLoS One 2021;16:e0255950. [PMID: 34506501 DOI: 10.1371/journal.pone.0255950] [Reference Citation Analysis]
711 Task Force for the management of COVID-19 of the European Society of Cardiology . European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Cardiovasc Res 2021:cvab342. [PMID: 34864874 DOI: 10.1093/cvr/cvab342] [Reference Citation Analysis]
712 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
713 Zamboni P. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers. Diagnostics (Basel) 2020;10:E440. [PMID: 32610564 DOI: 10.3390/diagnostics10070440] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
714 Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology 2021;162:30-43. [PMID: 32935333 DOI: 10.1111/imm.13262] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
715 Velasco-Rodríguez D, Alonso-Dominguez JM, Vidal Laso R, Lainez-González D, García-Raso A, Martín-Herrero S, Herrero A, Martínez Alfonzo I, Serrano-López J, Jiménez-Barral E, Nistal S, Pérez Márquez M, Askari E, Castillo Álvarez J, Núñez A, Jiménez Rodríguez Á, Heili-Frades S, Pérez-Calvo C, Górgolas M, Barba R, Llamas-Sillero P. Development and validation of a predictive model of in-hospital mortality in COVID-19 patients. PLoS One 2021;16:e0247676. [PMID: 33661939 DOI: 10.1371/journal.pone.0247676] [Reference Citation Analysis]
716 Gavioli EM, Sikorska G, Man A, Rana J, Vider E. Current Perspectives of Anticoagulation in Patients With COVID-19. J Cardiovasc Pharmacol 2020;76:146-50. [PMID: 32569013 DOI: 10.1097/FJC.0000000000000861] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
717 Wienbergen H, Retzlaff T, Schmucker J, Marin LAM, Rühle S, Garstka D, Osteresch R, Fach A, Hambrecht R. Impact of COVID-19 Pandemic on Presentation and Outcome of Consecutive Patients Admitted to Hospital Due to ST-Elevation Myocardial Infarction. Am J Cardiol 2021;151:10-4. [PMID: 34049671 DOI: 10.1016/j.amjcard.2021.04.011] [Reference Citation Analysis]
718 Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87. [PMID: 32653981 DOI: 10.1007/s11739-020-02432-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
719 Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, Bhatia C, Garrett D, Cotte C, Isaacs S, Gugerty E, Davidson A, Marder GS, Schnitzer A, Goldberg B, McGinn T, Davidson KW, Barish MA, Qiu M, Zhang M, Goldin M, Matsagkas M, Arnaoutoglou E, Spyropoulos AC. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood 2021;137:2838-47. [PMID: 33824972 DOI: 10.1182/blood.2020010529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
720 Komiyama M, Hasegawa K. Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness. Eur Cardiol 2020;15:e58. [PMID: 32944087 DOI: 10.15420/ecr.2020.24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
721 Verdoia M, Viglione F, Boggio A, Stefani D, Panarotto N, Malabaila A, Rolla R, Soldà PL, De Luca G; Novara Atherosclerosis Study Group (NAS). Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention. Vascul Pharmacol 2021;:106897. [PMID: 34274529 DOI: 10.1016/j.vph.2021.106897] [Reference Citation Analysis]
722 Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol 2020;16:1159-84. [PMID: 33356661 DOI: 10.1080/1744666X.2021.1847640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
723 Darwish HS, Habash MY, Habash WY. COVID-19 Viral Pneumonia Complicated with Acute Pulmonary Embolism: A Descriptive Study. Radiol Res Pract 2021;2021:6649086. [PMID: 33532097 DOI: 10.1155/2021/6649086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
724 Ly A, Alessandri C, Skripkina E, Meffert A, Clariot S, de Roux Q, Langeron O, Mongardon N. Rescue fibrinolysis in suspected massive pulmonary embolism during SARS-CoV-2 pandemic.